<SEC-DOCUMENT>0001553350-23-000210.txt : 20230329
<SEC-HEADER>0001553350-23-000210.hdr.sgml : 20230329
<ACCEPTANCE-DATETIME>20230328190009
ACCESSION NUMBER:		0001553350-23-000210
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20230323
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230329
DATE AS OF CHANGE:		20230328

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DUOS TECHNOLOGIES GROUP, INC.
		CENTRAL INDEX KEY:			0001396536
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		IRS NUMBER:				650493217
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39227
		FILM NUMBER:		23771286

	BUSINESS ADDRESS:	
		STREET 1:		7660 CENTURION PARKWAY
		STREET 2:		SUITE 100
		CITY:			JACKSONVILLE
		STATE:			FL
		ZIP:			32256
		BUSINESS PHONE:		904-296-2807

	MAIL ADDRESS:	
		STREET 1:		7660 CENTURION PARKWAY
		STREET 2:		SUITE 100
		CITY:			JACKSONVILLE
		STATE:			FL
		ZIP:			32256

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DUOS TECHNOLOGY GROUP, INC.
		DATE OF NAME CHANGE:	20150710

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INFORMATION SYSTEMS ASSOCIATES, INC.
		DATE OF NAME CHANGE:	20070416
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>duot_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:DUOT="http://duostech.com/20230323">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_037_DUOT_duostech.com_20230323 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20230323_20230323 -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0001396536 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:EntityCentralIndexKey">0001396536</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="duot-20230323.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-03-23to2023-03-23">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001396536</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-23</xbrli:startDate>
        <xbrli:endDate>2023-03-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 0.25pc solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES<br />
SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_908_edei--DocumentType_c20230323__20230323_zHz7sUHXAyth"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event reported):
<span id="xdx_906_edei--DocumentPeriodEndDate_c20230323__20230323_z3O239HSfg4e"> <ix:nonNumeric contextRef="From2023-03-23to2023-03-23" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">March 23, 2023</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 16pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90E_edei--EntityRegistrantName_c20230323__20230323_zA4y77qg0iF1"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:EntityRegistrantName">Duos Technologies Group, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Exact name of registrant as specified in its
charter)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 34%; text-align: center"><b><span id="xdx_90C_edei--EntityIncorporationStateCountryCode_c20230323__20230323_zIdi864Q3t3i"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Florida</ix:nonNumeric></span></b></td>
    <td style="width: 33%; text-align: center"><b><span id="xdx_90C_edei--EntityFileNumber_c20230323__20230323_zYSbEeGXyuu1"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:EntityFileNumber">001-39227</ix:nonNumeric></span></b></td>
    <td style="width: 33%; text-align: center"><b><span id="xdx_90E_edei--EntityTaxIdentificationNumber_c20230323__20230323_zFAAfTn1Oqzb"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:EntityTaxIdentificationNumber">65-0493217</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 8pt"><i>(State or Other Jurisdiction</i></span></td>
    <td style="text-align: center"><span style="font-size: 8pt"><i>(Commission</i></span></td>
    <td style="text-align: center"><span style="font-size: 8pt"><i>(I.R.S. Employer</i></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 8pt"><i>of Incorporation)</i></span></td>
    <td style="text-align: center"><span style="font-size: 8pt"><i>File Number)</i></span></td>
    <td style="text-align: center"><span style="font-size: 8pt"><i>Identification No.)</i></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_907_edei--EntityAddressAddressLine1_c20230323__20230323_zqkNBmg3n5il"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:EntityAddressAddressLine1">7660 Centurion Parkway</ix:nonNumeric></span>, <span id="xdx_90E_edei--EntityAddressAddressLine2_c20230323__20230323_z5rRVQ3NLhB3"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:EntityAddressAddressLine2">Suite 1000</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressCityOrTown_c20230323__20230323_zksyLxN4VUyd"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:EntityAddressCityOrTown">Jacksonville</ix:nonNumeric></span>,
<span id="xdx_906_edei--EntityAddressStateOrProvince_c20230323__20230323_zwWpTWc0mL09"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Florida</ix:nonNumeric></span> <span id="xdx_907_edei--EntityAddressPostalZipCode_c20230323__20230323_zYVK9gd9Xl39"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:EntityAddressPostalZipCode">32256</ix:nonNumeric></span></b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Address of Principal Executive Offices) (Zip
Code)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_907_edei--CityAreaCode_c20230323__20230323_zrAZqaPfCf3i"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:CityAreaCode">(904)</ix:nonNumeric></span> <span id="xdx_903_edei--LocalPhoneNumber_c20230323__20230323_zGCBKKU4niW6"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:LocalPhoneNumber">296-2807</ix:nonNumeric></span></b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Registrant&#8217;s telephone number, including
area code)</i></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0pc">Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0pc"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_901_edei--WrittenCommunications_c20230323__20230323_zT5WKbdS6wc4"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span>
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0pc"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_900_edei--SolicitingMaterial_c20230323__20230323_zqQTgBvSalck"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span>
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0pc"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_903_edei--PreCommencementTenderOffer_c20230323__20230323_zc0Wew3lsSFk"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span>
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0pc"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_90D_edei--PreCommencementIssuerTenderOffer_c20230323__20230323_zckONYIVLE9k"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span>
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 32%; text-align: center"><span style="font-size: 8pt"><b>Title of each class</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 32%; text-align: center"><span style="font-size: 8pt"><b>Trading Symbol(s)</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 32%; text-align: center"><span style="font-size: 8pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span id="xdx_909_edei--Security12bTitle_c20230323__20230323_z061FbEd8m3a"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:Security12bTitle">Common Stock (par value $0.001 per share)</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_906_edei--TradingSymbol_c20230323__20230323_zIms1ewibSsa"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:TradingSymbol">DUOT</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_90F_edei--SecurityExchangeName_c20230323__20230323_zIk350coITJe"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Emerging growth company <span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_906_edei--EntityEmergingGrowthCompany_c20230323__20230323_zQEw5tNLepZ1"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 0.25pc solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Item 1.01. Entry into a Material
Definitive Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">On March 27, 2023, Duos Technologies Group, Inc.
(the <span style="font-family: Arial Unicode MS,serif">&#8220;</span>Company<span style="font-family: Arial Unicode MS,serif">&#8221;</span>)
entered into a Securities Purchase Agreement (the <span style="font-family: Arial Unicode MS,serif">&#8220;</span>Purchase Agreement<span style="font-family: Arial Unicode MS,serif">&#8221;</span>)
with certain existing investors in the Company (the <span style="font-family: Arial Unicode MS,serif">&#8220;</span>Purchasers&#8221;).
Pursuant to the Purchase Agreement, the Purchasers purchased an aggregate of 4,000 shares of a
newly-authorized Series E Convertible Preferred Stock (the &#8220;Series E Preferred Stock&#8221;), and the Company received aggregate
proceeds of $4,000,000. The Series E Preferred Stock was sold at $1,000 a share.
The Purchase Agreement contains customary representations, warranties, agreements and indemnification rights and obligations of the parties. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Under the Purchase Agreement, the Company is
required to hold a meeting of shareholders at the earliest practical date, but in no event later than 120 days after closing (or 150
days in the event of a review of the proxy statement by the Securities and Exchange Commission (the &#8220;SEC&#8221;)). As
described below, the terms of the Series E Preferred Stock limit its convertibility until the Company receives shareholder
approval (the &#8220;Stockholder Approval&#8221;). &#160;If the Company does not obtain the Stockholder Approval at the first meeting,
it is required to hold shareholder meetings every four months until the Stockholder Approval is obtained.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Purchase Agreement also provides that the Company will not, with certain
exceptions, sell or issue common stock or Common Stock Equivalents (as defined in the Purchase Agreement) on or prior to December 31,
2023 that entitles any person to acquire shares of common stock at an effective price per share less than the then conversion price of
the Series E Preferred Stock without the consent of the Purchasers.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">In connection with the Purchase Agreement, the Company
also entered into a Registration Rights Agreement with the Purchasers. &#160;Pursuant to the Registration Rights Agreement, the Company
shall file with the SEC a registration statement covering the resale by the Purchasers of the shares of common stock into which the shares of Series E Preferred Stock are convertible. Subject to certain conditions,
the Company must cause the registration statement to be declared effective by 90 days after closing (or in the event of a full review
by the SEC, by 120 days). The Registration Rights Agreement contains customary representations, warranties, agreements and indemnification
rights and obligations of the parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The forgoing descriptions of the Purchase Agreement
and the Registration Rights Agreement do not purport to be complete and are subject to, and qualified in their entirety by, such documents,
forms of which are attached as exhibits to this Current Report on Form 8-K and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6.65pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Item 3.02 Unregistered Sales of Equity Securities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The information set forth in Item 1.01 of this Current
Report on Form 8-K is incorporated by reference into this Item 3.02.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The issuances of the shares of Series E Preferred Stock were not registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), but qualified
for an exemption under Section 4(a)(2) of the Securities Act and by Rule 506 of Regulation D promulgated thereunder as transactions by
an issuer not involving a public offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Item 3.03. Material Modification to Rights of Security Holders</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The information set forth in Item 1.01 of this Current
Report on Form 8-K is incorporated by reference into this Item 3.03.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">On March 23, 2023, the Company amended its
Certificate of Incorporation by filing the Certificate of Designation of Preferences, Rights and Limitations of Series E Convertible
Preferred Stock (the &#8220;Certificate of Designation&#8221;) with the Secretary of State of the State of Florida, which authorized
the Series E Preferred Stock with such preferences, rights and limitations as set forth in the Certificate of Designation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>General</i>. &#160;The Company&#8217;s Board of
Directors has designated 30,000 shares as the Series E Preferred Stock. &#160;Each share of the Series E Preferred Stock has a stated value
of $1,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Voting Rights</i>. &#160;The holders of the Series
E Preferred Stock, the holders of the common stock and the holders of any other class or series of shares entitled to vote with the common
stock shall vote together as one class on all matters submitted to a vote of shareholders of the Company. &#160;Each share of Series E
Preferred Stock has 333 votes (subject to adjustment); provided that in no event may
a holder of Series E Preferred Stock be entitled to vote a number of shares in excess of such holder&#8217;s Beneficial Ownership Limitation
(as defined in the Certificate of Designation and as described below).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Dividends</i>. &#160;There is no separate dividend
payable on the Series E Preferred Stock but holders of Series E Preferred Stock shall be entitled to receive dividends on shares of Series
E Preferred Stock equal (on an as-if-converted to common stock basis, without giving effect to the Beneficial Ownership Limitation) to
and in the same form as dividends actually paid on shares of common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Conversion</i>. &#160;Each share of Series E Preferred
Stock is convertible, at any time and from time to time, at the option of the holder, into that number of shares of common stock (subject
to the Beneficial Ownership Limitation) determined by dividing the stated value of such share ($1,000) by the conversion price, which
is $3.00 (subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Beneficial Ownership Limitation</i>. &#160;The
Company shall not effect any conversion of the Series E Preferred Stock, and a holder shall not have the right to convert any
portion of the Series E Preferred Stock, to the extent that after giving effect to the conversion sought by the holder such holder
(together with such holder&#8217;s Attribution Parties (as defined in the Certificate of Designation)) would beneficially own more
than 4.99% (or upon election by a holder, 19.99%) of the number of shares of common stock outstanding immediately after giving
effect to the issuance of shares of common stock issuable upon such conversion. The Purchasers have elected to have the 19.99% Beneficial Ownership Limitation be applicable to their shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Issuance Restrictions</i>.
&#160;Notwithstanding anything to the contrary in the Certificate of Designation, until the Company has obtained Stockholder
Approval, the Company may not issue upon the conversion of any shares of Series E Preferred Stock, a number of shares of common
stock which, when aggregated with any shares of common stock issued upon conversion of any other shares of Series E Preferred Stock,
would exceed 1,430,484 (subject to adjustment). Such number represented 20% of the number of shares of common stock issued and
outstanding upon the filing of the Certificate of Designation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Liquidation Preference</i>. &#160;Upon any liquidation,
dissolution or winding up of the Company, whether voluntary or involuntary, the holders of Series E Preferred Stock shall be entitled
to participate on an as-converted-to-common stock basis (without giving effect to the Beneficial Ownership Limitation) with holders of
the common stock in any distribution of assets of the Company to holders of the common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The foregoing description of the Certificate of Designation
does not purport to be complete and is subject to, and qualified in its entirety by, the Certificate of Designation, a copy of which is
attached as an exhibit to this Current Report on Form 8-K and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Item 5.03.&#160;Amendments to Articles of Incorporation or Bylaws;
Change in Fiscal Year</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The information set forth in Item 3.03 of this Current
Report on Form 8-K is incorporated by reference into this Item 5.03.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="letter-spacing: 0.2pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="letter-spacing: 0.2pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>(d) Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 62px"><span style="font-size: 8pt"><b>Exhibit No.</b></span></td>
    <td style="vertical-align: top; width: 10px">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom"><span style="font-size: 8pt"><b>Description of Exhibit</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,255,204)">
    <td style="font-size: 12pt; text-align: justify; text-indent: 0pc"><span style="font-size: 10pt">3.1</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 12pt; text-align: justify; text-indent: 0pc"><span style="font-size: 10pt"><a href="duot_ex3z1.htm">Certificate of Designation of Preferences, Rights and Limitations of Series E Convertible Preferred Stock</a></span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 12pt; text-align: justify; text-indent: 0pc"><span style="font-size: 10pt">10.1</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 12pt; text-align: justify; text-indent: 0pc"><span style="font-size: 10pt"><a href="duot_ex10z1.htm">Form of Securities Purchase Agreement</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,255,204)">
    <td style="font-size: 12pt; text-align: justify; text-indent: 0pc"><span style="font-size: 10pt">10.2</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 12pt; text-align: justify; text-indent: 0pc"><span style="font-size: 10pt"><a href="duot_ex10z2.htm">Form of Registration Rights Agreement</a></span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 12pt; text-align: justify; text-indent: 0pc"><span style="font-size: 10pt">104</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 12pt; text-align: justify; text-indent: 0pc"><span style="font-size: 10pt">Cover Page Interactive Data File
    (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0pc">Pursuant to the requirements of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 3pc">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><b>DUOS TECHNOLOGIES GROUP, INC.</b></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 55%">&#160;</td>
    <td style="width: 6%">&#160;</td>
    <td style="width: 39%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>Dated: March 28, 2023</td>
    <td>By:&#160;&#160;</td>
    <td style="border-bottom: Black 1pt solid">/s/&#160;<i>Andrew W. Murphy</i></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td rowspan="2">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Andrew W. Murphy</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Financial Officer</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0pc">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0pc">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0pc">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0pc">&#160;</p>



<p style="margin: 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKwjAMRb9g/xD6LLpORN2jQ0WcImOIr8VFKW7NSOt0n+Rf2m2IIRCSe0+uECOxpY0ukeGyylLIsapL5RAyvCGjuaJ3JLt9DH5meNfWsTKuX39gQp5Bz8zGS+XvvbPRFosYwsVETieRhFDGszmcDiLo9ITMTRdonFYlKFPAialmjU5xO3zI1ZsMVW2fdEa2mkwMchwO8geiUEZwpEa9iB8W0jQRwaivQGyZnnUX87SOKliXWPksO6D/Dr7iu0kh -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>duot_ex3z1.htm
<DESCRIPTION>CERTIFICATE OF DESIGNATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: right">EXHIBIT 3.1</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center">DUOS TECHNOLOGIES GROUP, INC.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center">ARTICLES OF AMENDMENT</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center">DESIGNATING PREFERENCES,<BR>
RIGHTS AND LIMITATIONS<BR>
OF<BR>
SERIES E CONVERTIBLE PREFERRED STOCK</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center">PURSUANT TO SECTIONS 607.1003 AND 607.1006 OF
THE<BR>
FLORIDA BUSINESS CORPORATION ACT</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">Duos Technologies Group, Inc.,
a corporation organized and existing under the Florida Business Corporation Act (the &ldquo;<U>Corporation</U>&rdquo;), certifies that
pursuant to the authority contained in Article Fifth, Section B of its Articles of Incorporation (the &ldquo;<U>Articles of Incorporation</U>&rdquo;)
and in accordance with the provisions of Sections 607.1003 and 607.1006 of the Florida Business Corporation Act, the board of directors
of the Corporation (the &ldquo;<U>Board of Directors</U>&rdquo;) by unanimous written consent dated March 23, 2023 duly approved and adopted
the following resolution which resolution remains in full force and effect on the date hereof:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">RESOLVED, that pursuant to
the authority vested in the Board of Directors by its Articles of Incorporation, the Board of Directors does hereby designate, create,
authorize and provide for the issue of Series E Convertible Preferred Stock, par value $0.001 per share (the &ldquo;<U>Series E Preferred
Stock</U>&rdquo;), consisting of Thirty Thousand (30,000) shares, having the voting powers, preferences and relative, participating, optional
and other special rights, and qualifications, limitations and restrictions thereof as follows:</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center">TERMS OF SERIES E PREFERRED STOCK</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">Section 1.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>Definitions. For the purposes hereof, the following terms shall have the following meanings:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 of the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Alternate Consideration</U>&rdquo;
shall have the meaning set forth in Section 7(d).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Beneficial Ownership
Limitation</U>&rdquo; shall have the meaning set forth in Section 6(d).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Business Day</U>&rdquo;
means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking
institutions in the State of Florida are authorized or required by law or other governmental action to close.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Common Stock</U>&rdquo;
means the Corporation&rsquo;s common stock, par value $0.001 per share, and stock of any other class of securities into which such securities
may hereafter be reclassified or changed.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Common Stock Equivalents</U>&rdquo;
means any securities of the Corporation or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock,
including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible
into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Conversion Amount</U>&rdquo;
means the sum of the Stated Value at issue.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Conversion Date</U>&rdquo;
shall have the meaning set forth in Section 6(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Conversion Price</U>&rdquo;
shall have the meaning set forth in Section 6(b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Conversion Shares</U>&rdquo;
means, collectively, the shares of Common Stock issuable upon conversion of the shares of Series E Preferred Stock in accordance with
the terms hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Exchange Act</U>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;&ldquo;<U>Fundamental
Transaction</U>&rdquo; shall have the meaning set forth in Section 7(d).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>GAAP</U>&rdquo;
means United States generally accepted accounting principles.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Holder</U>&rdquo;
shall have the meaning set forth in Section 2.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Notice of Conversion</U>&rdquo;
shall have the meaning set forth in Section 6(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Original Issue Date</U>&rdquo;
means the date of the first issuance of any shares of the Series&nbsp;E Preferred Stock regardless of the number of transfers of any particular
shares of Series E Preferred Stock and regardless of the number of certificates which may be issued to evidence such Series E Preferred
Stock.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Securities Act</U>&rdquo;
means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Series E Preferred
Stock</U>&rdquo; shall have the meaning set forth in Section 2.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Share Delivery Date</U>&rdquo;
shall have the meaning set forth in Section 6(c)(i).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Stated Value</U>&rdquo;
shall have the meaning set forth in Section 2, as the same may be increased pursuant to Section 3.</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Stockholder Approval</U>&rdquo;
means such approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market (or any successor entity) from
the stockholders of the Corporation with respect to the issuance of all of the Conversion Shares.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Corporation and shall, where applicable, also include any direct or indirect subsidiary of the Corporation
formed or acquired after the date hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Successor Entity</U>&rdquo;
shall have the meaning set forth in Section 7(d).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Trading Day</U>&rdquo;
means a day on which the principal Trading Market is open for business.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, OTCQB
or OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">&ldquo;<U>Transfer Agent</U>&rdquo;
means Continental Stock Transfer &amp; Trust, the current transfer agent of the Corporation, with a mailing address of 1 State Street,
30<SUP>th</SUP> Floor, New York, NY 10004, and any successor transfer agent of the Corporation.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">Section 2.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Designation, Amount and Par Value</U>. The series of preferred stock shall be designated as its Series E Convertible Preferred
Stock (the &ldquo;<U>Series E Preferred Stock</U>&rdquo;) and the number of shares so designated shall be Thirty Thousand (30,000) (which
shall not be subject to increase without the written consent of the holders of a majority of the outstanding Series E Preferred Stock
(each, a &ldquo;<U>Holder</U>&rdquo; and collectively, the &ldquo;<U>Holders</U>&rdquo;)). Each share of Series E Preferred Stock shall
have a par value of $0.001 per share and a stated value equal to one thousand dollars ($1,000.00) (the &ldquo;<U>Stated Value</U>&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">Section 3.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Dividends</U>. Except for stock dividends or distributions for which adjustments are to be made pursuant to Section 7, Holders
shall be entitled to receive, and the Corporation shall pay, dividends on shares of Series E Preferred Stock equal (on an as-if-converted-to-Common-Stock
basis (without giving effect to the Beneficial Ownership Limitation)) to and in the same form as dividends actually paid on shares of
the Common Stock when, as and if such dividends are paid on shares of the Common Stock. Other than as set forth in the previous sentence,
no other dividends shall be paid on shares of Series E Preferred Stock, and the Corporation shall pay no dividends (other than dividends
in the form of Common Stock) on shares of the Common Stock unless it simultaneously complies with the previous sentence.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">Section 4.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Voting Rights</U>. Except as otherwise expressly provided herein or in the Articles of Incorporation, or as provided by the
Florida Business Corporation Act, the holders of shares of Series E Preferred Stock, the holders of shares of Common Stock and the holders
of any other class or series of shares entitled to vote with the Common Stock shall vote together as one class on all matters submitted
to a vote of stockholders of the Corporation. In any such vote, each share of Series E Preferred Stock shall entitle the holder thereof
to cast the number of votes equal to the number of votes determined by dividing the Stated Value of such share of Series E Preferred</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 0pc">Stock by $3.00 (such dollar
amount being subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions
of the Common Stock that occur after the Original Issue Date), <U>provided</U>, <U>however</U>, that in no event will a holder of shares
of Series E Preferred Stock be entitled to vote a number of shares in excess of such holder&rsquo;s Beneficial Ownership Limitation. However,
as long as any shares of Series E Preferred Stock are outstanding, the Corporation shall not, without the affirmative vote of the Holders
of a majority of the then outstanding shares of the Series E Preferred Stock, (a) alter or change adversely the powers, preferences or
rights given to the Series E Preferred Stock or alter or amend this Certificate of Designation, (b) amend its articles of incorporation
or other charter documents in any manner that adversely affects any rights of the Holders, (c) increase the number of authorized shares
of Series E Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">Section 5.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Liquidation</U>. Upon any liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary (a &ldquo;<U>Liquidation</U>&rdquo;),
the Holders shall be entitled to participate on an as-converted-to-Common Stock basis (without giving effect to the Beneficial Ownership
Limitation) with holders of the Common Stock in any distribution of assets of the Corporation to the holders of the Common Stock.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">Section 6.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Conversion</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Conversions at Option of Holder</U>. Each share of Series E Preferred Stock shall be convertible, at any time and from time
to time from and after the Original Issue Date at the option of the Holder thereof, into that number of shares of Common Stock (subject
to the limitations set forth in Section 6(d)) determined by dividing the Stated Value of such share of Series E Preferred Stock by the
Conversion Price then in effect. Holders shall effect conversions by providing the Corporation with the form of conversion notice attached
hereto as <U>Annex A</U> (a &ldquo;<U>Notice of Conversion</U>&rdquo;). Each Notice of Conversion shall specify the number of shares of
Series E Preferred Stock to be converted, the number of shares of Series E Preferred Stock owned prior to the conversion at issue, the
number of shares of Series E Preferred Stock owned subsequent to the conversion at issue and the date on which such conversion is to be
effected, which date may not be prior to the date the applicable Holder delivers by e-mail such Notice of Conversion to the Corporation
(such date, the &ldquo;<U>Conversion Date</U>&rdquo;). Upon delivery of the Notice of Conversion, the Holder shall be deemed for all corporate
purposes to have become the holder of record of the Conversion Shares with respect to which the shares of Series E Preferred Stock have
been converted irrespective of the date of delivery of the Conversion Shares. If no Conversion Date is specified in a Notice of Conversion,
the Conversion Date shall be the date that such Notice of Conversion to the Corporation is deemed delivered hereunder. No ink original
Notice of Conversion shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Conversion form be required. To effect conversion of shares of Series E Preferred Stock, a Holder shall not be required to surrender the
certificate(s) representing such shares of Series E Preferred Stock to the Corporation unless and until all shares of Series E Preferred
Stock represented thereby are so converted, in which case such Holder shall deliver such certificate(s) within five (5) Trading Days after
delivery of the Notice of Conversion relating to the conversion of the last shares of Series E Preferred Stock. The calculations and entries
set forth in the Notice of Conversion shall control in the absence of manifest or mathematical error. Shares of Series D Preferred Stock
converted into Common Stock or redeemed in accordance with the terms hereof shall be canceled and shall not be reissued.</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Conversion Price</U>. The conversion price for the Series E Preferred Stock shall equal $3.00, subject to adjustment herein
(the &ldquo;<U>Conversion Price</U>&rdquo;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Mechanics of Conversion</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc 3pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Delivery of Conversion Shares Upon Conversion</U>. Promptly after each Conversion Date, but in any case within the earlier of
(i) two (2) Trading Days and (ii) the Standard Settlement Period, thereof (the &ldquo;<U>Share Delivery Date</U>&rdquo;), the Corporation
shall deliver, or cause to be delivered, to the converting Holder the number of Conversion Shares being acquired upon the conversion of
the Series E Preferred Stock and a wire transfer of immediately available funds in the amount of accrued and unpaid dividends, if any.
Conversion Shares issuable hereunder shall be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s
or its designee&rsquo;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;)
if the Corporation is then a participant in such system and either (A) there is an effective registration statement permitting the issuance
of the Conversion Shares to or resale of the Conversion Shares by the Holder or (B) the Conversion Shares are eligible for resale by the
Holder without volume or manner-of-sale limitations pursuant to Rule&nbsp;144, and otherwise by physical delivery of a certificate, registered
in the Corporation&rsquo;s share register in the name of the Holder or its designee, for the number of Conversion Shares to which the
Holder is entitled pursuant to such conversion to the address specified by the Holder in the Notice of Conversion. The Corporation shall
deliver (or cause to be delivered) to the converting Holder (A) a certificate or certificates for the number of shares of Common Stock
issuable upon conversion, and (B) if less than the number of shares of Series E Preferred Stock evidenced by the surrendered certificate
or certificates are being converted, a new certificate or certificates, of like tenor, for the number of shares evidenced by any surrendered
Series E Preferred Stock certificate or certificates (if applicable) less the number of shares converted. The Corporation agrees to maintain
a transfer agent that is a participant in the FAST program so long as any shares of Series E Preferred Stock remain outstanding. As used
herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on
the Corporation&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of
Conversion.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc 3pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">ii.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Failure to Deliver Conversion Shares</U>. If, in the case of any Notice of Conversion, such Conversion Shares are not delivered
to or as directed by the applicable Holder by the Share Delivery Date, in addition to any other rights herein, the Holder shall be entitled
to elect by written notice to the Corporation at any time on or before its receipt of such Conversion Shares, to rescind such Conversion,
in which event the Corporation shall promptly return to the Holder any original Series E Preferred Stock certificate delivered to the
Corporation and the Holder shall promptly return to the Corporation the Conversion Shares issued to such Holder pursuant to the rescinded
Notice of Conversion.</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc 3pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">iii.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Obligation Absolute; Partial Liquidated Damages</U>. The Corporation&rsquo;s obligation to issue and deliver the Conversion
Shares upon conversion of Series E Preferred Stock in accordance with the terms hereof are absolute and unconditional, irrespective of
any action or inaction by a Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any
judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or
any breach or alleged breach by such Holder or any other Person of any obligation to the Corporation or any violation or alleged violation
of law by such Holder or any other Person, and irrespective of any other circumstance which might otherwise limit such obligation of the
Corporation to such Holder in connection with the issuance of such Conversion Shares; <U>provided</U>, <U>however</U>, that such delivery
shall not operate as a waiver by the Corporation of any such action that the Corporation may have against such Holder. In the event a
Holder shall elect to convert any or all of the Stated Value of its Series E Preferred Stock, the Corporation may not refuse conversion
based on any claim that such Holder or any one associated or affiliated with such Holder has been engaged in any violation of law, agreement
or for any other reason, unless an injunction from a court, on notice to Holder, restraining and/or enjoining conversion of all or part
of the Series E Preferred Stock of such Holder shall have been sought and obtained. In the absence of such injunction, the Corporation
shall issue Conversion Shares and, if applicable, cash, upon a properly noticed conversion. Nothing herein shall limit a Holder&rsquo;s
right to pursue actual damages for the Corporation&rsquo;s failure to deliver Conversion Shares within the period specified herein and
such Holder shall have the right to pursue all remedies available to it hereunder, at law or in equity including a decree of specific
performance and/or injunctive relief. The exercise of any such rights shall not prohibit a Holder from seeking to enforce damages pursuant
to any other Section hereof or under applicable law.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc 3pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">iv.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Reservation of Shares Issuable Upon Conversion</U>. The Corporation covenants that it will at all times reserve and keep available
out of its authorized and unissued shares of Common Stock for the sole purpose of issuance upon conversion of the Series E Preferred Stock
as herein provided, free from preemptive rights or any other actual contingent purchase rights of Persons other than the Holder (and the
other holders of the Series E Preferred Stock), not less than such aggregate number of shares of the Common Stock as shall be issuable
(taking into account the adjustments and restrictions of Section 7) upon the conversion of the then outstanding shares of Series E Preferred
Stock. The Corporation covenants that all shares of Common Stock that shall be so issuable shall, upon issue, be duly authorized, validly
issued, fully paid and nonassessable.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc 3pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">v.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Fractional Shares</U>. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of the
Series E Preferred Stock. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion,
the Corporation shall at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction
multiplied by the Conversion Price or round to the next whole share, with 0.5 shares being rounded up to one whole share. Subject to the
foregoing, fractional shares of Series E Preferred Stock may be issued and / or converted hereunder.</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc 3pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">vi.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Transfer Taxes and Expenses</U>. The issuance of Conversion Shares on conversion of this Series E Preferred Stock shall be made
without charge to any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such
Conversion Shares, provided that the Corporation shall not be required to pay any tax that may be payable in respect of any transfer involved
in the issuance and delivery of any such Conversion Shares upon conversion in a name other than that of the Holders of such shares of
Series E Preferred Stock and the Corporation shall not be required to issue or deliver such Conversion Shares unless or until the Person
or Persons requesting the issuance thereof shall have paid to the Corporation the amount of such tax or shall have established to the
satisfaction of the Corporation that such tax has been paid. The Corporation shall pay all Transfer Agent fees required for same-day processing
of any Notice of Conversion and all fees to the Depository Trust Company (or another established clearing corporation preforming similar
functions) required for same-day electronic delivery of the Conversion Shares.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Beneficial Ownership Limitation</U>. The Corporation shall not effect any conversion of the Series E Preferred Stock, and a
Holder shall not have the right to convert any portion of the Series E Preferred Stock, to the extent that, after giving effect to the
conversion set forth on the applicable Notice of Conversion, such Holder (together with such Holder&rsquo;s Affiliates, and any Persons
acting as a group together with such Holder or any of such Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;))
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by such Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon conversion of the Series E Preferred Stock with respect to which such determination is being made,
but shall exclude the number of shares of Common Stock which are issuable upon (i) conversion of the remaining, unconverted Stated Value
of the Series E Preferred Stock beneficially owned by such Holder or any of its Affiliates or Attribution Parties and (ii) exercise or
conversion of the unexercised or unconverted portion of any other securities of the Corporation subject to a limitation on conversion
or exercise analogous to the limitation contained herein (including, without limitation, the Series E Preferred Stock) beneficially owned
by such Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section
6(d), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. To the extent that the limitation contained in this Section 6(d) applies, the determination of whether the Series E Preferred
Stock is convertible (in relation to other securities owned by such Holder together with any Affiliates and Attribution Parties) and of
how many shares of Series E Preferred Stock are convertible shall be in the sole discretion of such Holder, and the submission of a Notice
of Conversion shall be deemed to be such Holder&rsquo;s determination of whether the shares of Series E Preferred Stock may be converted
(in relation to other securities owned by such Holder together with any Affiliates and Attribution Parties) and how many shares of the
Series E Preferred Stock are convertible, in each case subject to the Beneficial Ownership Limitation. To ensure compliance with this
restriction, each Holder will be deemed to represent to the Corporation each time it delivers a Notice of Conversion that such Notice
of Conversion has not violated the restrictions set forth in this paragraph and the</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 0pc">Corporation shall have no
obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated
above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For
purposes of this Section 6(d), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as stated in the most recent of the following: (i) the Corporation&rsquo;s most recent periodic or annual report
filed with the Commission, as the case may be, (ii) a more recent public announcement by the Corporation or (iii) a more recent written
notice by the Corporation or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral
request of a Holder (which may be via email), the Corporation shall, within two Trading Days, confirm orally and in writing to such Holder
the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined
after giving effect to the conversion or exercise of securities of the Corporation, including the Series E Preferred Stock, by such Holder
or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The
&ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall initially be 4.99% (or upon the election by a Holder prior to the original
issuance by the Corporation of any shares of Series E Preferred Stock to such Holder, 19.99%) of the number of shares of the Common Stock
outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of Series E Preferred Stock
held by the applicable Holder. A Holder, upon notice to the Corporation, may increase or decrease the Beneficial Ownership Limitation
provisions of this Section 6(d) applicable to its Series E Preferred Stock provided that the Beneficial Ownership Limitation in no event
exceeds 19.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common
Stock upon conversion of this Series E Preferred Stock held by the Holder and the provisions of this Section 6(d) shall continue to apply.
Any such increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the
Corporation and shall only apply to such Holder and no other Holder. The provisions of this paragraph shall be construed and implemented
in a manner otherwise than in strict conformity with the terms of this Section 6(d) to correct this paragraph (or any portion hereof)
which may be defective or inconsistent with the intended Beneficial Ownership Limitation contained herein or to make changes or supplements
necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor
holder of Series E Preferred Stock.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Issuance Restrictions</U>. Notwithstanding anything herein to the contrary, if the Corporation has not obtained Stockholder
Approval, then the Corporation may not issue upon the conversion of any share of Series E Preferred Stock a number of shares of Common
Stock, which when aggregated with any shares of Common Stock issued upon the conversion of any other shares of Series E Preferred Stock
(such securities, collectively, the &ldquo;<U>Issuance Capped Securities</U>&rdquo; and the holders of Issuance Capped Securities, the
&ldquo;<U>Capped Holders</U>&rdquo;) would exceed 1,430,484, subject to adjustment for reverse and forward stock splits, stock dividends,
stock combinations and other similar transactions of the Common Stock that occur after the Original Issue Date (such number of shares,
the &ldquo;<U>Issuable Maximum</U>&rdquo;). Each Capped Holder shall be entitled to a portion of the Issuable Maximum equal to the quotient
obtained by dividing (x) the aggregate Stated Value of such Holder&rsquo;s Series E Preferred Stock by (x) the aggregate Stated Value
of all shares of Series E Preferred Stock issued by the Corporation.</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">Section 7.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Certain Adjustments</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Stock Dividends and Stock Splits</U>. If the Corporation, at any time while this Series E Preferred Stock is outstanding: (i)
pays a stock dividend or otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or
any other Common Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Corporation
upon conversion of, or payment of a dividend on, this Series E Preferred Stock), (ii) subdivides outstanding shares of Common Stock into
a larger number of shares, (iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller
number of shares, or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the
Corporation, then the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common
Stock (excluding any treasury shares of the Corporation) outstanding immediately before such event, and of which the denominator shall
be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section 7(a) shall
become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution
and shall become effective immediately after the effective date in the case of a subdivision, combination or reclassification.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 7(a) above, if at any time the Corporation
grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the
record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to
acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the
Holder had held the number of shares of Common Stock acquirable upon complete conversion of such Holder&rsquo;s Series E Preferred Stock
(without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately
before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights
(<U>provided</U>, <U>however</U>, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in
the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right
to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase
Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Pro Rata Distributions</U>. During such time as this Series E Preferred Stock is outstanding, if the Corporation declares or
makes any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way
of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options
by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Series E Preferred Stock, then, in each such case, the Holder shall be entitled to</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 0pc">participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete conversion of this Series E Preferred Stock (without regard to any limitations on conversion hereof, including without limitation,
the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record
is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution
(<U>provided</U>, <U>however</U>, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in
the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to
such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion
of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not
result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Fundamental Transaction</U>. If, at any time while this Series E Preferred Stock is outstanding, (i) the Corporation, directly
or indirectly, in one or more related transactions effects any merger or consolidation of the Corporation with or into another Person,
(ii) the Corporation, directly or indirectly, effects any sale, lease, exclusive license, assignment, transfer, conveyance or other disposition
of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender
offer or exchange offer (whether by the Corporation or another Person) is completed pursuant to which holders of Common Stock are permitted
to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of
the outstanding Common Stock, (iv) the Corporation, directly or indirectly, in one or more related transactions effects any reclassification,
reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively
converted into or exchanged for other securities, cash or property, or (v) the Corporation, directly or indirectly, in one or more related
transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization,
recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding
shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated
or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a
&ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent conversion of this Series E Preferred Stock, the Holder shall
have the right to receive, for each Conversion Share that would have been issuable upon such conversion immediately prior to the occurrence
of such Fundamental Transaction (without regard to any limitation in Section 6(d) or Section 6(e) on the conversion of this Series E Preferred
Stock), the number of shares of Common Stock of the successor or acquiring corporation or of the Corporation, if it is the surviving corporation,
and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction
by a holder of the number of shares of Common Stock for which this Series E Preferred Stock is convertible immediately prior to such Fundamental
Transaction (without regard to any limitation in Section 6(d) or Section 6(e) on the conversion of this Series E Preferred Stock). For
purposes of any such conversion, the determination of the Conversion Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction,</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 0pc">and the Corporation shall
apportion the Conversion Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different
components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be
received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon
any conversion of this Series E Preferred Stock following such Fundamental Transaction. To the extent necessary to effectuate the foregoing
provisions, any successor to the Corporation or surviving entity in such Fundamental Transaction shall file a new Certificate of Designation
with the same terms and conditions and issue to the Holders new preferred stock consistent with the foregoing provisions and evidencing
the Holders&rsquo; right to convert such preferred stock into Alternate Consideration. The Corporation shall cause any successor entity
in a Fundamental Transaction in which the Corporation is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing
all of the obligations of the Corporation under this Certificate of Designation in accordance with the provisions of this Section 7(d)
pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable
delay) prior to such Fundamental Transaction and shall, at the option of the holder of this Series E Preferred Stock, deliver to the Holder
in exchange for this Series E Preferred Stock a security of the Successor Entity evidenced by a written instrument substantially similar
in form and substance to this Series E Preferred Stock which is convertible for a corresponding number of shares of capital stock of such
Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion of this Series
E Preferred Stock (without regard to any limitations on the conversion of this Series E Preferred Stock) prior to such Fundamental Transaction,
and with a conversion price which applies the conversion price hereunder to such shares of capital stock (but taking into account the
relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such
number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of this Series E Preferred
Stock immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance
to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for
(so that from and after the date of such Fundamental Transaction, the provisions of this Certificate of Designation referring to the &ldquo;Corporation&rdquo;
shall refer instead to the Successor Entity), and may exercise every right and power of the Corporation and shall assume all of the obligations
of the Corporation under this Certificate of Designation with the same effect as if such Successor Entity had been named as the Corporation
herein.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Calculations</U>. All calculations under this Section 7 shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this Section 7, the number of shares of Common Stock deemed to be issued and outstanding as of a given
date shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Corporation) issued and outstanding.</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Notice to the Holders</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc 3pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Adjustment to Conversion Price</U>. Whenever the Conversion Price is adjusted pursuant to any provision of this Section 7, the
Corporation shall promptly deliver to each Holder by email or nationally recognized overnight courier service a notice setting forth the
Conversion Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc 3pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">ii.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Notice to Allow Conversion by Holder</U>. If (A) the Corporation shall declare a dividend (or any other distribution in whatever
form) on the Common Stock, (B) the Corporation shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock,
(C) the Corporation shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for or purchase
any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Corporation shall be required in
connection with any reclassification of the Common Stock, any consolidation or merger to which the Corporation is a party, any sale or
transfer of all or substantially all of the assets of the Corporation, or any compulsory share exchange whereby the Common Stock is converted
into other securities, cash or property or (E) the Corporation shall authorize the voluntary or involuntary dissolution, liquidation or
winding up of the affairs of the Corporation, then, in each case, the Corporation shall cause to be filed at each office or agency maintained
for the purpose of conversion of this Series E Preferred Stock, and shall cause to be delivered by email or nationally recognized overnight
courier service to each Holder at its last email address or address as it shall appear upon the stock books of the Corporation, at least
twenty (20) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which
a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken,
the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants
are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected
to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to
exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation,
merger, sale, transfer or share exchange, provided that the failure to deliver such notice or any defect therein or in the delivery thereof
shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided
hereunder constitutes, or contains, material, non-public information regarding the Corporation or any of the Subsidiaries, the Corporation
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to
convert the Conversion Amount of this Series E Preferred Stock (or any part hereof) during the 20-day period commencing on the date of
such notice through the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">Section 8.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Miscellaneous</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Notices</U>. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without
limitation, any Notice of Conversion, shall be in writing and delivered personally, by e-mail or sent by a nationally recognized overnight
courier service, addressed to the Corporation at 7660 Centurion Parkway, Suite 100, Jacksonville, Florida 32256, Attention: Chief Financial
Officer, email address: awm@duostech.com, or such other e-mail address or address as the Corporation may specify for such purposes by
notice to the Holders delivered in accordance with this Section 8. Any and all notices or other communications or deliveries to be provided
by the Corporation hereunder shall be in writing and delivered personally, by e-mail or sent by a nationally recognized overnight courier
service addressed to each Holder at the address of such Holder appearing on the books of the Corporation, or if no such address appears
on the books of the Corporation, at the principal place of business of such Holder. Any notice or other communication or deliveries hereunder
shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered via
e-mail at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City time) on a Trading Day, (ii) the next Trading
Day after the date of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section
on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following
the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom
such notice is required to be given. To the extent that any notice provided pursuant to this Certificate of Designation constitutes, or
contains, material, non-public information regarding the Corporation or any Subsidiaries, the Corporation shall simultaneously file such
notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Absolute Obligation</U>. Except as expressly provided herein, no provision of this Certificate of Designation shall alter or
impair the obligation of the Corporation, which is absolute and unconditional, to pay liquidated damages and accrued dividends, as applicable,
on the shares of Series E Preferred Stock at the time, place, and rate, and in the coin or currency, herein prescribed.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Lost or Mutilated Series E Preferred Stock Certificate</U>. If a Holder&rsquo;s Series E Preferred Stock certificate shall be
mutilated, lost, stolen or destroyed, the Corporation shall execute and deliver, or cause to be executed and delivered, in exchange and
substitution for and upon cancellation of a mutilated certificate, or in lieu of or in substitution for a lost, stolen or destroyed certificate,
a new certificate for the shares of Series E Preferred Stock so mutilated, lost, stolen or destroyed, but only upon receipt of evidence
of such loss, theft or destruction of such certificate, and of the ownership hereof reasonably satisfactory to the Corporation with the
actual third-party costs of the replacement of such certificate to be borne by the Holder (including customary indemnity).</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Certificate of
Designation shall be governed by and construed and enforced in accordance with the internal laws of the State of Florida, without regard
to the principles of conflict of laws thereof. Each party agrees that all legal proceedings concerning the interpretation, enforcement
and defense of the transactions contemplated by this Certificate of Designation (whether brought against a party hereto or its respective
Affiliates, directors, officers, shareholders, employees or agents) shall be commenced in the state and federal courts sitting in the
City of New York, Borough of Manhattan (the &ldquo;<U>New York Courts</U>&rdquo;). Each party hereto hereby irrevocably submits to the
exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any
claim that it is not personally subject to the jurisdiction of the New York Courts, or the New York Courts are an improper or inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Certificate of Designation and agrees that such service shall constitute
good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve
process in any other manner permitted by applicable law. Each party hereto hereby irrevocably waives, to the fullest extent permitted
by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Certificate of Designation
or the transactions contemplated hereby. If any party shall commence an action or proceeding to enforce any provisions of this Certificate
of Designation, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorneys&rsquo;
fees and other costs and expenses incurred in the investigation, preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Waiver</U>. Any waiver by the Corporation or a Holder of a breach of any provision of this Certificate of Designation shall
not operate as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Certificate
of Designation or a waiver by any other Holders. The failure of the Corporation or a Holder to insist upon strict adherence to any term
of this Certificate of Designation on one or more occasions shall not be considered a waiver or deprive that party (or any other Holder)
of the right thereafter to insist upon strict adherence to that term or any other term of this Certificate of Designation on any other
occasion. Any waiver by the Corporation or a Holder must be in writing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Severability</U>. If any provision of this Certificate of Designation is invalid, illegal or unenforceable, the balance of this
Certificate of Designation shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless
remain applicable to all other Persons and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder
violates the applicable law governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the
maximum rate of interest permitted under applicable law.</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Next Business Day</U>. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such
payment shall be made on the next succeeding Business Day.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Headings</U>. The headings contained herein are for convenience only, do not constitute a part of this Certificate of Designation
and shall not be deemed to limit or affect any of the provisions hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Status of Converted or Redeemed Series E Preferred Stock</U>. If any shares of Series E Preferred Stock shall be converted,
redeemed or reacquired by the Corporation, such shares shall resume the status of authorized but unissued shares of preferred stock and
shall no longer be designated as Series E Convertible Preferred Stock.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center">*********************</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">IN WITNESS WHEREOF, the Corporation
has caused this certificate to be duly executed this 23rd day of March, 2023.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><B>Duos Technologies Group, Inc.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 54%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 38%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">By:</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: left">/s/ Charles P. Ferry</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">Name:</TD>
    <TD STYLE="text-align: left">Charles P. Ferry</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">Title:</TD>
    <TD STYLE="text-align: left">Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc">&nbsp;</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center">ANNEX A</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center">NOTICE OF CONVERSION</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center">(TO BE EXECUTED BY THE REGISTERED HOLDER IN ORDER
TO<BR>
CONVERT SHARES OF SERIES E PREFERRED STOCK)</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify">The undersigned hereby elects to convert the
number of shares of Series E Convertible Preferred Stock indicated below into shares of common stock, par value $0.001 per share (the
&ldquo;<U>Common Stock</U>&rdquo;), of Duos Technologies Group, Inc., a Florida corporation (the &ldquo;<U>Corporation</U>&rdquo;), according
to the conditions hereof, as of the date written below. If shares of Common Stock are to be issued in the name of a Person other than
the undersigned, the undersigned will pay all transfer taxes payable with respect thereto. No fee will be charged to the Holders for any
conversion, except for any such transfer taxes.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc">Conversion calculations:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">Date to Effect Conversion:
_____________________________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">Number of shares of Series
E Preferred Stock owned prior to Conversion: _____________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">Number of shares of Series
E Preferred Stock to be Converted: ______________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">Stated Value of shares of
Series E Preferred Stock to be Converted: __________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">Number of shares of Common
Stock to be Issued: ___________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">Applicable Conversion Price:
___________________________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">Number of shares of Series
E Preferred Stock subsequent to Conversion: ______________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">Address for Delivery: ______________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><U>Or</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">DWAC Instructions:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 3pc">Broker no: _________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">Account no: ___________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 58%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 42%">
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">[HOLDER]</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">By: ___________________________</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 21.8pt; text-align: justify">Name:</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 21.8pt; text-align: justify">Title:</P></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>duot_ex10z1.htm
<DESCRIPTION>SECURITIES PURCHASE AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-transform: uppercase; text-align: right">EXHIBIT 10.1</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt; text-transform: uppercase; text-align: center">FORM OF</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-transform: uppercase; text-align: center">SECURITIES PURCHASE
AGREEMENT</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">This Securities Purchase Agreement
(this &#8220;<U>Agreement</U>&#8221;) is dated as of March 27, 2023, between Duos Technologies Group, Inc., a Florida corporation (the
&#8220;<U>Company</U>&#8221;), and each purchaser identified on the signature pages hereto (each, including its successors and assigns,
a &#8220;<U>Purchaser</U>&#8221; and collectively, the &#8220;<U>Purchasers</U>&#8221;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the &#8220;<U>Securities
Act</U>&#8221;), and Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally
and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which
are hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center; text-indent: 0pc"><FONT STYLE="text-transform: uppercase"><B>ARTICLE
I.<BR>
DEFINITIONS</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">1.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following
terms have the meanings set forth in this Section 1.1:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Acquiring Person</U>&#8221;
shall have the meaning ascribed to such term in Section 4.5.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Action</U>&#8221;
shall have the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Affiliate</U>&#8221;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>BHCA</U>&#8221;
shall have the meaning ascribed to such term in Section 3.1(mm).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Board of Directors</U>&#8221;
means the board of directors of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Business Day</U>&#8221;
means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking
institutions in the State of Florida are authorized or required by law or other governmental action to close; <U>provided</U>, <U>however</U>,
for clarification, banking institutions shall not be deemed to be authorized or required by law or other governmental actions to close
due to &#8220;stay at home,&#8221; &#8220;shelter-in-place,&#8221; &#8220;non-essential employee&#8221; or other similar orders or restrictions
or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer
system (including for wire transfers) of banks in the State of Florida generally are open for use by customers on such day.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Closing</U>&#8221;
means the closing of the purchase and sale of the Shares pursuant to Section 2.1.</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Closing Date</U>&#8221;
means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and
all conditions precedent to (i) the Purchasers&#8217; obligations to pay the Subscription Amount and (ii) the Company&#8217;s obligations
to deliver the Shares, in each case, have been satisfied or waived.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Commission</U>&#8221;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Common Stock</U>&#8221;
means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such securities may hereafter
be reclassified or changed.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Common Stock Equivalents</U>&#8221;
means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Company Counsel</U>&#8221;
means Shutts &amp; Bowen LLP, 200 S. Biscayne Blvd, Suite 4100, Miami, Florida 33131.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Conversion Shares</U>&#8221;
means the shares of Common Stock issuable upon conversion of the Preferred Stock.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Disclosure Schedules</U>&#8221;
shall have the meaning ascribed to such term in Section 3.1.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Disqualification
Event</U>&#8221; shall have the meaning ascribed to such term in Section 3.1(oo).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Effective Date</U>&#8221;
means the earliest of the date that (a) the initial Registration Statement has been declared effective by the Commission, (b) all of the
Conversion Shares have been sold pursuant to Rule 144 or may be sold pursuant to Rule 144 without the requirement for the Company to be
in compliance with the current public information required under Rule 144 and without volume or manner-of-sale restrictions or (c) following
the one-year anniversary of the Closing Date provided that a holder of Conversion Shares is not an Affiliate of the Company, all of the
Conversion Shares may be sold pursuant to an exemption from registration under Section 4(1) of the Securities Act without volume or manner-of-sale
restrictions and Company Counsel has delivered to the Transfer Agent for the benefit of such holders (and, if required by a holder, to
such holder or such holder&#8217;s custodian or prime broker) a standing written unqualified opinion that resales may then be made by
such holders of the Conversion Shares pursuant to such exemption which opinion shall be in form and substance reasonably acceptable to
such holders.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Environmental Laws</U>&#8221;
shall have the meaning ascribed to such term in Section 3.1(m).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Evaluation Date</U>&#8221;
shall have the meaning ascribed to such term in Section 3.1(s).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Exchange Act</U>&#8221;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Exempt Issuance</U>&#8221;
means the issuance of (a) shares of Common Stock or options to employees, officers, consultants or directors of the Company pursuant to
any stock or option plan or employee stock purchase plan duly adopted by a majority of the non-employee members of the Board of Directors
of the Company or a majority of the members of a committee of non-employee directors established for such purpose, (b) securities upon
the exercise or exchange of or conversion of any shares of the Preferred Stock and/or other securities exercisable or exchangeable for
or convertible into shares of Common Stock issued and outstanding on the date hereof, provided that such securities have not been amended
since the date hereof to increase the number of such securities or to decrease the exercise price, exchange price or conversion price
of any such securities or to extend the term of such securities, and (c) securities issued pursuant to acquisitions or strategic transactions
approved by a majority of the disinterested directors of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>FCPA</U>&#8221;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>GAAP</U>&#8221;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Indebtedness</U>&#8221;
shall have the meaning ascribed to such term in Section 3.1(bb).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Intellectual Property
Rights</U>&#8221; shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Legend Removal Date</U>&#8221;
shall have the meaning ascribed to such term in Section 4.1(c).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Liens</U>&#8221;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Material Adverse
Effect</U>&#8221; shall have the meaning ascribed to such term in Section 3.1(b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Material Permits</U>&#8221;
shall have the meaning ascribed to such term in Section 3.1(m).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Per Share Purchase
Price</U>&#8221; equals $1,000.00 per share of Preferred Stock.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Person</U>&#8221;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Preferred Stock</U>&#8221;
means the preferred stock of the Company, par value $0.001 per share, designated as Series E Preferred Stock which shall have the rights,
preferences, restrictions and other matters relating to a series of preferred stock as set forth in the Certificate of Designation of
Preferences, Rights and Limitations attached as <U>Exhibit A</U> hereto (the &#8220;<U>Certificate of Designation</U>&#8221;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Proceeding</U>&#8221;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Purchaser Party</U>&#8221;
shall have the meaning ascribed to such term in Section 4.8.</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Registration Rights
Agreement</U>&#8221; means the Registration Rights Agreement, dated as of the date hereof, among the Company and the Purchasers, in the
form of <U>Exhibit B</U> attached hereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Registration Statement</U>&#8221;
means a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering the resale by the
Purchasers of the Conversion Shares.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Required Approvals</U>&#8221;
shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Rule 144</U>&#8221;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Rule 424</U>&#8221;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>SEC Reports</U>&#8221;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Securities Act</U>&#8221;
means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Shares</U>&#8221;
means the shares of Preferred Stock issuable at Closing to each Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Short Sales</U>&#8221;
means all &#8220;short sales&#8221; as defined in Rule 200 of Regulation SHO under the Exchange Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Stockholder Approval</U>&#8221;
means such approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market (or any successor entity) from
the stockholders of the Company with respect to the transactions contemplated by the Transaction Documents, including the issuance of
all of the Conversion Shares in excess of 19.99% of the issued and outstanding Common Stock on the Closing Date and pursuant to this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Subscription Amount</U>&#8221;
means, as to each Purchaser, the aggregate amount to be paid for the Shares purchased hereunder as specified below such Purchaser&#8217;s
name on the signature page of this Agreement and next to the heading &#8220;Subscription Amount,&#8221; in United States dollars and in
immediately available funds.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Subsidiary</U>&#8221;
means any subsidiary of the Company as set forth on <U>Schedule 3.1(a)</U> and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Trading Day</U>&#8221;
means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Trading Market</U>&#8221;
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, OTCQB
or OTCQX (or any successors to any of the foregoing).</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Transaction Documents</U>&#8221;
means this Agreement, the Certificate of Designation, the Registration Rights Agreement, all exhibits and schedules thereto and hereto
and any other documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Transfer Agent</U>&#8221;
means Continental Stock Transfer &amp; Trust, the current transfer agent of the Company, with a mailing address of 1 State Street, 30<SUP>th</SUP>
Floor, New York, New York 10004, and any successor transfer agent of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center; text-indent: 0pc"><FONT STYLE="text-transform: uppercase"><B>ARTICLE
II.<BR>
PURCHASE AND SALE</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">2.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Closing</U>. On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with
the execution and delivery of this Agreement by the parties hereto, the Company shall sell, and the Purchasers, severally and not jointly,
shall purchase, up to an aggregate of $30,000,000 of Preferred Stock. Each Purchaser shall deliver to the Company, via wire transfer, immediately
available funds equal to such Purchaser&#8217;s Subscription Amount as set forth on the signature page hereto executed by such Purchaser,
and the Company shall deliver to each Purchaser its respective Shares, and the Company and each Purchaser shall deliver the other items
set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3,
the Closing shall occur at the offices of Company Counsel or such other location as the parties shall mutually agree. All share prices
set forth herein are subject to automatic adjustment for any stock split or reverse stock split occurring prior to Closing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">2.2</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Deliveries</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>this Agreement duly executed by the Company;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>a legal opinion of Company Counsel, substantially in the form of <U>Exhibit&nbsp;C</U> attached hereto;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver, on an expedited basis,
a certificate evidencing a number of Shares purchased by such Purchaser, registered in the name of such Purchaser;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iv)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>a stamped filed copy of the Certificate of Designation, as filed with the Secretary of State of the State of Florida; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(v)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>the Registration Rights Agreement duly executed by the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, the following:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>this Agreement duly executed by such Purchaser;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>to the Company, such Purchaser&#8217;s Subscription Amount by wire transfer to the account specified in writing by the Company;
and</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>the Registration Rights Agreement duly executed by such Purchaser.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">2.3</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Closing Conditions</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material
Adverse Effect, in all respects) on the Closing Date of the representations and warranties of the Purchasers contained herein (unless
as of a specific date therein in which case they shall be accurate as of such date);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have
been performed; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being
met:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material
Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein
(unless as of a specific date therein in which case they shall be accurate as of such date);</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been
performed;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(iv)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>there shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(v)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&#8217;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or Florida State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude
in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser,
makes it impracticable or inadvisable to purchase the Shares at the Closing.</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center; text-indent: 0pc"><FONT STYLE="text-transform: uppercase"><B>ARTICLE
III.<BR>
REPRESENTATIONS AND WARRANTIES</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">3.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Representations and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules
are delivered under separate cover from this Agreement, but shall be deemed a part hereof and shall qualify any representation or warranty
otherwise made herein to the extent of the disclosure contained in the corresponding section of the Disclosure Schedules to the extent
that it is reasonably apparent on its face that such disclosure is relevant to such section, the Company hereby makes the following representations
and warranties to each Purchaser as of the date hereof and as of the Closing Date (unless as of a specific date, in which case they shall
be accurate as of such date):</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Subsidiaries</U>. All of the direct and indirect Subsidiaries of the Company are set forth on <U>Schedule 3.1(a)</U>. The Company
owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all
of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free
of preemptive and similar rights to subscribe for or purchase securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Organization and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or
other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good
standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned
by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not
have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction
Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise)
of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&#8217;s ability to perform in
any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &#8220;<U>Material
Adverse Effect</U>&#8221;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking
to revoke, limit or curtail such power and authority or qualification.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate
the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations
hereunder and thereunder. The execution and delivery of each of this Agreement and the other Transaction Documents by the Company and
the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part
of the Company and no further action is required by the Company, the Board of Directors or the Company&#8217;s stockholders in connection
herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which
the Company is a party has been (or upon delivery will have been) duly</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 0pc">executed by the Company and,
when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable
against the Company in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting enforcement of creditors&#8217; rights generally, (ii) as limited
by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification
and contribution provisions may be limited by applicable law or public policy.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>No Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents
to which it is a party, the issuance and sale of the Shares and the consummation by it of the transactions contemplated hereby and thereby
do not and will not: (i) conflict with or violate any provision of the Company&#8217;s or any Subsidiary&#8217;s certificate or articles
of incorporation, bylaws or other organizational or charter documents, (ii) conflict with, or constitute a default (or an event that with
notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets
of the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation (with or without
notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or
otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or
any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule,
regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a
Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company
or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected
to result in a Material Adverse Effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Filings, Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give
any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings
required pursuant to Section 4.4 of this Agreement, (ii) the filings with the Commission pursuant to the Registration Rights Agreement,
(iii) the notice and/or application(s) to each applicable Trading Market for the issuance and sale of the Shares and the listing of the
Conversion Shares for trading thereon in the time and manner required thereby, and (iv) the filing of Form D with the Commission and such
filings as are required to be made under applicable state securities laws (collectively, the &#8220;<U>Required Approvals</U>&#8221;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Issuance of the Shares</U>. The Shares are duly authorized and, when issued and paid for in accordance with the applicable Transaction
Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than
restrictions on transfer provided for in the Transaction Documents. The Conversion Shares, when issued in accordance with the Preferred
Stock and the Transaction Documents will be validly issued, fully paid and non-assessable, free and clear of all Liens imposed by the
Company other than restrictions on transfer provided for in the Transaction Documents. The Company has reserved from its duly authorized
capital stock the maximum number of Conversion Shares issuable pursuant to this Agreement, the Certificate of Designation and the Preferred
Stock.</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Capitalization</U>. The capitalization of the Company is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule 3.1(g)</U>
shall also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date
hereof. Except as set forth on <U>Schedule 3.1(g)</U>, the Company has not issued any capital stock since its most recently filed periodic
report under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&#8217;s stock option plans,
the issuance of shares of Common Stock to employees pursuant to the Company&#8217;s employee stock purchase plans and pursuant to the
conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the
Exchange Act. No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate
in the transactions contemplated by the Transaction Documents. Except as a result of the purchase and sale of the Shares or as set forth
in <U>Schedule 3.1(g)</U>, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person
any right to subscribe for or acquire any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings
or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock
Equivalents or capital stock of any Subsidiary. The issuance and sale of the Shares will not obligate the Company or any Subsidiary to
issue shares of Common Stock or other securities to any Person (other than the Purchasers) and will not result in a right of any holder
of Company securities to adjust the exercise, conversion, exchange or reset price under any of such securities. There are no outstanding
securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts,
commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the
Company or such Subsidiary. The Company does not have any stock appreciation rights or &#8220;phantom stock&#8221; plans or any similar
plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable,
have been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation
of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder,
the Board of Directors or others is required for the issuance and sale of the Shares. There are no stockholder agreements, voting agreements
or other similar agreements with respect to the Company&#8217;s capital stock to which the Company is a party or, to the knowledge of
the Company, between or among any of the Company&#8217;s stockholders.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the
two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein
as the &#8220;<U>SEC Reports</U>&#8221;) on a timely basis or has received a valid extension of such time of filing and has filed any
such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material
respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make
the statements therein, in the light</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 0pc">of the circumstances under
which they were made, not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities Act. The financial
statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the
rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared
in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved (&#8220;<U>GAAP</U>&#8221;),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and
its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended,
subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements
included within the SEC Reports, except as set forth on <U>Schedule 3.1(i)</U> or in the SEC Reports: (i) there has been no event, occurrence
or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred
any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business
consistent with past practice and (B) liabilities not required to be reflected in the Company&#8217;s financial statements pursuant to
GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has
not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements
to purchase or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director
or Affiliate, except pursuant to existing Company stock option plans. The Company does not have pending before the Commission any request
for confidential treatment of information. Except for the issuance of the Shares contemplated by this Agreement or as set forth on <U>Schedule
3.1(i)</U>, no event, liability, fact, circumstance, occurrence or development has occurred or exists, or is reasonably expected to occur
or exist, with respect to the Company or its Subsidiaries or their respective businesses, properties, operations, assets or financial
condition, that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made
or deemed made that has not been publicly disclosed at least 1 Trading Day prior to the date that this representation is made.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(j)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Litigation</U>. There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge
of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by any court,
arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an
&#8220;<U>Action</U>&#8221;) which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction
Documents or the Shares or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse
Effect. Neither the Company nor any Subsidiary, nor, to the knowledge of the Company, any director or officer thereof, is or has been
the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of
fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the
Commission involving the Company or any current or former director or officer of the Company. The Commission has not issued any stop order
or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act
or the Securities Act.</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(k)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&#8217;s or its Subsidiaries&#8217;
employees is a member of a union that relates to such employee&#8217;s relationship with the Company or such Subsidiary, and neither the
Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that
their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and
foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours,
except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(l)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Compliance</U>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred
that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under),
nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree, or order of any court, arbitrator
or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental
authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational
health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be
expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(m)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Environmental Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws
relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface
or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants,
or toxic or hazardous substances or wastes (collectively, &#8220;<U>Hazardous Materials</U>&#8221;) into the environment, or otherwise
relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials,
as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters,
orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&#8220;<U>Environmental Laws</U>&#8221;);
(ii) have received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective
businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i),
(ii) and (iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(n)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the
appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the
SEC Reports, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect
(&#8220;<U>Material Permits</U>&#8221;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to
the revocation or modification of any Material Permit.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(o)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Title to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned
by them and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment
of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and the payment of which
is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(p)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Intellectual Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights as described in the SEC Reports as necessary or required for use in connection with their respective businesses and
which the failure to so have could have a Material Adverse Effect (collectively, the &#8220;<U>Intellectual Property Rights</U>&#8221;).
None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property
Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the
date of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements
included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate
or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To
the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person
of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy,
confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(q)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such
losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged,
including, but not limited to, directors and officers insurance coverage at least equal to the dollar amount specified on <U>Schedule
3.1(q)</U>. Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance
coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business
without a significant increase in cost.</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(r)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Transactions With Affiliates and Employees</U>. None of the officers or directors of the Company or any Subsidiary and, to the
knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company
or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement
providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing
of money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge
of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director,
trustee, stockholder, member or partner, in each case in excess of $120,000 other than for: (i) payment of salary or consulting fees for
services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock
option agreements under any stock option plan of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(s)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company and the Subsidiaries are in material compliance with any and all
applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and
regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company
and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions
are executed in accordance with management&#8217;s general or specific authorizations, (ii) transactions are recorded as necessary to
permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted
only in accordance with management&#8217;s general or specific authorization, and (iv) the recorded accountability for assets is compared
with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the
Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company
and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company
in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified
in the Commission&#8217;s rules and forms. The Company&#8217;s certifying officers have evaluated the effectiveness of the disclosure
controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report
under the Exchange Act (such date, the &#8220;<U>Evaluation Date</U>&#8221;). The Company presented in its most recently filed periodic
report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures
based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over
financial reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or
is reasonably likely to materially affect, the internal control over financial reporting of the Company or its Subsidiaries.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(t)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Certain Fees</U>. Other than any commissions and expenses payable to Northland Securities, Inc., no brokerage or finder&#8217;s
fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement
agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers
shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type
contemplated in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(u)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Private Placement</U>. Assuming the accuracy of the Purchasers&#8217; representations and warranties set forth in Section 3.2,
no registration under the Securities Act is required for the offer and sale of the Shares by the Company to the Purchasers as contemplated
hereby. The issuance and sale of the Shares hereunder do not contravene the rules and regulations of the Trading Market.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(v)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Shares,
will not be or be an Affiliate of, an &#8220;investment company&#8221; within the meaning of the Investment Company Act of 1940, as amended.
The Company shall conduct its business in a manner so that it will not become an &#8220;investment company&#8221; subject to registration
under the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(w)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Registration Rights</U>. Other than each of the Purchasers, no Person has any right to cause the Company to effect a registration
under the Securities Act of any securities of the Company or any Subsidiary.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(x)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Listing and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange
Act, and the Company has taken no action designed to terminate, or which to its knowledge is likely to have the effect of terminating,
the registration of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating
terminating such registration. Other than as disclosed in the SEC Reports, the Company has not, in the 12 months preceding the date hereof,
received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not
in compliance with the listing or maintenance requirements of such Trading Market. Other than as disclosed in the SEC Reports, the Company
is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance
requirements. The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established
clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing
corporation) in connection with such electronic transfer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(y)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in
order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights
agreement) or other similar anti-takeover provision under the Company&#8217;s certificate of incorporation (or similar charter documents)
or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company
fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of the
Company&#8217;s issuance of the Shares and the Purchasers&#8217; ownership of the Shares.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(z)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their
agents or counsel with any information that it believes constitutes or might constitute material, non-public information. The Company
understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of the
Company. All of</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 0pc">the disclosure furnished by
or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions
contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct and does not contain any untrue statement
of a material fact or omit to state any material fact necessary in order to make the statements made therein, in light of the circumstances
under which they were made, not misleading. The press releases disseminated by the Company during the 12 months preceding the date of
this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made and when
made, not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect
to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(aa)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>No Integrated Offering</U>. Assuming the accuracy of the Purchasers&#8217; representations and warranties set forth in Section
3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any
offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the
Shares to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration
of any such securities under the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which
any of the securities of the Company are listed or designated.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(bb)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Solvency</U>. &nbsp;Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect
to the receipt by the Company of the proceeds from the sale of the Shares hereunder: (i) the fair saleable value of the Company&#8217;s
assets exceeds the amount that will be required to be paid on or in respect of the Company&#8217;s existing debts and other liabilities
(including known contingent liabilities) as they mature, (ii) the Company&#8217;s assets do not constitute unreasonably small capital
to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular
capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability
thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all
of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of
its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts
as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge
of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one year from the Closing Date. <U>Schedule 3.1(bb)</U> sets forth as of the date hereof all outstanding
secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. Neither
the Company nor any Subsidiary is in default with respect to any Indebtedness. For the purposes of this Agreement, &#8220;<U>Indebtedness</U>&#8221;
means (x) any liabilities for borrowed money or amounts owed in excess of $100,000 (other than trade accounts payable incurred in the
ordinary course of business); (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others,
whether or not the same are or should be reflected in the Company&#8217;s consolidated balance sheet (or the notes thereto), except guaranties
by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (z)
the present value of any lease payments in excess of $100,000 due under leases required to be capitalized in accordance with GAAP.</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(cc)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Tax Status</U>. Except as set forth on <U>Schedule 3.1(cc)</U> and for matters that would not, individually or in the aggregate,
have or reasonably be expected to result in a Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all
United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any
jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount,
shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate
for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There
are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company
or of any Subsidiary know of no basis for any such claim.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(dd)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>No General Solicitation</U>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the
Shares by any form of general solicitation or general advertising. Assuming the accuracy of the Purchasers&#8217; representations and
warranties under this Agreement, the Company has offered the Shares for sale only to the Purchasers and certain other &#8220;accredited
investors&#8221; within the meaning of Rule 501 under the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ee)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Foreign Corrupt Practices</U>. Neither the Company nor any Subsidiary nor, to the knowledge of the Company or any Subsidiary,
any agent or other person acting on behalf of the Company or any Subsidiary, has: (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law or (iv) violated in any material respect any provision of FCPA.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ff)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Accountants</U>. The Company&#8217;s accounting firm is set forth on <U>Schedule 3.1(ff)</U> of the Disclosure Schedules. To
the knowledge and belief of the Company, such accounting firm: (i) is a registered public accounting firm as required by the Exchange
Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company&#8217;s Annual Report for
the fiscal year ended December 31, 2022.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(gg)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>No Disagreements with Accountants and Lawyers</U>. There are no disagreements of any kind presently existing, or reasonably
anticipated by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company
and the Company is current with respect to any fees owed to its accountants and lawyers which could affect the Company&#8217;s ability
to perform any of its obligations under any of the Transaction Documents.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(hh)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Acknowledgment Regarding Purchasers&#8217; Purchase of Shares</U>. To the Company&#8217;s knowledge, the Company acknowledges
and agrees that each of the Purchasers is acting solely in the capacity of an arm&#8217;s-length purchaser with respect to the Transaction
Documents and the transactions contemplated thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor
or fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 0pc">and any advice given by any
Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated
thereby is merely incidental to the Purchasers&#8217; purchase of the Shares. The Company further represents to each Purchaser that the
Company&#8217;s decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation
of the transactions contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ii)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Acknowledgment Regarding Purchaser&#8217;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary
notwithstanding (except for Sections 3.2(g) and 4.14 herein), it is understood and acknowledged by the Company that: (i) none of the Purchasers
has been asked by the Company to agree, nor has any Purchaser under this Agreement agreed, to desist from purchasing or selling, long
and/or short, securities of the Company, or &#8220;derivative&#8221; securities based on securities issued by the Company or to hold the
Shares for any specified term, (ii) past or future open market or other transactions by any Purchaser, specifically including, without
limitation, Short Sales or &#8220;derivative&#8221; transactions, before or after the closing of this or future private placement transactions,
may negatively impact the market price of the Company&#8217;s publicly-traded securities, (iii) any Purchaser, and counter-parties in
&#8220;derivative&#8221; transactions to which any such Purchaser is a party, directly or indirectly, may presently have a &#8220;short&#8221;
position in the Common Stock and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&#8217;s
length counter-party in any &#8220;derivative&#8221; transaction. The Company further understands and acknowledges that (y) one or more
Purchasers may engage in hedging activities at various times during the period that the Shares are outstanding, and (z) such hedging activities
(if any) could reduce the value of the existing stockholders&#8217; equity interests in the Company at and after the time that the hedging
activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any
of the Transaction Documents.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(jj)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Regulation M Compliance</U>. Within the past 12 months, the Company has not, and to its knowledge no one acting on its behalf
has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of
any security of the Company to facilitate the sale or resale of any of the Shares, (ii) sold, bid for, purchased, or paid any compensation
for soliciting purchases of, any of the Shares, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to
purchase any other securities of the Company, other than compensation paid to the Placement Agent in connection with the placement of
the Series D Convertible Preferred Stock and any compensation payable to Northland Securities, Inc. in connection with the Preferred Stock.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(kk)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&#8217;s knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(ll)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&#8217;s request.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc">(mm)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or, to the knowledge of the Company, Affiliates
is subject to the Bank Holding Company Act of 1956, as amended (the &#8220;<U>BHCA</U>&#8221;), and to regulation by the Board of Governors
of the Federal Reserve System (the &#8220;<U>Federal Reserve</U>&#8221;). Neither the Company nor any of its</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 0pc">Subsidiaries or, to the knowledge
of the Company, Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class
of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or, to the knowledge of the Company, Affiliates
exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation
by the Federal Reserve.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(nn)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Money Laundering</U>. &nbsp;The operations of the Company and its Subsidiaries &nbsp;are and have been conducted at all times
in compliance in all material respects with applicable financial record-keeping and reporting requirements of the Currency and Foreign
Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively,
the &#8220;<U>Money Laundering Laws</U>&#8221;), and no Action or Proceeding by or before any court or governmental agency, authority
or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge
of the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(oo)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>No Disqualification Events</U>. With respect to the Shares to be offered and sold hereunder in reliance on Rule 506 under the
Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of
the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&#8217;s outstanding voting equity
securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected
with the Company in any capacity at the time of sale (each, an &#8220;<U>Issuer Covered Person</U>&#8221; and, together, &#8220;<U>Issuer
Covered Persons</U>&#8221;) is subject to any of the &#8220;Bad Actor&#8221; disqualifications described in Rule 506(d)(1)(i) to (viii)
under the Securities Act (a &#8220;<U>Disqualification Event</U>&#8221;), except for a Disqualification Event covered by Rule 506(d)(2)
or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event.
The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Purchasers
a copy of any disclosures provided thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(pp)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Other Covered Persons</U>. The Company is not aware of any person (other than any Issuer Covered Person) that has been or will
be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Shares.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(qq)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Notice of Disqualification Events</U>. The Company will notify the Purchasers in writing, prior to the Closing Date of (i) any
Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, become a Disqualification
Event relating to any Issuer Covered Person.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">3.2</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Representations and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents
and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which
case they shall be accurate as of such date):</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Organization; Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its</P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 0pc">obligations hereunder and
thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the transactions contemplated
by the Transaction Documents have been duly authorized by all necessary corporate, partnership, limited liability company or similar action,
as applicable, on the part of such Purchaser. Each Transaction Document to which it is a party has been duly executed by such Purchaser,
and when delivered by such Purchaser in accordance with the terms hereof and thereof, will constitute the valid and legally binding obligation
of such Purchaser, enforceable against it in accordance with its terms, except: (i) as limited by general equitable principles and applicable
bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#8217; rights
generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies
and (iii) insofar as indemnification and contribution provisions may be limited by applicable law or public policy.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Own Account</U>. Such Purchaser understands that the Shares and Conversion Shares are &#8220;restricted securities&#8221; and
have not been registered under the Securities Act or any applicable state securities law and is acquiring the Shares and Conversion Shares
as principal for its own account and not with a view to or for distributing or reselling such Shares or Conversion Shares or any part
thereof in violation of the Securities Act or any applicable state securities law, has no present intention of distributing any of such
Shares or Conversion Shares in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement
or understandings with any other persons to distribute or regarding the distribution of such Shares or Conversion Shares in violation
of the Securities Act or any applicable state securities law (this representation and warranty not limiting such Purchaser&#8217;s right
to sell the Conversion Shares pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities
laws). Such Purchaser is acquiring the Shares and Conversion Shares hereunder in the ordinary course of its business.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Purchaser Status</U>. At the time such Purchaser was offered the Shares, it was, and as of the date hereof it is, either: (i)
an &#8220;accredited investor&#8221; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(5), (a)(7), (a)(8) or (a)(9) under the Securities
Act or (ii) a &#8220;qualified institutional buyer&#8221; as defined in Rule 144A(a) under the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Shares and Conversion Shares, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the
economic risk of an investment in the Shares and Conversion Shares and, at the present time, is able to afford a complete loss of such
investment.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>General Solicitation</U>. Such Purchaser is not purchasing the Shares or the Conversion Shares as a result of any advertisement,
article, notice or other communication regarding the Shares or the Conversion Shares published in any newspaper, magazine or similar media
or broadcast over television or radio or presented at any seminar or, to such Purchaser&#8217;s knowledge, any other general solicitation
or general advertisement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Access to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, representatives of the Company concerning</P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 0pc">the terms and conditions of
the offering of the Shares and Conversion Shares and the merits and risks of investing in the Shares and Conversion Shares; (ii) access
to information about the Company and its financial condition, results of operations, business, properties, management and prospects sufficient
to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or
can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Certain Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser
has not directly or indirectly, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, executed
any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such
Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the
material terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing,
in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of
such Purchaser&#8217;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser&#8217;s assets, the representation set forth above shall only apply with respect to the portion
of assets managed by the portfolio manager that made the investment decision to purchase the Shares covered by this Agreement. Other than
to other Persons party to this Agreement or to such Purchaser&#8217;s representatives, including, without limitation, its officers, directors,
partners, legal and other advisors, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to
it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for avoidance
of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to the identification
of the availability of, or securing of, available shares to borrow in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The Company acknowledges and
agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&#8217;s right to rely on
the Company&#8217;s representations and warranties contained in this Agreement or any representations and warranties contained in any
other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation
of the transaction contemplated hereby.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center; text-indent: 0pc"><FONT STYLE="text-transform: uppercase"><B>ARTICLE
IV.</B></FONT><BR>
<B>OTHER AGREEMENTS OF THE PARTIES</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Transfer Restrictions</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>The Shares and Conversion Shares may only be disposed of in compliance with state and federal securities laws. In connection with
any transfer of Shares or Conversion Shares other than pursuant to an effective registration statement or Rule 144, to the Company or
to an Affiliate of a Purchaser or in connection with a pledge as contemplated in Section 4.1(b), the Company may require the transferor
thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form
and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration
of such transferred Shares or Conversion</P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 0pc">Shares under the Securities
Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and the Registration
Rights Agreement and shall have the rights and obligations of a Purchaser under this Agreement and the Registration Rights Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Shares and Conversion
Shares in the following form:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 3pc 1pc; text-align: justify">THIS SECURITY HAS NOT BEEN REGISTERED WITH
THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY MAY BE
PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT
IS AN &#8220;ACCREDITED INVESTOR&#8221; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The Company acknowledges and
agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant
a security interest in some or all of the Shares or Conversion Shares to a financial institution that is an &#8220;accredited investor&#8221;
as defined in Rule 501(a) under the Securities Act and who agrees to be bound by the provisions of this Agreement and the Registration
Rights Agreement and, if required under the terms of such arrangement, such Purchaser may transfer pledged or secured Shares or Conversion
Shares to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company and no legal opinion
of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no notice shall be required
of such pledge. At the appropriate Purchaser&#8217;s expense, the Company will execute and deliver such reasonable documentation as a
pledgee or secured party of Shares or Conversion Shares may reasonably request in connection with a pledge or transfer of the Shares or
Conversion Shares, including, if the Conversion Shares are subject to registration pursuant to the Registration Rights Agreement, the
preparation and filing of any required prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable provision
of the Securities Act to appropriately amend the list of Selling Stockholders (as defined in the Registration Rights Agreement) thereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>Certificates evidencing the Shares or Conversion Shares shall not contain any legend (including the legend set forth in Section
4.1(b) hereof), (i) while a registration statement (including the Registration Statement) covering the resale of such security is effective
under the Securities Act, (ii) following any sale of such Shares or Conversion Shares pursuant to Rule 144, (iii) if such Shares are eligible
for sale under Rule 144, and the Company is then in compliance with the current public information required under Rule 144 or if the Conversion
Shares may be sold without the requirement for the Company to</P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 0pc">be in compliance with the
current public information required under Rule 144 as to such Shares or Conversion Shares and without volume or manner-of-sale restrictions,
or (iv) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements
issued by the staff of the Commission), the Company shall instruct its Transfer Agent to remove the legend from certificates evidencing
the Shares or Conversion Shares. The Company shall, at its expense, cause its counsel to issue a legal opinion to the Transfer Agent promptly
after the Effective Date if required by the Transfer Agent to effect the removal of the legend hereunder or if requested by a Purchaser
and shall instruct its Transfer Agent to remove the legend without requiring a medallion guarantee and provide such indemnity to its Transfer
Agent as the Transfer Agent may require to waive any medallion guarantee requirement. The Company agrees that following the Effective
Date or at such time as such legend is no longer required under this Section 4.1(c), it will, no later than the earlier of (i) two (2)
Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined below), in each case following
the delivery by a Purchaser to the Company or the Transfer Agent of a certificate representing Shares and Conversion Shares issued with
a restrictive legend (such earlier date, the &#8220;<U>Legend Removal Date</U>&#8221;), deliver or cause to be delivered to such Purchaser
a certificate representing such shares that is free from all restrictive and other legends. The Company may not make any notation on its
records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4. The Company
shall cause certificates for Shares or Conversion Shares subject to legend removal hereunder to be transmitted by the Transfer Agent to
the Purchaser by crediting the account of the Purchaser&#8217;s prime broker with the Depository Trust Company System as directed by such
Purchaser. As used herein, &#8220;<U>Standard Settlement Period</U>&#8221; means the standard settlement period, expressed in a number
of Trading Days, on the Company&#8217;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of
a stock certificate for removal of legends.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>Each Purchaser, severally and not jointly with the other Purchasers, agrees that such Purchaser may only sell any Shares or Conversion
Shares pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements,
or an exemption therefrom, and that if Shares or Conversion Shares are sold pursuant to a Registration Statement, they will be sold in
compliance with the plan of distribution set forth therein, and acknowledges that the removal of the restrictive legend from certificates
representing Shares or Conversion Shares as set forth in this Section 4.1 is predicated upon the Company&#8217;s reliance upon this understanding.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>The Company shall hold a special meeting of stockholders (which may also be the annual meeting of stockholders) at the earliest
practical date, but in no event later than 120 days following the Closing Date (150 days in the event of a review of the proxy statement
by the Commission), for the purpose of obtaining Stockholder Approval, with the recommendation of the Company&#8217;s Board of Directors
that such approval be approved, and the Company shall solicit proxies from its stockholders in connection therewith in the same manner
as all other management proposals in such proxy statement and all management-appointed proxyholders shall vote their proxies in favor
of such proposal. The Company shall use best efforts to obtain Stockholder Approval. If the Company does not obtain Stockholder Approval
at the first meeting, the Company shall call a meeting every four months thereafter to seek Stockholder Approval until Stockholder Approval
is obtained. Prior to any such stockholder meeting, the Company shall timely file a proxy statement pursuant to Section 14(a) of the Exchange
Act in compliance in all material respects with the provisions of the Company&#8217;s bylaws and all applicable law.</P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.2</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Furnishing of Information; Public Information</U>. Until the time that (i) no Purchaser owns Shares or (ii) 24 months after
the date hereof, the Company covenants to maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act
and to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed
by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements
of the Exchange Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.3</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Integration</U>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any
security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Shares in a manner that
would require the registration under the Securities Act of the sale of the Shares or that would be integrated with the offer or sale of
the Shares for purposes of the rules and regulations of any Trading Market such that it would require shareholder approval prior to the
closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.4</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Securities Laws Disclosure; Publicity</U>. The Company shall file a Current Report on Form 8-K disclosing the material terms
of the transactions contemplated hereby, including the Transaction Documents as exhibits thereto, with the Commission within the time
required by the Exchange Act. From and after the filing of such Form 8-K, the Company represents to the Purchasers that it shall have
publicly disclosed all material, non-public information delivered to any of the Purchasers by the Company or any of its Subsidiaries,
or any of their respective officers, directors, employees or agents in connection with the transactions contemplated by the Transaction
Documents. The Company and each Purchaser shall consult with each other in issuing any press releases with respect to the transactions
contemplated hereby, and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement
without the prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser,
with respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure
is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement
or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name
of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such
Purchaser, except: (a) as required by federal securities law in connection with (i) any registration statement contemplated by the Registration
Rights Agreement and (ii) the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required
by law or Trading Market regulations, in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted
under this clause (b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.5</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Shareholder Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other
Person, that any Purchaser is an &#8220;Acquiring Person&#8221; under any control share acquisition, business combination, poison pill
(including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the
Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Shares
under the Transaction Documents or under any other agreement between the Company and the Purchasers.</P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.6</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Non-Public Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the
Transaction Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other
Person acting on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company
reasonably believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented to the receipt
of such information and agreed with the Company to keep such information confidential. The Company understands and confirms that each
Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company
delivers any material, non-public information to a Purchaser without such Purchaser&#8217;s consent, the Company hereby covenants and
agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective
officers, directors, agents, employees or Affiliates, or a duty to the Company, and of its Subsidiaries or any of their respective officers,
directors, agents, employees or Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser
shall remain subject to applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains,
material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the
Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the
foregoing covenant in effecting transactions in securities of the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.7</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Use of Proceeds</U>. Except as set forth on <U>Schedule 4.7</U> attached hereto, the Company shall use the net proceeds from
the sale of the Shares hereunder for working capital purposes.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.8</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Indemnification of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser
and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser
(within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a &#8220;<U>Purchaser Party</U>&#8221;) harmless from any
and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in
settlements, court costs and reasonable attorneys&#8217; fees and costs of investigation that any such Purchaser Party may suffer or incur
as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in
this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any
of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Parties, with respect
to any of the transactions contemplated by the Transaction Documents (unless such action is based upon a breach of such Purchaser Party&#8217;s
representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Parties may
have with any such stockholder or any violations by such Purchaser Parties of state or federal securities laws or any conduct by such
Purchaser Parties which constitutes fraud, gross negligence, willful misconduct or malfeasance). If any action shall be brought against
any</P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 0pc">Purchaser Party in respect
of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the
Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party.
Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the
fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof
has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such
defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel, a material conflict on any material
issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for
the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under
this Agreement (y) for any settlement by such Purchaser Party effected without the Company&#8217;s prior written consent, which shall
not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable
to such Purchaser Party&#8217;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party
in this Agreement or in the other Transaction Documents. The indemnification required by this Section 4.8 shall be made by periodic payments
of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity
agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or
others and any liabilities the Company may be subject to pursuant to law.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.9</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Reservation of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and
keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the
Company to issue Conversion Shares upon conversion of the Preferred Stock.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.10</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Listing of Common Stock</U>. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common
Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote
all of the Conversion Shares on such Trading Market and promptly secure the listing or quotation of all of the Conversion Shares on such
Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will
then include in such application all of the Conversion Shares, and will take such other action as is necessary to cause all of the Conversion
Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary
to continue the listing or quotation and trading of its Common Stock on a Trading Market and will comply in all respects with the Company&#8217;s
reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company shall maintain the eligibility of
the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including,
without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection
with such electronic transfer.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.11</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Equal Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered
or paid to any Person to amend or consent to a waiver or modification of any provision of this Agreement or any of the Transaction Documents
unless the same consideration is also offered to all of the parties to this Agreement or any of the Transaction Documents. For clarification
purposes, this provision constitutes a</P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 0pc">separate right granted to
each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as
a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition
or voting of Shares or Conversion Shares or otherwise.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.12</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Certain Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants
that neither it, nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales,
including Short Sales, of any of the Company&#8217;s securities during the period commencing with the execution of this Agreement and
ending at such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the Form 8-K as described
in Section 4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions
contemplated by this Agreement are publicly disclosed by the Company pursuant to the Form 8-K as described in Section 4.4, such Purchaser
will maintain the confidentiality of the existence and terms of this transaction and the information included in the Transaction Documents
and the Disclosure Schedules. Notwithstanding the foregoing, and notwithstanding anything contained in this Agreement to the contrary,
the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that it will
not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated by this Agreement
are first publicly announced pursuant to the Form 8-K as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited
from effecting any transactions in any securities of the Company in accordance with applicable securities laws from and after the time
that the transactions contemplated by this Agreement are first publicly announced pursuant to the Form 8-K as described in Section 4.4
and (iii) this Agreement shall impose no duty on any Purchaser of confidentiality or to not trade in the securities of the Company to
the Company or its Subsidiaries after the issuance of the Form 8-K as described in Section 4.4. Notwithstanding the foregoing, in the
case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&#8217;s
assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions
of such Purchaser&#8217;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio
manager that made the investment decision to purchase the Shares covered by this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.13</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Form D; Blue Sky Filings</U>. The Company shall timely file a Form D with respect to the Shares and Conversion Shares as required
under Regulation D and provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company
shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Shares for, sale to the Purchasers at the
Closing under applicable securities or &#8220;Blue Sky&#8221; laws of the states of the United States, and shall provide evidence of such
actions promptly upon request of any Purchaser.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.14</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Acknowledgment of Dilution</U>. The Company acknowledges that the issuance of the Shares may result in dilution of the outstanding
shares of Common Stock, which dilution may be substantial. The Company further acknowledges that its obligations under the Transaction
Documents, including, without limitation, its obligation to issue the Shares and Conversion Shares pursuant to the Transaction Documents,
are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of
any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive effect that such issuance may
have on the ownership of the other stockholders of the Company.</P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.15</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Subsequent Financing</U>. From the date hereof until the date that is the twenty four (24) month anniversary of the Effective
Date, the Company shall use its commercially reasonable efforts to, prior to any issuance by the Company or any of its Subsidiaries of
Common Stock or Common Stock Equivalents for cash consideration, or a combination of units thereof (a &#8220;<U>Subsequent Financing</U>&#8221;),
provide each Purchaser with (x) written notice of the Subsequent Financing (including the contemplated terms and conditions of the Subsequent
Financing, the amount of proceeds intended to be raised thereunder and the Person or Persons through or with whom such Subsequent Financing
is proposed to be effected) and (y) the opportunity to consult reasonably with the Company with respect to the terms and conditions of
such Subsequent Financing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.16</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Subsequent Equity Sales</U>. Without the prior written consent of the Purchasers, the Company or any Subsidiary as applicable
shall not, on or prior to December 31, 2023, sell or issue Common Stock or Common Stock Equivalents (a &quot;<U>Subsequent Issuance</U>&quot;),
if such Subsequent Issuance entitles any Person to acquire shares of Common Stock at an effective price per share that is lower than the
then Conversion Price (as defined in the Preferred Stock) (such lower price, the &quot;<U>Base Conversion Price</U>&quot;). If the Purchasers
do consent to a Subsequent Issuance, the Company shall authorize a new series of its preferred stock, par value $0.001 per share (the
&quot;<U>New Preferred</U>&quot;), which shall contain the identical rights, preferences and terms as the Preferred Stock except that
the conversion price of the New Preferred shall be the Base Conversion Price. The Company shall thereupon issue to each Purchaser (in
exchange for such Purchaser's shares of Preferred Stock) a number of shares of New Preferred equal to the number of shares then held by
such Purchaser of the Preferred Stock. Any such exchange shall be pursuant to the terms of Section 3(a)(9) of the Securities Act. Any
shares of New Preferred, upon issuance to a Purchaser pursuant hereto, and any shares of Common Stock issuable upon conversion of the
New Preferred, upon conversion pursuant to the terms thereof, shall be duly authorized, validly issued, fully paid and nonassessable.
Any shares of Preferred Stock exchanged for shares of New Preferred shall be cancelled. This Section 4.16 shall not be applicable in respect
to an Exempt Issuance.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center; text-indent: 0pc"><FONT STYLE="text-transform: uppercase"><B>ARTICLE
V.<BR>
MISCELLANEOUS</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.1</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Termination</U>. This Agreement may be terminated by any Purchaser, as to such Purchaser&#8217;s obligations hereunder only
and without any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties,
if the Closing has not been consummated on or before _____________, 2023; provided, however, that such termination will not affect the
right of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.2</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Fees and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the
fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident
to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees
(including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company), stamp taxes
and other taxes and duties levied in connection with the delivery of any Shares and Conversion Shares to the Purchasers.</P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.3</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding
of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written,
with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.4</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall
be in writing and shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication
is delivered via email at the address set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on
a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via email at the
address set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time)
on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight
courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and
communications shall be as set forth on the signature pages attached hereto. To the extent that any notice provided pursuant to any Transaction
Document constitutes, or contains material, non-public information regarding the Company or any of the Subsidiaries, the Company shall
simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.5</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written
instrument signed, in the case of an amendment, by the Company and the Purchasers holding at least 51% in interest of the Shares then
outstanding or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought; provided, that
if any amendment, modification or waiver disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of
such disproportionately impacted Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect to any
provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent
default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise
any right hereunder in any manner impair the exercise of any such right.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.6</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed
to limit or affect any of the provisions hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.7</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom
such Purchaser assigns or transfers any Shares or Conversion Shares, provided that such transferee agrees in writing to be bound, with
respect to the transferred Shares or Conversion Shares, by the provisions of the Transaction Documents that apply to the &#8220;Purchasers.&#8221;</P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.8</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>No Third-Party Beneficiaries</U>. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise
set forth in Section 4.8.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.9</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles
of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the
transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective
affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and
federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal
courts sitting in the City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith
or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents),
and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the
jurisdiction of any such court, or that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party
hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding by mailing
a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect
for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.
If any party hereto shall commence an Action or Proceeding to enforce any provisions of &nbsp;the Transaction Documents, then, in addition
to the obligations of the Company under Section 4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing
party for its reasonable attorneys&#8217; fees and other costs and expenses incurred with the investigation, preparation and prosecution
of such Action or Proceeding.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.10</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Survival</U>. The representations and warranties contained herein shall survive the Closing and the delivery of the Shares.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.11</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission,
by electronic mail (including &#8220;.pdf&#8221; or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g.,
docusign.com) or other transmission method, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if it were an original thereof.</P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.12</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by
such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.13</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar
provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may
rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.14</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Replacement of Shares</U>. If any certificate or instrument evidencing any Shares or Conversion Shares is mutilated, lost, stolen
or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case
of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably
satisfactory to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances
shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Shares
or Conversion Shares.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.15</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of
damages, each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties
agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in
the Transaction Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the
defense that a remedy at law would be adequate.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.16</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction
Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement
or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged
by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law
(including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent
of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force
and effect as if such payment had not been made or such enforcement or setoff had not occurred.</P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.17</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Independent Nature of Purchasers&#8217; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction
Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the
performance or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in
any other Transaction Document, and no action taken by any Purchaser pursuant hereof or thereto, shall be deemed to constitute the Purchasers
as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any
way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of
this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional
party in any proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation
of the Transaction Documents. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the
convenience of the Company and not because it was required or requested to do so by any of the Purchasers.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.18</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.19</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to
revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved
against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition,
each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.20</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>WAIVER OF JURY TRIAL</U>. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY,
THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center"><I>(Signature Pages Follow)</I></P>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 54%">
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">DUOS TECHNOLOGIES GROUP, INC.</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">By: __________________________</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Name: ________________________</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Title: _________________________</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD>
    <TD STYLE="width: 46%">
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Address for Notice:</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">7660 Centurion Parkway</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Suite 100</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Jacksonville, Florida 32256</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Attn:</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Email:</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">With a copy to</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">(which shall not constitute notice):</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Shutts &amp; Bowen LLP</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">200 South Biscayne Boulevard</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Suite 4100</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Miami, Florida 33131</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Attn: J. Thomas Cookson</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Email: tcookson@shutts.com</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center">[PURCHASER SIGNATURE PAGES TO DUOS TECHNOLOGIES
GROUP, INC. SECURITIES PURCHASE AGREEMENT]</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc">Name of Purchaser: ________________________________________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc"><I>Signature of Authorized Signatory of Purchaser</I>: _________________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc">Name of Authorized Signatory: _______________________________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc">Title of Authorized Signatory: ________________________________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc">Email Address of Authorized Signatory: ________________________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc">Facsimile Number of Authorized Signatory: _____________________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc">Address for Notice to Purchaser: ______________________________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc">Address for Delivery of Securities to Purchaser (if not same as address
for notice):</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc">_________________________________________________________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc">Subscription Amount: $ _____________________________________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc">Number of Shares: _________________________________________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc">EIN Number: _____________________________________________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>duot_ex10z2.htm
<DESCRIPTION>REGISTRATION RIGHTS AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-transform: uppercase; text-align: right">EXHIBIT 10.2</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt; text-transform: uppercase; text-align: center">fORM OF</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-transform: uppercase; text-align: center">REGISTRATION
RIGHTS AGREEMENT</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">This Registration Rights Agreement
(this &#8220;<U>Agreement</U>&#8221;) is made and entered into as of March&nbsp;27, 2023, between <B>Duos Technologies Group, Inc</B>.,
a Florida corporation (the &#8220;<U>Company</U>&#8221;), and each of the several purchasers signatory hereto (each such purchaser, a
&#8220;<U>Purchaser</U>&#8221; and, collectively, the &#8220;<U>Purchasers</U>&#8221;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">This Agreement is made pursuant
to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the &#8220;<U>Purchase Agreement</U>&#8221;).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The Company and each Purchaser
hereby agrees as follows:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">1.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Definitions</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><B>Capitalized terms used
and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement</B>.
As used in this Agreement, the following terms shall have the following meanings:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Advice</U>&#8221;
shall have the meaning set forth in Section 6(b).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Effectiveness Date</U>&#8221;
means, with respect to the Initial Registration Statement required to be filed hereunder, the 90<SUP>th</SUP> calendar day following the
date hereof (or, in the event of a &#8220;full review&#8221; by the Commission, the 120<SUP>th</SUP> calendar day following the date hereof)
and with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section 3(c), the 45<SUP>th</SUP>
calendar day following the date on which an additional Registration Statement is required to be filed hereunder (or, in the event of a
&#8220;full review&#8221; by the Commission, the 75<SUP>th</SUP> calendar day following the date such additional Registration Statement
is required to be filed hereunder); <U>provided</U>, <U>however</U>, that in the event the Company is notified by the Commission that
one or more of the above Registration Statements will not be reviewed or is no longer subject to further review and comments, the Effectiveness
Dates as to such Registration Statement shall be the fifth Trading Day following the date on which the Company is so notified if such
date precedes the dates otherwise required above, subject to the Commission agreeing to the five Trading Day or shorter period, provided,
further, if such Effectiveness Date falls on a day that is not a Trading Day, then the Effectiveness Date shall be the next succeeding
Trading Day.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Effectiveness Period</U>&#8221;
shall have the meaning set forth in Section 2(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Event</U>&#8221;
shall have the meaning set forth in Section 2(d).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Event Date</U>&#8221;
shall have the meaning set forth in Section 2(d).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Filing Date</U>&#8221;
means, with respect to the Initial Registration Statement required hereunder, the 45<SUP>th</SUP> calendar day following the date hereof
and, with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section 3(c), the earliest
practical date on which the Company is permitted by SEC Guidance to file such additional Registration Statement related to the Registrable
Securities.</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Holder</U>&#8221;
or &#8220;<U>Holders</U>&#8221; means the holder or holders, as the case may be, from time to time of Registrable Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Indemnified Party</U>&#8221;
shall have the meaning set forth in Section 5(c).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Indemnifying Party</U>&#8221;
shall have the meaning set forth in Section 5(c).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Initial Registration
Statement</U>&#8221; means the initial Registration Statement filed pursuant to this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Losses</U>&#8221;
shall have the meaning set forth in Section 5(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Plan of Distribution</U>&#8221;
shall have the meaning set forth in Section 2(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Prospectus</U>&#8221;
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information previously
omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the Commission
pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of
any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus,
including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Registrable Securities</U>&#8221;
means, as of any date of determination, (a) all Conversion Shares then issued and issuable to the Purchasers upon conversion of the Series
E Preferred Stock (assuming on such date the Series E Preferred Stock is converted in full without regard to any limitations on conversions
of the Series E Preferred Stock); and (b) any securities issued or then issuable to the Purchasers upon any stock split, dividend or other
distribution, recapitalization or similar event with respect to the foregoing; <U>provided, however</U>, that any such Registrable Securities
shall cease to be Registrable Securities (and the Company shall not be required to maintain the effectiveness of any, or file another,
Registration Statement hereunder with respect thereto) for so long as (a) a Registration Statement with respect to the sale of such Registrable
Securities is declared effective by the Commission under the Securities Act and such Registrable Securities have been disposed of by the
Holder in accordance with such effective Registration Statement, (b) such Registrable Securities have been previously sold in accordance
with Rule 144, or (c) such securities become eligible for resale without volume or manner-of-sale restrictions and without current public
information pursuant to Rule 144 as set forth in a written opinion letter to such effect, addressed, delivered and acceptable to the Transfer
Agent and the affected Holders (solely in the case that such securities and any securities issuable upon exercise, conversion or exchange
of which, or as a dividend upon which, such securities were issued or are issuable, were at no time held by any Affiliate of the Company,
as reasonably determined by the Company, upon the advice of counsel to the Company).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Registration Statement</U>&#8221;
means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional registration statements contemplated
by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such registration statement
or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated by reference or deemed
to be incorporated by reference in any such registration statement.</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Rule 415</U>&#8221;
means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Rule 424</U>&#8221;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>Selling Stockholder
Questionnaire</U>&#8221; shall have the meaning set forth in Section 3(a).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&#8220;<U>SEC Guidance</U>&#8221;
means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements or requests of the Commission
staff and (ii) the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">2.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Shelf Registration</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>On or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale
of all of the Registrable Securities that are not then registered on an effective Registration Statement for an offering to be made on
a continuous basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on Form S-3 (except if the Company is not
then eligible to register for resale the Registrable Securities on Form S-3, in which case such registration shall be on another appropriate
form in accordance herewith, subject to the provisions of Section 2(e)) and shall contain (unless otherwise directed by at least 51% in
interest of the Holders) substantially the &#8220;<U>Plan of Distribution</U>&#8221; attached hereto as <U>Annex A</U> and substantially
the &#8220;<U>Selling Stockholder</U>&#8221; section attached hereto as <U>Annex B</U>; <U>provided</U>, <U>however</U>, that no Holder
shall be required to be named as an &#8220;underwriter&#8221; without such Holder&#8217;s express prior written consent. Subject to the
terms of this Agreement, the Company shall use its best efforts to cause a Registration Statement filed under this Agreement (including,
without limitation, under Section 3(c)) to be declared effective under the Securities Act as promptly as possible after the filing thereof,
but in any event no later than the applicable Effectiveness Date, and shall use its best efforts to keep such Registration Statement continuously
effective under the Securities Act until the date that all Registrable Securities covered by such Registration Statement (i) have been
sold, thereunder or pursuant to Rule 144, or (ii) may be sold without volume or manner-of-sale restrictions pursuant to Rule 144 and without
the requirement for the Company to be in compliance with the current public information requirement under Rule 144, as determined by the
counsel to the Company pursuant to a written opinion letter to such effect, addressed and acceptable to the Transfer Agent and the affected
Holders (the &#8220;<U>Effectiveness Period</U>&#8221;). The Company shall request effectiveness of a Registration Statement as of 5:00
p.m. Eastern Time on a Trading Day. The Company shall notify the Holders via facsimile or by e-mail of the effectiveness of a Registration
Statement on the same Trading Day that the Company confirms effectiveness with the Commission, which shall be the date requested for effectiveness
of such Registration Statement. The Company shall, by 9:30 a.m. Eastern Time on the Trading Day after the effective date of such Registration
Statement, file a final Prospectus with the Commission as required by Rule 424. Failure to so notify the Holder within one (1) Trading
Day of such notification of effectiveness or failure to file a final Prospectus as foresaid shall be deemed an Event under Section 2(d).</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc 6pc; text-align: justify; text-indent: 0pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>Notwithstanding the registration obligations set forth in Section 2(a), if the staff of the Commission informs the Company that
all of the Registrable Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering
on a single registration statement, the Company shall promptly inform each of the Holders thereof and use its commercially reasonable
efforts to file amendments to the Initial Registration Statement as required by the staff of the Commission, covering the maximum number
of Registrable Securities permitted to be registered by the staff of the Commission, on Form S-3 or such other form available to register
for resale the Registrable Securities as a secondary offering, subject to the provisions of Section 2(e), with respect to filing on Form
S-3 or other appropriate form, and subject to the provisions of Section 2(d) with respect to the payment of liquidated damages; <U>provided</U>,
<U>however</U>, that prior to filing such amendment, the Company shall use diligent efforts to advocate with the staff of the Commission
for the registration of all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, Compliance
and Disclosure Interpretation 612.09.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>Notwithstanding any other provision of this Agreement and subject to the payment of liquidated damages pursuant to Section 2(d),
if the staff of the Commission or any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered
on a particular Registration Statement as a secondary offering (and notwithstanding that the Company used diligent efforts to advocate
with the staff of the Commission for the registration of all or a greater portion of Registrable Securities), unless otherwise directed
in writing by a Holder as to its Registrable Securities to register a lesser number, the number of Registrable Securities to be registered
on such Registration Statement will be reduced as follows:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">a.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>First, the Company shall reduce or eliminate any securities to be included other than Registrable Securities; and</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 9pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">b.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>Second, the Company shall reduce Registrable Securities represented by the Conversion Shares on a pro rata basis based on the total
number of unregistered Conversion Shares held by such Holders.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify">In the event of a cutback hereunder, the Company
shall give the Holder at least five (5) Trading Days prior written notice along with the calculations as to such Holder&#8217;s allotment.
In the event the Company amends the Initial Registration Statement in accordance with the foregoing, the Company will use its best efforts
to file with the Commission, as promptly as allowed by the staff of the Commission or SEC Guidance provided to the Company or to registrants
of securities in general, one or more registration statements on Form S-3 or such other form available to register for resale those Registrable
Securities that were not registered for resale on the Initial Registration Statement, as amended.</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>If: (i) the Initial Registration Statement is not filed on or prior to its Filing Date (if the Company files the Initial Registration
Statement without affording the Holders the opportunity to review and comment on the same as required by Section 3(a) herein, the Company
shall be deemed to have not satisfied this clause (i)), or (ii) prior to the effective date of a Registration Statement, the Company fails
to file a pre-effective amendment and otherwise respond in writing to comments made by the staff of the Commission in respect of such
Registration Statement within ten (10) Trading Days after the receipt of comments by or notice from staff of the Commission that such
amendment is required in order for such Registration Statement to be declared effective or (iii) a Registration Statement registering
for resale Registrable Securities is not declared effective by the Commission by the Effectiveness Date of the Initial Registration Statement,
or (iv) after the effective date of a Registration Statement, such Registration Statement ceases for any reason to remain continuously
effective as to the Registrable Securities included in such Registration Statement, or the Holders are otherwise not permitted to utilize
the Prospectus therein to resell such Registrable Securities, for more than twenty (20) consecutive calendar days or more than an aggregate
of thirty (30) Trading Days (which need not be consecutive Trading Days) during any 12-month period (any such failure or breach being
referred to as an &#8220;<U>Event</U>&#8221;, and for purposes of clauses (i) and (ii), the date on which such Event occurs, and for purpose
of clause (iii) the date on which such ten (10) Trading Day period is exceeded, and for the purpose of clause (iv) the date on which such
twenty (20) calendar day or thirty (30) Trading Day period, as applicable, is exceeded being referred to as &#8220;<U>Event Date</U>&#8221;),
then, in addition to any other rights the Holders may have hereunder or under applicable law, on each such Event Date and on each monthly
anniversary of each such Event Date (if the applicable Event shall not have been cured by such date) until the applicable Event is cured,
the Company shall pay to each Holder an amount in cash, as partial liquidated damages and not as a penalty, equal to the product of 1.00%
multiplied by the aggregate Subscription Amount paid by such Holder pursuant to the Purchase Agreement. If the Company fails to pay any
partial liquidated damages pursuant to this Section in full within thirty (30) days after the date payable, the Company will pay interest
thereon at a rate of 4.00% per annum (or such lesser maximum amount that is permitted to be paid by applicable law) to the Holder, accruing
daily from the date such partial liquidated damages are due until such amounts, plus all such interest thereon, are paid in full. The
partial liquidated damages pursuant to the terms hereof shall apply on a daily pro rata basis for any portion of a month prior to the
cure of an Event.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>If Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register
the resale of the Registrable Securities on another appropriate form and (ii) undertake to register the Registrable Securities on Form
S-3 as soon as such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement then in
effect until such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the
Commission.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>Notwithstanding anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate
of a Holder as any Underwriter without the prior written consent of such Holder.</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc 6pc; text-align: justify; text-indent: 0pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">3.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT> <U>Registration Procedures</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">In connection with the Company&#8217;s
registration obligations hereunder, the Company shall:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>Not less than five (5) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior
to the filing of any related Prospectus or any amendment or supplement thereto, the Company shall (i) furnish to each Holder copies of
all such documents proposed to be filed, which documents will be subject to the review of such Holders, and (ii) cause its officers and
directors, counsel and independent registered public accountants to respond to such inquiries as shall be necessary, in the reasonable
opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning of the Securities Act. The Company
shall not file a Registration Statement or any such Prospectus or any amendments or supplements thereto to which any Holder shall reasonably
object in good faith, provided that, the Company is notified of such objection in writing no later than three (3) Trading Days after the
Holders have been so furnished copies of a Registration Statement or one (1) Trading Day after the Holders have been so furnished copies
of any related Prospectus or amendments or supplements thereto. Each Holder agrees to furnish to the Company a completed questionnaire
in the form attached to this Agreement as <U>Annex C</U> (a &#8220;<U>Selling Stockholder Questionnaire</U>&#8221;) on a date that is
not less than two (2) Trading Days prior to the Filing Date or by the end of the fourth (4<SUP>th</SUP>) Trading Day following the date
on which such Holder receives draft materials in accordance with this Section.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>(i) Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and
the Prospectus used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable
Registrable Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in
order to register for resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended
or supplemented by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to
be filed pursuant to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect
to a Registration Statement or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies
of all correspondence from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information
contained <A NAME="second"></A>therein which would constitute material non-public information regarding the Company or any of its Subsidiaries),
and (iv) comply in all material respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the
disposition of all Registrable Securities covered by a Registration Statement during the applicable period in accordance (subject to the
terms of this Agreement) with the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so
amended or in such Prospectus as so supplemented.</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc 6pc; text-align: justify; text-indent: 0pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>If during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common
Stock then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior
to the applicable Filing Date (subject to SEC Guidance), an additional Registration Statement covering the resale by the Holders of not
less than the number of such Registrable Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>Notify the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be
accompanied by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably
possible (and, in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person)
confirm such notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement
or post-effective amendment to a Registration Statement is proposed to be filed, (B) when the Commission notifies the Company whether
there will be a &#8220;review&#8221; of such Registration Statement and whenever the Commission comments in writing on such Registration
Statement, and (C) with respect to a Registration Statement or any post-effective amendment, when the same has become effective, (ii)
of any request by the Commission or any other federal or state governmental authority for amendments or supplements to a Registration
Statement or Prospectus or for additional information, (iii) of the issuance by the Commission or any other federal or state governmental
authority of any stop order suspending the effectiveness of a Registration Statement covering any or all of the Registrable Securities
or the initiation of any Proceedings for that purpose, (iv) of the receipt by the Company of any notification with respect to the suspension
of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation
or threatening of any Proceeding for such purpose, (v) of the occurrence of any event or passage of time that makes the financial statements
included in a Registration Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus
or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions
to a Registration Statement, Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the
case may be, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein
or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, and (vi) of the
occurrence or existence of any pending corporate development with respect to the Company that the Company believes may be material and
that, in the determination of the Company, makes it not in the best interest of the Company to allow continued availability of a Registration
Statement or Prospectus, <U>provided</U>, <U>however</U>, in no event shall any such notice contain any information which would constitute
material, non-public information regarding the Company or any of its Subsidiaries.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>Use its best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the
effectiveness of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the
Registrable Securities for sale in any jurisdiction, at the earliest practicable moment.</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc 6pc; text-align: justify; text-indent: 0pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>Furnish to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto,
including financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent
requested by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated
by reference) promptly after the filing of such documents with the Commission; provided, that any such item which is available on the
EDGAR system (or successor thereto) need not be furnished in physical form.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>Subject to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement
thereto by each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus
and any amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>Prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate
with the selling Holders in connection with the registration or qualification (or exemption from the registration or qualification) of
such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United
States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during
the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions
of the Registrable Securities covered by each Registration Statement; provided, that, the Company shall not be required to qualify generally
to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction
where it is not then so subject or file a general consent to service of process in any such jurisdiction.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>If requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing
Registrable Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the
extent permitted by the Purchase Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such denominations
and registered in such names as any such Holder may request.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(j)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>Upon the occurrence of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking
into account the Company&#8217;s good faith assessment of any adverse consequences to the Company and its stockholders of the premature
disclosure of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement
to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required
document so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of
the circumstances under which they were made, not misleading. If the Company notifies the Holders in accordance with clauses (iii)</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 0pc">through (vi) of Section 3(d)
above to suspend the use of any Prospectus until the requisite changes to such Prospectus have been made, then the Holders shall suspend
use of such Prospectus. The Company will use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is
practicable. The Company shall be entitled to exercise its right under this Section 3(j) to suspend the availability of a Registration
Statement and Prospectus, subject to the payment of partial liquidated damages otherwise required pursuant to Section 2(d), for a period
not to exceed 60 calendar days (which need not be consecutive days) in any 12-month period.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(k)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>Otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission under the Securities
Act and the Exchange Act, including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any supplement
or amendment thereof, with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing if, at
any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof,
the Holders are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take such other actions
as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(l)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>The Company shall use its best efforts to acquire and maintain eligibility for use of Form S-3 (or any successor form thereto)
for the registration of the resale of Registrable Securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(m)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>The Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common
Stock beneficially owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive
control over the shares. During any periods that the Company is unable to meet its obligations hereunder with respect to the registration
of the Registrable Securities solely because any Holder fails to furnish such information within three Trading Days of the Company&#8217;s
request, any <A NAME="third"></A>liquidated damages that are accruing at such time as to such Holder only shall be tolled and any Event
that may otherwise occur solely because of such delay shall be suspended as to such Holder only, until such information is delivered to
the Company.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Registration Expenses</U>. All fees and expenses incident to the performance of or compliance with, this Agreement by the Company
shall be borne by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses
referred to in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation,
fees and expenses of the Company&#8217;s counsel and independent registered public accountants) (A) with respect to filings made with
the Commission, (B) with respect to filings required to be made with any Trading Market on which the Common Stock is then listed for trading,
and (C) in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing (including, without
limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions of the Registrable
Securities), (ii) printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities), (iii)
messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability insurance,
if the Company so desires such insurance, and (vi) fees and expenses of all other Persons</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 0pc">retained by the Company in
connection with the consummation of the transactions contemplated by this Agreement. In addition, the Company shall be responsible for
all of its internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement (including,
without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any
annual audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange
as required hereunder. In no event shall the Company be responsible for any broker or similar commissions of any Holder or, except to
the extent provided for in the Transaction Documents, any legal fees or other costs of the Holders.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Indemnification</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Indemnification by the Company</U>. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold
harmless each Holder, the officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities
as principal as a result of a pledge or any failure to perform under a margin call of Common Stock), investment advisors and employees
(and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any
other title) of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other Persons with
a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such
controlling Person, to the fullest extent permitted by applicable law, from and against any and <A NAME="fourth"></A>all losses, claims,
damages, liabilities, costs (including, without limitation, reasonable attorneys&#8217; fees) and expenses (collectively, &#8220;<U>Losses</U>&#8221;),
as incurred, arising out of or relating to (1) any untrue or alleged untrue statement of a material fact contained in a Registration Statement,
any Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of
or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein
(in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading or (2)
any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or
regulation thereunder, in connection with the performance of its obligations under this Agreement, except to the extent, but only to the
extent, that (i) such untrue statements or omissions are based solely upon information regarding such Holder furnished in writing to the
Company by such Holder expressly for use therein, or to the extent that such information relates to such Holder or such Holder&#8217;s
proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly
for use in a Registration Statement, such Prospectus or in any amendment or supplement thereto (it being understood that the Holder has
approved Annex A hereto for this purpose) or (ii) in the case of an occurrence of an event of the type specified in Section 3(d)(iii)-(vi),
the use by such Holder of an outdated, defective or otherwise unavailable Prospectus after the Company has notified such Holder in writing
that the Prospectus is outdated, defective or otherwise unavailable for use by such Holder and prior to the receipt by such Holder of
the Advice contemplated in Section 6(d). The Company shall notify the Holders promptly of the institution, threat or assertion of any
Proceeding arising from or in connection with the transactions contemplated by this Agreement of which the Company is aware. Such indemnity
shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified person and shall survive
the transfer of any Registrable Securities by any of the Holders in accordance with Section 6(e).</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc 6pc; text-align: justify; text-indent: 0pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Indemnification by Holders</U>. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors,
officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section
20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted
by applicable law, from and against all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged
untrue statement of a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto
or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be
stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances
under which they were made) not misleading (i) to the extent, but only to the extent, that such untrue statement or omission is contained
in any information so furnished in writing by such Holder to the Company expressly for inclusion in such Registration Statement <A NAME="fifth"></A>or
such Prospectus or (ii) to the extent, but only to the extent, that such information relates to such Holder&#8217;s information provided
in the Selling Stockholder Questionnaire or the proposed method of distribution of Registrable Securities and was reviewed and expressly
approved in writing by such Holder expressly for use in a Registration Statement (it being understood that the Holder has approved Annex
A hereto for this purpose), such Prospectus or in any amendment or supplement thereto. In no event shall the liability of a selling Holder
be greater in amount than the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating
to this Section 5 and the amount of any damages such Holder has otherwise been required to pay by reason of such untrue statement or omission)
received by such Holder upon the sale of the Registrable Securities included in the Registration Statement giving rise to such indemnification
obligation.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Conduct of Indemnification Proceedings</U>. If any Proceeding shall be brought or asserted against any Person entitled to indemnity
hereunder (an &#8220;<U>Indemnified Party</U>&#8221;), such Indemnified Party shall promptly notify the Person from whom indemnity is
sought (the &#8220;<U>Indemnifying Party</U>&#8221;) in writing, and the Indemnifying Party shall have the right to assume the defense
thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses
incurred in connection with defense thereof; provided, that, the failure of any Indemnified Party to give such notice shall not relieve
the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be
finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure
shall have materially and adversely prejudiced the Indemnifying Party.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">An Indemnified Party shall
have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees and expenses
of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed in writing
to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding and to employ
counsel reasonably satisfactory to such Indemnified Party in any such Proceeding or (3) the named parties to any such Proceeding (including
any impleaded parties) include both such Indemnified Party and the Indemnifying Party,</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 0pc">and counsel to the Indemnified
Party shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent such Indemnified
Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to
employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense
thereof and the reasonable fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying Party).
The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which consent
shall not be unreasonably withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified Party,
effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes
an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">Subject to the terms of this
Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent incurred in
connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall be paid to
the Indemnified Party, within thirty (30) Trading Days of written notice thereof to the Indemnifying Party; provided, that, the Indemnified
Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such actions for which
such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further
review) not to be entitled to indemnification hereunder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Contribution</U>. If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to
hold an Indemnified Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such
Indemnified Party, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party
in connection with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations.
The relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any
action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material
fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties&#8217;
relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount
paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement,
any reasonable attorneys&#8217; or other fees or expenses incurred by such party in connection with any Proceeding to the extent such
party would have been indemnified for such fees or expenses if the indemnification provided for in this Section was available to such
party in accordance with its terms.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The parties hereto agree that
it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata allocation or by any other
method of allocation that does not take into account the equitable considerations referred to in the immediately preceding paragraph.
In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the dollar amount of the
proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the amount of any damages
such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission) received
by it upon the sale of the Registrable Securities giving rise to such contribution obligation.</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The indemnity and contribution
agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to the Indemnified Parties.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">6.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Miscellaneous</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Remedies</U>. In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement,
each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement,
including recovery of damages, shall be entitled to specific performance of its rights under this Agreement. Each of the Company and each
Holder agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any
of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect of
such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>No Piggyback on Registrations; Prohibition on Filing Other Registration Statements</U>. Neither the Company nor any of its security
holders (other than the Holders in such capacity pursuant hereto) may include securities of the Company in any Registration Statements
other than the Registrable Securities. The Company shall not file any other registration statements until all Registrable Securities are
registered pursuant to a Registration Statement that is declared effective by the Commission, provided that this Section 6(b) shall not
prohibit the Company from filing amendments to registration statements filed prior to the date of this Agreement or a Registration Statement
on Form S-8 relating to any stock option or similar plan.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Discontinued Disposition</U>. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice
from the Company of the occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue
disposition of such Registrable Securities under a Registration Statement until it is advised in writing (the &#8220;<U>Advice</U>&#8221;)
by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will
use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company agrees and acknowledges
that any periods during which the Holder is required to discontinue the disposition of the Registrable Securities hereunder shall be subject
to the provisions of Section 2(d).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Amendments and Waivers</U>. The provisions of this Agreement, including the provisions of this sentence, may not be amended,
modified or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be
in writing and signed by the Company and the Holders of 51% or more of the then outstanding Registrable Securities, provided that, if
any amendment, modification or waiver disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately
impacted Holder (or group of Holders) shall be required. If a Registration Statement does not register all of the Registrable Securities
pursuant to a waiver or amendment done in compliance with the previous sentence, then the number of Registrable Securities to be registered
for each Holder shall be reduced pro rata among all Holders and each Holder shall have the right to</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 0pc">designate which of its Registrable
Securities shall be omitted from such Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions
hereof with respect to a matter that relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly
affect the rights of other Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such waiver
or consent relates; <U>provided</U>, <U>however</U>, that the provisions of this sentence may not be amended, modified, or supplemented
except in accordance with the provisions of the first sentence of this Section 6(d). No consideration shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration also is offered
to all of the parties to this Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(e)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall
be delivered as set forth in the Purchase Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(f)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Successors and Assigns</U>. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns
of each of the parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations
hereunder without the prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign
their respective rights hereunder in the manner and to the Persons as permitted under Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(g)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>No Inconsistent Agreements</U>. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall
the Company or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities,
that would have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions
hereof. Except as set forth on <U>Schedule 6(g)</U>, neither the Company nor any of its Subsidiaries has previously entered into any agreement
granting any registration rights with respect to any of its securities to any Person that have not been satisfied in full.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(h)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Execution and Counterparts</U>. This Agreement may be executed in two or more counterparts, all of which when taken together
shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered
to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered
by facsimile transmission, by electronic mail (including &#8220;.pdf&#8221; or any electronic signature complying with the U.S. federal
ESIGN Act of 2000, e.g. docusign.com) or other transmission method, such signature shall create a valid and binding obligation of the
party executing (or on whose behalf such signature is executed) with the same force and effect as if it were an original thereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(i)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall
be determined in accordance with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(j)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Cumulative Remedies</U>. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc 6pc; text-align: justify; text-indent: 0pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(k)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by
such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(l)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Headings</U>. The headings in this Agreement are for convenience only, do not constitute a part of this Agreement and shall
not be deemed to limit or affect any of the provisions hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(m)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><U>Independent Nature of Holders&#8217; Obligations and Rights</U>. The obligations of each Holder hereunder are several and not
joint with the obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations
of any other Holder hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action
taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture
or any other kind of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity
with respect to such obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges
that the Holders are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations
or transactions. Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out
of this Agreement, and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such purpose.
The use of a single agreement with respect to the obligations of the Company contained herein was solely in the control of the Company,
not the action or decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested
to do so by any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company and
a Holder, solely, and not between the Company and the Holders collectively and not between and among Holders.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">********************</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">IN WITNESS WHEREOF, the parties
have executed this Registration Rights Agreement as of the date first written above.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">DUOS TECHNOLOGIES GROUP, INC.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 52%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 38%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By: </TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name: </TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title: </TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">[SIGNATURE PAGES OF HOLDERS FOLLOW]</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc">SIGNATURE PAGE OF HOLDERS TO REGISTRATION RIGHTS AGREEMENT OF DUOS
TECHNOLOGIES GROUP, INC.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Name of Holder: __________________________________________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Signature of Authorized Signatory of Holder: ___________________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Name of Authorized Signatory: ______________________________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Title of Authorized Signatory: _______________________________________________</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Annex A</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center"><U>Plan of Distribution</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">Each Selling Stockholder (the
&#8220;<U>Selling Stockholders</U>&#8221;) of the securities and any of their pledgees, assignees and successors-in-interest may, from
time to time, sell, separately or together, any or all of their securities covered hereby on the principal Trading Market or any other
stock exchange, market or trading facility on which the securities are traded or in private transactions. These sales may be at fixed
or negotiated prices. To the extent the Selling Stockholders gift, pledge or otherwise transfer the securities offered hereby, such transferees
may offer and sell the securities from time to time under this prospectus, provided that, if required under the Securities Act, and the
rules and regulations promulgated thereunder, this prospectus has been amended under Rule 424(b)(3) or other applicable provision of the
Securities Act, to include the name of such transferee in the list of selling securityholders under this prospectus. A Selling Stockholder
may use any one or more of the following methods when selling securities:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 1pc"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3pc"></TD><TD STYLE="width: 1.5pc"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 1pc"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3pc"></TD><TD STYLE="width: 1.5pc"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">block trades in which the broker-dealer will attempt to sell the securities as agent but may position
and resell a portion of the block as principal to facilitate the transaction;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 1pc"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3pc"></TD><TD STYLE="width: 1.5pc"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 1pc"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3pc"></TD><TD STYLE="width: 1.5pc"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">an exchange distribution in accordance with the rules of the applicable exchange;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 1pc"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3pc"></TD><TD STYLE="width: 1.5pc"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">privately negotiated transactions;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 1pc"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3pc"></TD><TD STYLE="width: 1.5pc"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">through one or more underwritten offerings on a firm commitment or best efforts basis;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 1pc"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3pc"></TD><TD STYLE="width: 1.5pc"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">settlement of short sales that are not in violation of Regulation SHO;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 1pc"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3pc"></TD><TD STYLE="width: 1.5pc"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">in transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number
of such securities at a stipulated price per security;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 1pc"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3pc"></TD><TD STYLE="width: 1.5pc"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">through the writing or settlement of options or other hedging transactions, whether through an options
exchange or otherwise;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 1pc"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3pc"></TD><TD STYLE="width: 1.5pc"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">through the distribution of securities by any Selling Stockholder to its partners, members or securityholders;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 1pc"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3pc"></TD><TD STYLE="width: 1.5pc"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">a combination of any such methods of sale; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 1pc"><TR STYLE="vertical-align: top">
<TD STYLE="width: 3pc"></TD><TD STYLE="width: 1.5pc"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">any other method permitted pursuant to applicable law.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The Selling Stockholders may
also sell securities under Rule 144 or any other exemption from registration under the Securities Act of 1933, as amended (the &#8220;<U>Securities
Act</U>&#8221;), if available, rather than under this prospectus. The Selling Stockholders have the sole and absolute discretion not to
accept any purchase offer or make any sale of securities if they deem the purchase price to be unsatisfactory at any particular time.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">Broker-dealers engaged by
the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts
from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts
to be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction not in excess of a
customary brokerage commission in compliance with FINRA Rule 2440; and in the case of a principal transaction a markup or markdown in
compliance with FINRA IM-2440.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">In connection with the sale
of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial
institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling
Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities
to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option or other transactions with
broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer
or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution
may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The Selling Stockholders may
from time to time pledge or grant a security interest in some or all of their securities to their broker-dealers under the margin provisions
of customer agreements or to other parties to secure other obligations. If a Selling Stockholder defaults on a margin loan or other secured
obligation, the broker-dealer or secured party may, from time to time, offer and sell the securities pledged or secured thereby pursuant
to this prospectus. The Selling Stockholders and any other persons participating in the sale or distribution of the securities will be
subject to applicable provisions of the Securities Act and the Exchange Act, and the rules and regulations thereunder, including, without
limitation, Regulation M. These provisions may restrict certain activities of, and limit the timing of purchases and sales of any of the
securities by, the Selling Stockholders or any other person, which limitations may affect the marketability of the securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The Selling Stockholders also
may transfer the shares of our securities in other circumstances, in which case the transferees, pledgees or other successors-in-interest
will be the selling beneficial owners for purposes of this prospectus.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">A Selling Stockholder that
is an entity may elect to make a pro rata in-kind distribution of securities to its members, partners or shareholders pursuant to the
registration statement of which this prospectus is part by delivering a prospectus. To the extent that such members, partners or shareholders
are not affiliates of ours, such members, partners or shareholders would thereby receive freely tradeable securities pursuant to the distribution
through a registration statement.</P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The Selling Stockholders and
any broker-dealers or agents that are involved in selling the securities may be deemed to be &#8220;underwriters&#8221; within the meaning
of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any
profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities
Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding, directly
or indirectly, with any person to distribute the securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The Company is required to
pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company has agreed to indemnify
the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">We agreed to keep this prospectus
effective until the earlier of the date on which (i) the securities may be resold by the Selling Stockholders without registration and
without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for the Company to be in compliance
with the current public information under Rule 144 under the Securities Act or any other rule of similar effect or (ii) all of the securities
have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect. The resale securities
will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in
certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable
state or an exemption from the registration or qualification requirement is available and is complied with.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">Under applicable rules and
regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market
making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement
of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the Exchange Act and the rules
and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the common stock by the Selling
Stockholders or any other person. We will make copies of this prospectus available to the Selling Stockholders and have informed them
of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule
172 under the Securities Act).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">&nbsp;</P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-transform: uppercase; text-align: right"><FONT STYLE="text-transform: none">Annex</FONT>
b</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-transform: uppercase; text-align: center">SELLING STOCKHOLDERS</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The common stock being offered
by the selling stockholders are those [previously issued] [issuable to] the selling stockholders upon conversion of the preferred stock.
For additional information regarding the issuances of those shares of preferred stock, see &#8220;Private Placement of Preferred Shares&#8221;
above. We are registering the shares of common stock in order to permit the selling stockholders to offer the shares for resale from time
to time. Except for the ownership of the shares of preferred stock and common stock and as otherwise set forth in this prospectus, the
selling stockholders have not had any material relationship with us within the past three years.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The table below lists the
selling stockholders and other information regarding the beneficial ownership of the shares of common stock by each of the selling stockholders.
The second column lists the number of shares of common stock beneficially owned by each selling stockholder, based on its ownership of
the shares of preferred stock, common stock and warrants, as of ________________, 2023, assuming conversion of the preferred stock and
exercise of the warrants held by the selling stockholders on that date, without regard to any limitations on conversions or exercises.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The third column lists the
shares of common stock being offered by this prospectus by the selling stockholders.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">In accordance with the terms
of a registration rights agreement with the selling stockholders, this prospectus generally covers the resale of the maximum number of
shares of common stock issuable upon conversion of the preferred stock, determined as if the outstanding shares of preferred stock were
converted in full as of the trading day immediately preceding the date this registration statement was initially filed with the SEC as
of the trading day immediately preceding the applicable date of determination and subject to adjustment as provided in the registration
rights agreement, without regard to any limitations on the conversion of the preferred stock. The fourth column assumes the sale of all
of the shares offered by the selling stockholders pursuant to this prospectus.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">Under the terms of the Certificate
of Designation, a selling stockholder may not convert the preferred stock to the extent such conversion would cause such selling stockholder,
together with its affiliates and attribution parties, to beneficially own a number of shares of common stock which would exceed [4.99%][19.99%]
of our then outstanding common stock following such conversion, excluding for purposes of such determination shares of common stock issuable
upon conversion of the preferred stock which has not been converted. The number of shares in the second column does not reflect this limitation.
The selling stockholders may sell all, some or none of their shares in this offering. See &#8220;Plan of Distribution.&#8221;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 28%; text-align: center"><FONT STYLE="font-size: 10pt"><U>Name of Selling Stockholder</U></FONT></TD>
    <TD STYLE="width: 24%; text-align: center"><FONT STYLE="font-size: 10pt"><U>Number of shares of Common Stock Owned Prior to Offering</U></FONT></TD>
    <TD STYLE="width: 25%; text-align: center"><FONT STYLE="font-size: 10pt"><U>Maximum Number of shares of Common Stock to be Sold Pursuant to this Prospectus</U></FONT></TD>
    <TD STYLE="width: 23%; text-align: center"><FONT STYLE="font-size: 10pt"><U>Number of shares of Common Stock Owned After Offering</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Annex C</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-transform: uppercase; text-align: center">DUOS TECHNOLOGIES
GROUP, INC.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: center">Selling Stockholder Notice and Questionnaire</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The undersigned beneficial
owner of common stock (the &#8220;<U>Registrable Securities</U>&#8221;) of Duos Technologies Group, Inc., a Florida corporation (the &#8220;<U>Company</U>&#8221;),
understands that the Company has filed or intends to file with the Securities and Exchange Commission (the &#8220;<U>Commission</U>&#8221;)
a registration statement (the &#8220;<U>Registration Statement</U>&#8221;) for the registration and resale under Rule 415 of the Securities
Act of 1933, as amended (the &#8220;<U>Securities Act</U>&#8221;), of the Registrable Securities, in accordance with the terms of the
Registration Rights Agreement (the &#8220;<U>Registration Rights Agreement</U>&#8221;) to which this document is annexed. A copy of the
Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise
defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">Certain legal consequences
arise from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial
owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or
not being named as a selling stockholder in the Registration Statement and the related prospectus.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-transform: uppercase; text-align: center">NOTICE</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The undersigned beneficial
owner (the &#8220;<U>Selling Stockholder</U>&#8221;) of Registrable Securities hereby elects to include the Registrable Securities owned
by it in the Registration Statement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The undersigned hereby provides
the following information to the Company and represents and warrants that such information is accurate:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-transform: uppercase; text-align: center">QUESTIONNAIRE</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">1.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><B>Name.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>Full Legal Name of Selling Stockholder:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>Full Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities are held:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power
to vote or dispose of the securities covered by this Questionnaire):</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">2.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><B>Address for Notices to Selling Stockholder:</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="display: inline-block; width: 1in; float: left; white-space:nowrap">Telephone:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">Fax:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">Email:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">Contact</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">Person:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">3.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><B>Broker-Dealer Status:</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>Are you a broker-dealer?</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc 9pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">Yes </FONT><font STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT>
No <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>If &#8220;yes&#8221; to Section 3(a), did you receive your Registrable Securities as compensation for investment banking services
to the Company?</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc 9pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">Yes </FONT><font STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT>
No <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc">Note: If &#8220;no&#8221; to Section 3(b), the Commission&#8217;s
staff has indicated that you should be identified as an underwriter in the Registration Statement.</P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>Are you an affiliate of a broker-dealer?</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc 9pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">Yes </FONT><font STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT>
No <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>If you are an affiliate of a broker-dealer, do you certify that you purchased the Registrable Securities in the ordinary course
of business, and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly
or indirectly, with any person to distribute the Registrable Securities?</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc 9pc">Yes <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;
</FONT>No <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc">Note: If &#8220;no&#8221; to Section 3(d), the Commission&#8217;s
staff has indicated that you should be identified as an underwriter in the Registration Statement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">4.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><B>Beneficial Ownership of Securities of the Company Owned by the Selling Stockholder.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc"><I>Except as set forth below in this Item 4, the undersigned is not
the beneficial or registered owner of any securities of the Company other than the securities issuable pursuant to the Purchase Agreement.</I></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 5pc; text-align: justify; text-indent: 6pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT>Type and Amount of other securities beneficially owned by the Selling Stockholder:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">5.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">
</FONT><B>Relationships with the Company:</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc"><I>Except as set forth below, neither the undersigned nor any of
its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity securities of the undersigned) has
held any position or office or has had any other material relationship with the Company (or its predecessors or affiliates) during the
past three years.</I></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc">State any exceptions here:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">The undersigned agrees to
promptly notify the Company of any material inaccuracies or changes in the information provided herein that may occur subsequent to the
date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall not be required to notify
the Company of any changes to the number of securities held or owned by the undersigned or its affiliates.</P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR STYLE="font-size: 10pt"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">By signing below, the undersigned
consents to the disclosure of the information contained herein in its answers to Items 1 through 5 and the inclusion of such information
in the Registration Statement and the related prospectus and any amendments or supplements thereto. The undersigned understands that such
information will be relied upon by the Company in connection with the preparation or amendment of the Registration Statement and the related
prospectus and any amendments or supplements thereto.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc; text-align: justify; text-indent: 3pc">IN WITNESS WHEREOF the undersigned,
by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized
agent.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>Date:</TD>
    <TD COLSPAN="2">Beneficial Owner:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 61%">&nbsp;</TD>
    <TD STYLE="width: 12%">&nbsp;</TD>
    <TD STYLE="width: 27%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By: </TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name: </TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title: </TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 1pc"><B>PLEASE FAX A COPY (OR EMAIL A .PDF COPY) OF THE COMPLETED AND
EXECUTED NOTICE AND QUESTIONNAIRE TO:</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>duot-20230323.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +qsps7xRiXgOn8uMY3pMOaePybP9z5V9KYkhsWtxbVkqfyEplDyABiEWV/HW8VsH -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:DUOT="http://duostech.com/20230323" elementFormDefault="qualified" targetNamespace="http://duostech.com/20230323">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://duostech.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="duot-20230323_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="duot-20230323_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>duot-20230323_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>duot-20230323_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://duostech.com/role/Cover" xlink:href="duot-20230323.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://duostech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140415711591696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 23, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 23,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39227<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Duos Technologies Group, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001396536<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">65-0493217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7660 Centurion Parkway<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Jacksonville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">32256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(904)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">296-2807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock (par value $0.001 per share)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DUOT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>duot_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="duot-20230323.xsd" xlink:type="simple"/>
    <context id="From2023-03-23to2023-03-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001396536</identifier>
        </entity>
        <period>
            <startDate>2023-03-23</startDate>
            <endDate>2023-03-23</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-03-23to2023-03-23">0001396536</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-03-23to2023-03-23">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2023-03-23to2023-03-23">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="From2023-03-23to2023-03-23">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-03-23to2023-03-23">2023-03-23</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-03-23to2023-03-23">Duos Technologies Group, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-03-23to2023-03-23">FL</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-03-23to2023-03-23">001-39227</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-03-23to2023-03-23">65-0493217</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-03-23to2023-03-23">7660 Centurion Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-03-23to2023-03-23">Suite 1000</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-03-23to2023-03-23">Jacksonville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-03-23to2023-03-23">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-03-23to2023-03-23">32256</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-03-23to2023-03-23">(904)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-03-23to2023-03-23">296-2807</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-03-23to2023-03-23">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-03-23to2023-03-23">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-03-23to2023-03-23">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-03-23to2023-03-23">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-03-23to2023-03-23">Common Stock (par value $0.001 per share)</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-03-23to2023-03-23">DUOT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-03-23to2023-03-23">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-03-23to2023-03-23">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M;U\=;$^L2O/']9FR\/"?'RXY@\7@;H#?YTK9_8E[ U"\P!G\"U!+ P04
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M%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    "  $F'Q6!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    (  28?%9E'V7([0   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (  28?%:97)PC$ 8  )PG   3
M          "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
M!)A\5NZ87$J+!   S!$  !@              ("!# @  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    (  28?%:?H!OPL0(  .(,   -
M          "  <T,  !X;"]S='EL97,N>&UL4$L! A0#%     @ !)A\5I>*
MNQS     $P(   L              ( !J0\  %]R96QS+RYR96QS4$L! A0#
M%     @ !)A\5JK$(A8S 0  (@(   \              ( !DA   'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    (  28?%8D'INBK0   /@!   :
M      "  ?(1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   (  28?%9ED'F2&0$  ,\#   3              "  =<2  !;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  "$4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="duot_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://duostech.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="duot_8k.htm">duot_8k.htm</File>
    <File>duot-20230323.xsd</File>
    <File>duot-20230323_lab.xml</File>
    <File>duot-20230323_pre.xml</File>
    <File>duot_ex10z1.htm</File>
    <File>duot_ex10z2.htm</File>
    <File>duot_ex3z1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "duot_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 24
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "duot_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "duot-20230323_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "duot-20230323_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "duot-20230323.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "DUOT",
   "nsuri": "http://duostech.com/20230323",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "duot_8k.htm",
      "contextRef": "From2023-03-23to2023-03-23",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://duostech.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "duot_8k.htm",
      "contextRef": "From2023-03-23to2023-03-23",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://duostech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001553350-23-000210-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001553350-23-000210-xbrl.zip
M4$L#!!0    (  28?%;>.KA<*@,  *L+   1    9'5O="TR,#(S,#,R,RYX
M<V2U5=MRVC 0?6YG^@^J7SO&-DS:0""9-"0-4RB9D)#TJ2/L-6@0DB/) ?KU
ME7SA#@':^DG:/>?LKK0K5R\F(XI>04C"6<WR"JZ%@/D\(*Q?LQX[]F7GJM&P
MT,7YA_=(?]6/MHUN"-"@@NK<MQLLY&?H!QY!!7T#!@(K+LY0%]/86/@-H2#0
M%1]%%!1H1QJI@DX*WBE&MKV';A=8P,7C?6.F.U JDA7'&8_'!<9?\9B+H2SX
M?+2?8$=A%<N9FCMQLV\_>HM(?T;^]"(C^65R3Y[[;78:MWZ6HE8;P]VT=U?^
M?=(M?_\Y',@G->EUAR_A]#JB]>GE5W+]U'5NGTZ[\C8-697^ $88Z<M@LF:9
M^K+RQJ4"%WVGZ+J>\]QJ=A*<E0(K$TK8<!/<*Y?+3N+-H6O(24_07+KD&'</
M2Y@I:R_9@2=,*LS\)7R@9H1%\(F3.I>@9"/T<PHE.32 %9P$O]#GKXYV:'RQ
ME -C:?<QCF;@$,M>(IHYEL!2J'6@-JZ";#6-0&Z$IJXE0OVQ_3##!C&7"OR!
MZ<D$Y98,$BB,@*D;+D9U"'%,=2(O,:8D)!!82&'1!V6:3$;8AS?4\D[%C''=
MT'JJ,HNQ11'1':L-[ZKF:BN"4WC0.2.ST*.T6=LXG2NNGP,+D:!FI4NCHC43
MG0!"PD@2+)L9#]EF0F)3F%XFE*JS"EZ0B"4$;7:>K",!4O.2[)O:D!$SR!:2
MCZD?T\,X\U0V4C)#?DKS<\OGXAY"E,Q3Q=Q\S9+$O&A69AL("&N6/DIEY]?S
M2Y=6T)V10XSTCGE*3G[U-++ N006_IK*VKQK$1Z!4$2WY\)0IZD39>AW"V&0
MB2,MY/R+DBGN'5JRI@#]C[4VC?YBD=F ./,)R?:K4U35Y7*A$%L;QUVO8?J.
M-[F?2.V@F)V=\VQCLKVB7?(*$QG,,STDB?D)')9$SCLBB2UO\J;X<AO<+)(6
MVC?HEK=]9]"-' >HDKGEZ!06_P1_D4,B<U 22]<9*.$8"2/JVJYG%[WMZ;S%
M3/;RJ";P><R4F![2"(N4?'/<;<S_X?M=1(Y/+\'\UH\->T07K ??U )5)U73
MRS]02P,$%     @ !)A\5BT:84O^"@  @(8  !4   !D=6]T+3(P,C,P,S(S
M7VQA8BYX;6S-G5UOX[@5AN\+]#^P[DT+C.-Q@BV:[&07&4^R,#:;I+%GMNVB
M6- 2XPBAR8"2$_O?EY1$6:)X)"5%2<[%C$=\#_52?$Q27\>??MQM*'HA(DTX
M.Q]-CSZ.$&$1CQ.V/A]]78PO%K/Y?(32#+,84\[(^8CQT8\__/$/2/[Y]*?Q
M&%TEA,9GZ N/QG/VP+]'-WA#SM!/A!&!,RZ^1]\PW:HM_"JA1* 9WSQ3DA%9
M4.SX#'UW-/T[1N/Q@'J_$19S\?5^7M7[F&7/Z=ED\OKZ>L3X"W[EXBD]BOAF
M6(6+#&?;M*KMX^YC^:<(_T03]G2F_EKAE"!YO%AZMDN3\Y':;[G;UY,C+M:3
MXX\?IY-__G*]B![)!H\3IHY;1$8Z2M5BBYN>GIY.\E(M;2EW*T'U/DXFVDY5
MLRQ-.O0U)VEREN;VKGF$L[S;>W>#0(7ZWUC+QFK3>'H\/ID>[=)XI ]^?@0%
MI^2>/*"\F6?9_EFBE":*A%&Y[5&0![L9*L1$Q4\86>.,Q&I'IVI'T[^I'?VY
MW'R-5X2.D%)*/L!VG3;J*H,FKLW>$9'P^)*]S[49[<F^_.Z([']H0#W>>1.6
M/,/T7>;KD<YMWY#W'?%#G/LC+<=Y\KXC78O\O]C.VI;??'CMQY6JC=?R4\,B
MV65R B.Q-JFJZ!B!\SWD$T-9=U4[CQKU4C6:<]%NNYH9\SI3$AVM^<LD)HFL
M^_A$?1BK#WFSY7]^GW&Y$KA8I9G 4:9KRIMQ/K*43TQ+2GDAM"\LHI[&E8I)
MQ.74])R-:7$8B_ 'P3?6W9:MYI;"W^FJBB\.B]P%8+0A$R3E6Q&1-_5*W2UT
ME$I'&RH5:DE%V/CK8O1#KD&_:=5_/DT.M3CH:+D$VFX(RY:R1DL+FL6NNMEF
M2O=RO2R(3K88,OM82Y#2..[@"[GC6.W\BN*UQ;Y1[JJ+K;9T'S<*@^ADFR.S
MERL-4B)?W?R%I)%(GM5ROJL=#9GS3K>8;/5]31,6 FUC, DUK:>!_9ZL$S6U
M* OJ_):HC1W#&*!W/?1WVC;G JLX"&B&. 1GBWH0JJ(\<73!V!;3>_+,11<^
M39EK:FPF35CJFJ 8L1@#T2BTJ!![(N(?6WG&3@3=]T+14KKF K!JHF'(@J+#
M[@T$I)+[960I,$L3-8#U0M*6.C_= ,RV3CT,75"< .;@4Y)*[Y>4Q2.A5-T/
MP*Q_0+&)7=,"&S9Y:2N#(@:T!S*31Z R)!QL+E_4ZEPNDP8VMJ;W"4_+=A<_
ME3A8A$R' RG*PY"*\T12[39$#T,MI6MZ *LF-X8L*&+LWD!6"CG*]?XAN63Q
M($0JG1] #)MV/$I1@' TG?6A(=4^P;A*T@C3PLN5W)9V-,^B=0T(:->$I"4,
M"A3('0A+$:"9R4.\ O,O@L4P7&I*/["TK-I1J60!@F)ZZ\-$Z;U ,ML*T7 -
MSSBPU-E-V1ZSU?U90!<$*#WF6G=M"WD#%$\ST"7+DFROGJ>[V6Y61%@:UY:X
M8@,RIYDPRX-@ 3!E,E#(D-*A0NBEY_5= I:IAQC!YI@RMP38338I:&H"(L%J
M#*#AH,V?*?5"Q$R.3 +3.8O)[F>R!]O5TKEE K#9A,(0!42%W1F 12E&N1I)
MN1<P[D2RP6*_2**>J:(M=(L&9+3)AJD*" [ &D!'J4:+^<SG3++$NWDL04T>
MDN)Y\!Y*0+U;6'IL-YD!Q &AT^T0($@&H6:43Y#F+.+BF=<>=YCQK1P ]S,>
MPRN4GBBW4 UJ0A.MSI"  !OB$\"L$?JA>"8%<?4>3UX!4C5X(>XBCN6!2LM_
MKA-&IF#[K5JW='78;3)E$09$$NP.X*=4?M ?D(I!MRP4:([?T-1C_] <#X7F
M.&AHCM\#S?*5!P+-R1N:>N(?FI.AT)P$#<W)NZ"1'>]UK)G)C[=BR5]M#V>#
M2B_(M*U:@3G(PL.EY:T/%A6@UC,JQ"<F^<+J5MP)_I*P"%XR0W(OP "FK=08
MVO#0L1OLXZ=:$.LXKV--L2CO_9)HF9]1IFG2/L04FO @:1KK'5P*M4\D[GB:
M8?KOY+GS1-PN]H*'U; 5DH8R/%1L]OJ *6*0#/)Q8EWBJFYH6%\E,\K=O0)L
ML75X!;A6& 0$-D?M5X"+JR>%R'4W*T8%P<"(T"QVULD64U4?U\K"Z.*VH58/
MY]]KJ?'Q15;97>C=(V?P P)MB:N>ALSIWC;+@^AQP)39Z[D,Y3I/5^-5AHG4
M/GS7RIS-[*:=:B+7!4'TKNFF-4WK<L>]^:M(,KGG&=]LMJR\RV-[;A#0N>KE
M3INZQZVB('J_RYE)0JE%3;%C+!:<)E&2)6S]BSSY% FVM<HF<@4$;%#3T%8$
M@0)HR^3@($1:Z1B".T$4A$1V1/X2H$HL)&X?'JRS?9?8%13]AC4<L#((2'KM
MF;#(@'%4BT!%",IC_&(S3],M$6^"QQ+B"2'0/ !22Q\B3I#)7JB*0)]L+4BT
ME?/C?GJ\6B89M9U<MB7.YB3 7#4C&>5!L &8,EG(RQ!_0-/COZS^BG24X^Z_
MX4N!5?+8Q7ZSXA3(/F55N8*@PZ+FP"() @78ETG##4>E%!5:']FI&F8MS3'*
M70%@M:6[OE$81*?;'+6^_(V^]C3D7^ZB1VF* "\DV&6NAWZ;27/XKVN"0*##
M6.NDI)0BK?7Q0L)AREKW+P+6WA8!ZYY%P#K$1<!ZZ")@[6T1H'=;I B1X]+M
MBB9K#"0G[%2[AJ+#LLF'11H4*K _<,RH0M AQG5&RSS%F4K/+S;Y_J_D!TLK
M 9VSG)9=-JNDEC91$(QT.6NEM2R2SM7$2*E=<[&-DXS$A9FKA&$6)9A6Z1%M
M5\3[0YS1,M!\!4Z//@R&AIELX52$Z5R&5> AU:7K2^G% QB_$DI_9OR5+0A.
M.2-Q<2W%=J>H6^_VB9D>V\V'9@!Q$#@-<0@\.J."QD\J"NFP\DJ8%Y*^<;IE
M&1;YN^3"-C(!.K?D #:;Q!BB@$BQ.P,(J<2H4/MY0;O('E$MLHK?'0(;",D=
MOZ[=:=IX:]NJ#8B93H/0.]QESH_#VKB(\O2*94;4[T4D+^0+SG#I#6PO)'?]
M4F67:?-M2ILV((0Z#8+O3U8Q*E4,UDQY2QDC9G*IM>8=3XD;*O>)8UH6V[EC
M*DE >-A\=620$4AKO;"PV&!*/V_3A)$4GH@,E5L6K!:;+#0D ;%@\P6PD$N1
MUGIAX7)#Q%I.;S\)_IH]EOE9P;8!:K=L=%IN,F*5!L1*ES^ &1V"BAB=4M</
M/+M#0O$BRR+<4HO4,3:@68.9EBXD8"!S+5HHB=3UEAN>H25'7U."LD>"+LN?
MH:MG@B_J\?5+(U&D7H@H5N4LQL*&4)?8^:^.@(9;OSW24@8!4J\]^'=(J@BD
M0QQ3<RL9%O7SN-S$/",;\&V'_A!7! TUKSGJTP=!TT"3)E-Y6//D.@]$*M)G
M-J-Z<GMXB=<0.5X96PP:"^.:(@A&0%O0LKC^6P%^<N=M5S2)KBC'\%66AL9Q
MQKRV/2-9WD$0$ %M5U"*O%R(<J67_O^,V9/8/F?1_D[PB!#UE%5:C59]U]\&
M1KMEYDU-:M(T*#0@SM[B%R#P4 6JU?&A-F/YO)BG'AI7V=QX]+1XQ/( WFZS
M5,V@TAA\%;PSR/'MA0$-,&XR=$0$A-X F] -ASP2Y:$?4!&,:M&>SL_20Q9
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M3A$@_C>O!?^16Z0(W%/%9&)/Z0K _D@,I'Z&2=WC$)7WC4B@M+=2</Z##_O
M'A+J(=,QX46/AG:;#N.ND$.1H^2<M391L?]+B0)#WQ%#D:.DH346&P8^R)3:
MZTQP5/&KH<A1$M ZDPTSOQ&&F;6[Y_\Y2R<_;ISNLSY601FC))T^4RALRSL-
MPKA'&2&^ATHH8Y1<,V0.A?/ ^E&$CT1"5Q_I.@3Z2 HEC9)C!NVAH+Y7+"5J
M/69Q_:!QK(7"1LDLPP91:#^2U2BQKMB4%0\#ZZ%[BT#9HZ25(+LH(1B)6*J%
MW+E=/)"9/1[7 YD$A_2:@M!PH.2;+[".$I2K)+&X].;/+1.T&PI%I1S\C @O
M  &;KP1[[V78>W#L*'EHK<U7@KW_,NQ].':47+36)B;V@?UXIQ[ETO,$VBN&
M(D?)16LL8@+/SS1WZE[)9U;,B:JC?E0"BAXQ10V;1=WABY,\9&\OE5#>B.EJ
MM3E,SO=2&\+_8XNZ*\EJ/90Y8N(:,MKT#<8B[NZFA6\JT8$$RA<E5ZVTTS12
M%V%%B7_WW5= @:(DH%5F&N9Y*]VSC[D4P?NQQRHH5Y1,TF>JZ8'73236WD-_
MYVOP##:48?701L,8OREF; \&,DTSL;E'XWDJYI%"\:*D?T%[#:,>2\YB9IB8
M?;)7B(H17LVY2@>%C)+L^8TU3/A>41=I:B^[\WE<;J6!NIM.?2-O2 \ECI+K
MU1O%)3_2.J/JI?PK2D&C@)+V04TW/<[0.+/#WKK;FSRZ%3.>4>9(!66-DO+Y
M3#7,]K-\5,2MU1NOTXGD_N4AE4(H890$+V"M8<A[_:C&>R"!@D7)["KM((T)
M-ZMX3L2,^F<O5"NA@%$RO9 YM+%W!AI[9R\<>U$R/I\I)+;%W'![1-U-.)L1
M_TJR8 'P.AM,X@&K3:_?RY?\N%7<*LW[,;0?JK%[I%#@.$LD0_::1ITES-"D
MZ-*0"2)BFU)MU[5YLO/Z4M  X*RA!)I&N;W_C7+^4<BE&%.BI:!)<:D?NL/O
M+0*- N(SQ!J[*"'X*GEF*:E\(JCR' ,>*10YXK-#CSV<N9?%I.;MN:=X74>(
MN*\$%#SB0\2P6:3Y:8:Z/K-G^IX8LNEAB+^O!)0_X@/%L%FT^?-J8$\\,QE^
M9GX@A-)&G I;:0T%\C@EG%]GF@FJ@V/+@1 *&7'.:Z4U%,@W*54S.ZA]4')I
MYINUG2'8G@)0Z(@S6X-6<>"O?JPC+]:_!<E7J,%O)T#$[C6)]=J-.'83*8HS
MN4B(\E /Z:'<41=6^HTV3/[.S*G:O7[*.S.R>5MHTD-]*6@44-)5J&F<<^O.
M2O[@J75/!^6-F)A6&<-9,Y5-.(N'7)+@=?F>#,H7,0NML(6"]YJ()Y4M3+R^
M5S*FU#T^T=NC#9 0 2N A@0Q/WT1"IS;!3)-W6(B&3^-Y]:TOLM,_O92V[_@
M38-@.6AH,!=Q HPC707I'PN]:'*]?J!3JMPTA4>Z,M>VH:?P11&@.#0^J&\4
M F.H"--%Y\C7K=W@WD];?.-^N7>PVBW_ U!+ P04    "  $F'Q6M9':2$4;
M   'D@  "P   &1U;W1?.&LN:'1M[3UK=]JXMM]9B_^@RYDY*UD#Q+R2D*2<
ME1*2,LVK@?0Q7[*$+<"-L5W+!.BOOWOK 388DJ:0T\R9Z;0)MJ2]M5_:#TD<
M_6<\<,@#"[CMN6\RA;R1(<PU/<MV>V\RP[";V\_\IY9.'?5#: =M7?XFTP]#
M_V!G9S0:Y4>EO!?T=@K5:G5GC&TRLM'!.+%=T3 *.Y\OSEMFGPUHSG9Y2%V3
M33LYMGN_?'Q\.VW:"1P[UA2?:""EG86AX:TUZQ!MO+LC7\::AHE-*[)IJ)O:
MW"L7"WNK\) MIAW&R]H6$&>8(?O\]N9\UCQ,;C]KNA,&U.5=+QC0$'B((U5R
M1C%7W(T,DN/,C T$G_,][^'1<?9SI8(>9X$Y\9GBZP[E4XI;;([<&B:\@![%
MDFX8L.[287=WX*UN..2Y'J7^M'&7\HYHJ%[$1H5G@><PGMA:O(DU-[VA&P:3
M9(S5RU@''H2+0\/#6*.3VZOVM)4U]'C(S'[>] :BE5&"ED*Y&+7@)\'_CD([
M=%CM:$?^A+<#%E*"8^38MZ']\"93]]R0N6&N/?&!VJ;\]"83LG&X(W5P!_OM
MJ&&/_B^7(Z<V<ZP#TF+A(;FD W9 QM;XD#1/Q"]W1K%^=]OZO7AR=GQ\#3\0
M/9++/;5W:>\.IWH7G>*=GN(/C%,VIKV>T[VR?\= N@!_^+_A @4G=2!-0)VF
M:['Q>S:Y,\ "E:J[E=+NCXQ;C8Q[/&"N!7_#4X?V[KK4X>Q'ABI$AJH/@P '
MLKE)G2^,!@W7.J$ANY.OSUO&^,(VOE]\>//F!T#LO@56GMP5[I3MD8/!HQ\9
MHWC7ZM. \;OBG3"U<A NGOW(.">(R[4:J[2 TM+!.YXU(3R<..Q-I@L2?D *
MAA^2MCV )I=L1&Z\ 76S\D$6$ CLKM ERW[0_2R;^PZ='!#7<YEX:8\/4"E8
M@-HF/MF6Q5RA>_@1&EX.!S"6*=5J'-Z@<3H-O &*8\XHY8JET)O]GB$NS!I
M,?L@4> RM9G$'>W$0*P':DP<,S4ACQL!M$Q8,[5<KE"$=2(1ZDZ,R(@$&'0&
M YF,RQ:X;AQPX1  -D2L\@=]L2B .0ESV@[DQ]S*J-<A6+XW&6X/?(=):Z=
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MVCX 9.9LT^Z<;;H648+.:20:J=)5L51]U^KVRF!5GANCRJ3EFXP]#@\L #6
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M[5Q/]_=FH+C#3[*670^35_0PS\LR5R-,_W99+N <P1YX $K(=/#WNJD?P!Y
M0Q&^5"Y7BV93EOJ0ZT]7@891P$\M+&S'70<A5''/0/-EN8/=0^L25@<7=76Y
MZ6"B%MD$=#A85U!\"AX*]!:?YY.!JR!OA./FN>HW6=? NR0BZ+423<NVJ:LI
MF KU#'Y).F+9@FS9='VYS Z\+8MK=@W?<0]U9(SANHWOJ8NR9BN'=E>S M,=
MVP$QC$LUA>,%<XT34;.H@NW[F4_S<YAZ&.Z(+)KR7U4 .>N,K+]B43KS]+)
M RYER#Y^>.2&"(/\'P\>9"^K<C'[1_:NN(#3<P9[N:Q!8\V.L@</!.[[[L6K
M_PJAN0=]L_I']B7"6/*+2=/#;,KO)K3#W.^>P9[] #/2PQ8 (0*:]?GQL]<G
MV?.3UZ_?';]X\>K-#__K;X_^1C^?O3M^KC_+)T7'/GKTZ#_QU=- :V9-&"%&
M_-N+P.B([)2P'3-T'?2WV?EF!:T=M\6D@N5[ \8\3\R;!F?CR+[T=WT+__(_
MZTFW^O:[OY^_0$ST%/\'1PC_A:E+S.*D+8L/#R8E;$?XPHJF_A8S^WMG[J-F
MZ%9CLA."$\6;YG<>'__M/\%9A(LUJ7+B03MOBQD_8NX]O#3D()ZCL)(;ZD4S
M7:-(%.MH@D!B^2NH>(0WP@F>E8L*Y";?(_AVL5HM0/ B?+ J6M(#>\;Z"&_8
MW\,O&6!KA8@"#@4/_$%U2(UXF [[?_057 <3F(3"74:K@K]VMIZ@ZK:BSAXO
MF[7 80>5M"3ZCC33V7; [FNT_T8"(1C)\ 2:^[D9> ?O=8QI@EPOX+W9YY:\
MH,Q771=;3'ZM0X7'Z.8X22>_PB37%S1)TLR?8#RPD&=],_TP=IWP(QT^$BFU
M.>XX0J_*[#\>/7STZ"A;H0*!R\I@%][SK%6 *M614FP@0;"I&CD.=+.:/RUA
MO^$N+N8]7O43 L*PB4KW T_EGV%#Z 1F)Z#AP6S@\1U1LL?Q4-&J\'Q58F3*
MU%PWZ\4L0ZVM7[ 5!4JV6']MB<TTH#:2<HFZ%C;6PR@SVS4#^.=L@C;K/EN
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MY"D,;OK9!U>5==*AD2W@+SEZ8MH+$.@KBCUV0=^;3*4AR/IZ"E<%1H:4XD]
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M+;4B@&PYPW&QOZ<D%WF&7H^;/\0=H[V'LZM.##Y-N5L)JG<E;C4N*<6.R^S
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MX&ZI2Y")%8/;!)_/05;CQ85@678\1V6/<Y(&I<5,2"][+YMY.@)\R^#ZZ)Y
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MS8^)!8<_[4F,S$:@QID!1L.EY8KHWRJ6&B+VZ8C1^7)B'S<>*[R4,+?8F,[
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M'SP@@=@C:Z'4T%*Q@C#(JIYCVF')E1=(*W5%$CS/D4U2NBW).Z>T]3?L=XR
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M,H[,- AE5RP$(J'BBHN>BY9Q\1ZDBY7-T"+S"9GWA+FV9;6<(-,"IV]AIN.
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MB6G,3 T\=>'P4T5O%YJV"<60%5S)VCF]1&^!1AG.2J6PS*JY4)$FL#$. QB
M8W#5P9=!N2AG-I'([4WQ"$[!(D?[]H!P_3E29.+,VBQ?8KWKLJ,GQ8.C+PY*
M#A,[^F+&/QTZW6+[Z2$EBNHJE3.)6+^Y5XA1DS4M1K[)>KHEUX<KYR"TNP@4
M8,XSTU>O)Q0&D<YN9CX4W@XN9I-0:JR$[.J@2<L6*E?J$"4P<T"(ZXT79#YA
MS_'S$1MPL-!1.>,-JVFBGO)R(WBI[*/##'"2A&Z^"?Y,3O@MW-Y&@I:UAD(J
MIR\A(GX1;E$ 9']O9/8/>)-03$WHKCGAL5+=#?ASX*$)CH=8#+RE?V=I&,UN
M ^VHL\R)J14I)@CDW&(AQC;^_MX$&9PRON<PQ]$-V<Y_-!&63RWZD](?>,\Z
ME@1@[C:%%]U5)IW*<"V1@,&CG#@_.%*4%DQ"C$F-52 ZXHD[3&VJ82X?YQM=
ME<-0"/9=D2_?P.2+Z@/2@M"-$KV0CP\G2XUF:'S&W;LS>FR_VYPU. MXM;]T
MN,);;P.QK:QBCW>\,UV$<PZ7\PVR8%&:P9FI*_.JGCZDK-U)VWQ@T+6AU82S
MJM(1]FI9^E(V^AWV<&JY1/W2C1EH<O?R]W*S<8K95=6Q:2N66X&A^MP7"FN?
MBL&/##I]+GPB[!<K:FH-_^M1 JEZDB+5^JU5B% ,^JHI6@J,#A@6)G&U>9+Z
MADYCZF_D,!72O F7"+;6IAT0AP;-!=\ILGZSDJO'#8+D!1QL)9PG,2"@^6P]
M%BSP6V?EEMCYDWOL?("=/[G'SN^Q\S_++;;>Z2WVKJVNT#)[IX*<K[)CL-67
M2K%48*)T,77A#%[4RF444?:)?Y%+LJ&^X_D>0<2I]'OR\#%E/(=D3:,5/5*E
M;AJT%+.12E[1G2=7C.\[QZ%X:<J5&R>WK!/F 1D)3F5D''5?ML"V$9"'%='O
MC+YUM>.P!J=8R)H.T4$F/&.40\C/0!ESWB 7RU8ME^4,?T-J=$]E_J9EM9(R
MBAL'-_L5SQ'^\#YWB1P;-JZFF]&#IMZNQ;)<QG!>ED5ME/+A$!5_//KFZ2,N
M"+(D;O"'^WMVW*SP:%Z%=;5S*@-,=8W4:4TJ?H JF-VFXR:*V)Y9:]1^Q CN
MRJZ_WG7FCQ>./D@S,#:$/C"2;V1 )(N*8E@&94-&\E$K'HRN;B22-1/3U/J[
MP;-Y9Q;]UQV3N/H ^9\00BZ9&>+4^"L"X>?+3=(UB:M'R%2RS-7C@PF7N7I\
M<.'P"@4Q]O>X]%!$7$6D) 39.AY9#W#BU:HAM>2BE&@MINSVWG'HFP<R.*C1
MH4;4#VD$([8TN\GL?E.]PPUW!+Y*\:@,LJM<HI2+>+6LEU8Y(!>RZ1W#0;9S
MH?'?A=SK@^C<>&8E<))^?_08'=+]Y98B8Q1"&5+ .*=TJ%J@N1J$S@4;Q3*4
M+'#+4"3U+^M&HC'-ZM@I,C<M0;RQMPT?6\@.)EH/OX%CAQO-8Z0-_=:99+XR
MK0Q&>N6-P7/2)%IG72G5>->]8I44M^;9SE(9ZC2 A3FN9K2X2GZXZ;,J_*F8
M5@YRK))RP/ #3'K;U-64K?\Y34C;K"]X>E^45+X$LRS/T8D?2EQQ=WN?R/X>
M96FQNXZKODG]ZWA-E<\5AFN\]S1');LHMG[>5;\;="'3'B FXKIPF,(\.+AA
M. -WYO+8[/3R./:)-+AVYR"U"0Q^Y^A2MKC5$]5&3?0Y[GCO*E4Z\8K4 #PB
MPGLAL:@SRKBQ59LT@*B1&L]<P;H3>GNGLL)!FY"D)2+RIL)3O,(C>Q &(P6E
M(R1.PV?S: C'H8<>7>%2.-L/>IT85TEX2T5[DSO-CG![CFC7:Y0LC*NWA2P/
M'6\P4S_/I8Y%LB7-U"2TE:DG6#OWDYBT8^/BZ_:OX2'?WYNO%V"Q+.1>J<+:
MY8TK5>[_+LD<?G*2>.--3%2#3CK*33?)(R4E= 1#V '37%OB_ S>N#."XM\[
M%10OG&>.Y8$4^$@!\P&O9XJ1Y6-Q:D-$'ZI#E*J"WZ"CH#EG5>]Y6:T3H> 2
M @T[/ 68Q^M?PD]F-@O''(I&*G2(UT(/7-V5"Q\Q9!WPJCF()L'5P?H*"=RX
M%C@95OZ7F2^_A22E7!@CK*<2Q.#XNN1N=LTT1+TG]:5%/;KQ^@O3?<:U,[2,
M'9UFNSX8V!_;;>Y$:D7P6[H0GMZ[$ 8NA*?W+H2_I OA8TIR1N$-$M],\HZI
M(L<B4X=W..;&M<[6VQ8\D.NM/)9 /)#%D1>24>ZX7+2_##+-7!)UWV:Z$NLX
M51-F(=6VI50O=K3&KG)C/:P\S'F1Z=+#INZP)9*F1\8+"U/?33R>IU"0XL)4
M6-B%K]CBJ0ILW;YX*HK6SM/TP=)WI:8@1]X&4XASJT'/!>V#$EFB:J.^='W9
M8+F5YL:)S6XUKUOK.4OIUEL6=([G_793GHW/N$M)PQJ@-U6OA3M"026),<39
M4YVA\0>+^NJ #E<5+G97$4VB\U99!8BJQFU7;O@\V0!X4'Y]V=0IQ>J,>< $
MT;DS&FM1[%1EA<L5P\4ON&S]6W3_P>;XHUR6F,KY.$\1(>1QV0"?@.3_E-19
M51,URJOF:&C^M/Z4NPV,<G0N>BSZ)KL(BN>2!Z! 32G957))\ 4\ZNM-\&PN
MIS(\J:;6G/H*T"Z5&7<*HYAH2K#NEH8+8%*1-WUGX)%%H&NU;I&FAP8@Y4=C
M+P-+"V77)I&5Q=BP2[@G[,@HMF.^B]P5O")Y8HKCX8 X%<9323J$P$WT",S*
MY4AESXW[11#Z\( KX^@X;7=&#$PFNTTAP8K6]50<P*P /C,QI&'M9A_,YFS6
MP8(D\R1R\0U?5%3^JA3Z-[D1U&,<Q]9)B#"3MGGRD*U!!*[V+A6SID=I-SJ2
MA@0FA6RW%'R/V5@E5X[69'0^O1($& 6/KXJ*YHFY&=30'ZG=X@+]9^6DMU0Z
MIHPM\JDZ71(OYCHS-7C-@X<9NV1(O2-NX+B^K_NN#,VK/FI7KVL3%MLMR>W-
M]5II8:8@P3<.#U! L> *)N(?ETAV1@DL29C_NQ^/+0A;\S07'SBS'F,$.6^"
M5[QH^VJZ7A0M*-SR1BK!R,"<^KEP"^7A]I5@Z9^9)"/9,I<4YS\45T6U<#5"
M>IN1Y"O\*LSOZI /,E?[YH)I]YU+Q^UHN]M5+),W*F=UCG7.104=)!V7LJ[D
M7N1UU8.5FDI*EX+=,ZU6-/QUY^4G=C?W%5"CC*-BPR\+R41BBW-A=UN!V9,@
M.&Z*-GEB1NKMDK.'GJ-\1#DFDW+3B.FF*3720:E>,"&$.C@,V<'8QNJKI7J7
MW-BD3K+VCZ-\4X<:^X#?BY(%Q$46)J72I5QHW<E '>!+&)5Q6=ZD2PUS#"1W
MMVDOBEJRCBC?5K9#"+-C9'"[7O5:>=.^M;^G@'E!Y1K:JIM5WDV$%DE=$D.3
ME[%AEEM<_9QNI???9R1:6+D;29U#]&O=$QY'+BNZRN4L(DK(/[VJ<6;+68I#
M<1#ZD M+:H+*),W_06'=O?@.A3>$O>);B$/"NA^ID&;;Z8?92Z4S-'I8;/);
MZC#_KDE$ 9.M1';S@U]9G;('#$?,>=A8-I@RK9O6[^-K]NO:A.)'G%!L\]:9
M\4W.A(^?CZJSD_=IK#S[X;?9P>:05O9B78B6C\3KLT;2B^WM9FO(&^](=+2B
MY:=7*4XLK%C"ES]Z<3@XO[OTK.(W%'L/+H))L2#O2'=9@LIY("L'7RC%_NZ;
M0T?4Y =)9*)FG-C5NKQH^DHF46NV\&+-V+?+B#BSR/$)5@]7#"-C)[9,O%"]
M__N0]ZX8789^"C<,D;ZX//OTAL (><-%V<526BY RE0;X<Z\;4S\%_> ]@#0
M_N(>T/Y+ MIW,B9^.MTMH4SQ:W:&Y9FZP#-:6%@H9/DB_8)Z!?J%I+5J02.+
MI=R6(N_W%=86OKS0LYK,1*30T0,J$B+X*"6:+4HA2WA?$X*$DX&7^5@%*8QB
M6):.[D#)X,VOYYCY?XG$*CU,+MQ5Z[:F4CA"I$H)T].%Y-L;X<XEW??W @4P
MJBXF@<EB3Y+_%XU<*B&"',SF9@\+=Q%+O+&AN$)/YC@6'&".TTPZ2X[996CB
MTE7),8$^+WM-2KA$!]XT1&^27<K.*CJD3%#KM6D^="8XQ6P%6*=?UL2^&=%1
M*Y^C]]?3\.=,GL/IV;#\)3-#"Y"A?W&3FNX_#=AV?[5::(ERIFX @V)=T\SS
M9\59X3HCX 0EU05S)O8OO$6&CB^G-M3]?6BJ9VX*-&_VO,UCQ1@M'=)\X*,P
MS3PG#C&D+MT9]&TVVS4(_X,039PQQDP[XF:"PP$ GO:.4FU&XH"8"8YMPS@<
MYLR"@?@#\$_*?=&9+N'K^OL"16-/<4V?PE< 6KYW%JA!&]I-8V,R .!< /R,
M2#X2H5THE"3/F.67&&/09RK+R"P+F'/1<'?'$TR0V"+[XM'1*"9^9_9_6>YT
M_[^4V^TYF+5KF)EW6KKVHR@^ZUL4^4Z@".QA*"X"XK75[0Y6 I. ?<;8\YC+
M:=V) VF^QM@DXC6O%\7U?+T08@T)P(2YNZCF5)@%]6G<LB$[G+[F\^"YK#==
M!*HQX"4#*@-LERD6OH.]244!,<Y!&7,.O1_7]T3OOY&F_*W/UP:6BZ-81\_)
MU[I\\*U=(917\NX+F%9X4C!^C>/$6WE-5>7X<D>R9!ZDAK+#7!)_@X;#:@BK
MIIEOQX8.2+/D)XGW8SP4CE"](=Z$C' @O<I#5:*&%5)A7ME#=G6H5-^SP7VN
M6 BSCZB> F^_?/[N^,Y(D_E\M^':0KT4I_2$[A#/MX5A@:3S;K-$J,]@B8@
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M=QC^C@04N-9/'QX]E<:PY  Y=20E3HN?FIM_J,X[/FE;<,$R KK-6W0?TN8
M#C!WQ!$$5[OCE<)W^0VN H$1O%W/,)"<:2$_Z$K*M,5"R1A'! /Y.T> M'T^
M'B!,IHP@O?!E9.B"[>]H>/QKCCC5_"ZHWFQQ)"3=0"S=@NC."^*J%Z%+2W"V
M5<$5!(02H5E1C5(.>'8U3NW)%D3*35P>)D&8>DR2(;R_YU.$86?CM&1GA1 6
MCTZ _29:<'AUDVSGH$+<B1('IM%,?A KX3MSQ)5A:YA]LL'PF(*+)V853)\8
M5C)T:&$Z%I,KX,=B\X!"EF9F71S;=SA!G$>U1LG\0+%%3*2_U>"]R\YYLD)=
MF$N';$LHV!@+5JJOR:=ID[H(+PH*DI12&;@GLG"DXM&UQ$B.,&;-\-R8*F\U
M,=A2EH2[@YEEU!/8<K#\TH<\B^EA9VRC.OMMIBQ]M\;9MT,K V/'2+1@C6WT
M=QH+"B>1BXYA3R[A+3) 6* 2AS2&.[55L^Z(*;NSV6%")>W2?#7G'7>TCT#,
M-8B*%WGX#8S!)G3D4 "!M@0CAQ,E@B!R%]!M:GXX?03Q.9I/KA[21<!95K"F
MX,\9$7^[ODNW0,R9L;=(P2R% CC<>4LN%S7%4",>:CR?%1;F3,WJ,#:\R%"9
M9RM7LF3^&Z 8/_^\:P(RH2_,?J)%8PH<UA/^Z3V-=%FX7,<1CB,IBQ#20B%%
M;UV..# H'XJ2(S M<ER2\58:\%)Q[E+3AA$S/2<O(C#F(Y1A7JK5VKM .%J1
M93U[W7QVU2"=5XIFX\W2NUP/LD4DZ\. :L(G*& WG$"XPRJ*&,J=1< 5;#F*
MA=Q$2_29B5(]]]E=5)](WNF$@7#P(4YUH@N]FK$1A*J+QJ0+[JC>^>AS6?0U
MI1>B0AEJOQ2.F&&;3N,#>H,/<,2(V$CN6CZ^$!ZBE)WF;V].H"UI)\,W7V#I
M&'+T8VSKN[:<EQ0A[.^IP?ANQ<8]UI'H"W=&J'SXL%.A\I9B=\A5*-[68T[X
MD<(_O]F3O@4II;P-7_S*%<02WG)3L\OI)3?[XT,.+T.0B8^]?WCV$$1!K45G
M9LNJ5B\9J^?[>S?-A/: VCIOJ=3O!@FX0/.AVM-W9<<M%CO=<31_IZ6MO_PC
MB%XN-N4(F,8893-'*U>B6LJ6)*\)%:=S!>DNI4U+ZL3A."RF3#R.9H%__<U7
MGO]5JCB<PF>0?.YY,RN9//7K+RUYZI"@D55M+,7,)3JX%O?0WD<?;-E]GFUS
ML%P>?K+%95QR^+]VT9]AX0&_S(Z/]F;Q(LZQ(%;V%@$[N4G\IAH>1B+@8V,=
MXC7^(ECC[ #?\,DWSWY\?FRKOSAMRA-,J]'O6-Q^H+B7!A$0Z>A+#N&%'88U
M]^#>Y.)>T;>BI\*B,S?/VRT=&U_=.S8&CHVO[AT;=]ZQ<:-4&98(-05MF^NZ
M,T#)%KJ(.?I X%["J<\.OOC/0X4O5&H9A(&)#UR,Q711="PTKAJ&"XQ>#T?_
M&IK</ @_\#CQA;Y!!XC@"D12H\5@\"LE%SU5UL-86(+ XU#;I)"+9-0?(,^%
M&1%1#9W]!8/D\P4?4P*M&"O4XGQDQY'YI)5A/GX&0BE/"7VI&;@KJF!=[U05
M_(FR4%\7A/HY^A@6!ZCZH2JGQ$"W*.;%+Q*;*2F)6G/,L UP5CMA?S%C<E6'
M"1OBO91(*4-,8FMY86;C@P]EN=*\<%_>*\4X\)P,E"GW7\R,_;V@:O:I:\!I
M(U\]BC1.WQ?.XUVX&:30N[56VTX5.PVJ8/2^>,:!YI@BV"ZDWUX-B5<*(\6Z
MH0Y4-^2^8ACG'=,4X--<L4G\ VSWKULZD&$6T 5.3N[S3BA*9-+,G+U7M),*
MF69(OEXUBZN8J&UH%Z;"19+#X6J?4HSZ%G=!*HJ[OX2[OB_K.\0@TS1_0&#B
M+VL8G*.!/[GRO/K_3"Q?P'6DR1Q4'@:]:GY/4Y:X'&\LVL!Y%U_ZO(O]O9B,
MR+HMW=5C[JT5?(JXV)JVRP/7"4:WHL.OC0 .J:.+%[1#.AB DQ\=<J;[BOE+
M,%[2.7Y+3_CDAL??X1+:)(Z(A!<[^OC1?\;7?PS'6(5#% O6#81B01"W:;%
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M!C& 1" [-B#69 6E$+AGCA@^R2@\;'88AG2&^AD)(RJSBJ%1'.U./TA@&Q4
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MF^@BM="J/G>667!9&MI6*B_$U*UT0:LZ%5X94AY,[%S2\SDRVY6D&O 2>ZK
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M<^YV2M]V[%1*A81?5(MUFHDQS>\?7Z=!<50*Q8=M.9-&]:%FW?N,BK2[6\.
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M7:_A?JEC2^0C^?C>O>>>>TZ6S&[%Z[<33><S(D5FB23G.8+.586#DP[$I7/
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M9'*!(\&/U^EE6B5YM%C"J&"[JCJJ8:F2IJRNHPL8.XQ[C[Y0+^$_]F/PI.'
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MIL.AVYXDJOZR^'7E K%6Y:Q .P*0C0=)GJ(P:HB/VL:9WX>(J:.]EG710TK
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ME[$U[>= 9>N&-O2=VD*/F3V@KL\'58RL>J1W3RS-N0G"^>TI5G8N,T/P>EB
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MI(TZ'M'4Q\LZHT4)>'P88, >SY:;B&+&M7E:AF.P$=T6,J.1LR;YY+7+U>^
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M9K_MQ=)P"KU=+ FV'0[F2$\.3B2RIZ5YNKC S#TO/FC>(W5.-UXY+@5J$6S
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M3Y!(QV9"6\"0"7@9,<0#G9<U.6:3/,GF=8S=H @[C*U_1?2@K,S6^9,JDIF
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MRA9[9(9'6!-XDHYBB]60YM0;%#&J/A76528]<FFUE$<KXD9VI5T3E8\3+'(
M5WE>,ML&-Y+J3&&%8@R/>;0_')RMF\V877*5M5NG39,[H#&@'3B4!SMF$H_0
M,L1- 7/,, A:.CC^IS&BY)7+0AU:?,H%W%VFE0(O+IWN1R#K^L;M$I[8_<>0
M;>OM[46QQRLV?0)ZIFHZ"JC99H7KVF(BHF$+&V.CI""I<I(0=UHZ]1K1FD0Z
M!Y^QY 34&@;)ME<9.@P^8Z:8 U$*21>+;($I76"Q=$$ -*HYGYO5G5BCJZB.
MAP/E+GA2K>?"A!TNE:6Z\@&^^Z&<KVZ1A(I/LR7%5&V":-.%GW:N" %UL'1%
M6DG7%3R9U"NF,=%X!RV-W.4FO,IDP'>/KZM6SFBZ#Q^,.C7+YBZ(CV<D44N-
MN%L5]B=[U8VU;JLTFU/-6)_,=+VU2INW$#:P=9S%&+<F2P&?0K=.<.3@O?O2
M[B*B<>PO"I=/B\6H!99]AQ0;6^R$R5"9!=DM(,:Y,?[",I1E(=J]A%*B'N^-
M1T) 8--^R-4)NX]8BHAQQ(P+K,$WQK!I\-,VEFK4I0G^-5@U2S'27GT[,9.R
M+0@$2*9+CY(EN::A"L [' 0$@ G!4&2"KQ7Q;#&L#]HP:<1<F^6&/9@Q;7)0
M)>>^Y\;BG>R\DZ(FH60BN:%Q;\ZBM#C#1'_%J\HKAJ.^PI(!(5@UG)!Y>HD@
M$H+E#2T&"4YL.$@O$YNF.R-/-JR;DI.WOL#0/2)BW!V4^#0P9JN.;5T\5VU-
M#"?UOR1XU"97^KRT9QWA6QLE'0[P.[$TJ41.N.1C2M^37*K81F%9\7GA00S<
M<,?7N'<)X>N!@^BP34($)/"&@E&VAAK4P\ ^@LR@ H\8TZHH#\$?!*&""SS-
M2\*'B7*KJH2A&GMG6*\CD7Y)P1@)I]OQG1H. I=*K+-. 8J]QOI<&'Y3RS;0
M8HESV?8U6G@H$,A::(.?C*"LRL>W=6JF:JU;[V="/@OC X4"6,K^\.T;%B;\
M76Z7YL@$=4Z=[?O8'4A8^G9K\U2\#*.?GOC5PPCDV%&#%;0)[\0X/7-'V<1#
M"28D(08BL)&5$P\&G\0FC!54V<Q)^#9%FA](!.7);K4O?6 U(Q!S"37?<QU"
M39(BVQTN$*T^18+6TI\1B5B'\[A/HD8!ZHUL#H<?-0DCVQ,^5.B0GH/VO]A'
MS12*[GKS=[$"%E@N;[@O&_/&P5_*'-]&]+>[9ZN#OV*;WD+T=Z6J6*T71I$)
M$5/N$AS9FX2&0S'?GOW<- /V<(?>=M#;PQUZ^SVCMP_O+/O5:C$7:&<4V5UA
M,$6,65+[*8.>K$,4*7.L#B9(Y% GFU74,191D" A&8.DX;#X'1 1;JOX_L>M
M%M__EM43\)"2(BV7]:[T_@;D:FB]&#ZU$]: MOHIB5!P@G)K%QU6NBV+T>^L
M,[/*8,!46;2N$' X4&7W)I70)EYS;X/([ZWM7S?.XPO28A,VBI$'T-@56)=L
M.N;)%=WVGN%H5)2:(='$;'UQD(A;BL,FH5)(&4#H;9*O[M.E1:8'W7!@JJWP
M\X(0@)N=-IB^:S+IG*4M#@8L#BA*CH;,T;9CL])@,%PY[7E+SKC2^YT9N\T2
M2M(++"%)JP**,NBYUYY)$U'CMMVWW='"F4[LT((KZ(43Q&SD <8N X8H]RBW
MB[(KZ6=727;I)Q)(E*_"XWY-W3KA%/#:C=V2?3="8[M5&&">O<_.SZ_'Q!E0
M>)F1]5/TK:D'*!G"!9@KE+9*5.(]290B?MY*PQ)]&PK#0L"W22J7KQEW)+(-
M SHE/L6_@= F"2P-:F+K8YK&G"A03&J&IN#SK^/*(H':LE.8U_>P"8>K&[MM
M7M1+%%+(W*))+VD(FB%4M>UX%-?S2TI,&/E)P:'#;[DF.0%Z7(M?B$6CC* ?
M$4*VDR)'DPZ MXX4D1-B29L0K?H:=F<]DPPA56>*E:L!X5/V-[F!#2H,9?1?
M.P46Q,@1E0N#'QCR);B#NTS=S83!*["\2J3M6L)FO7+L[7RE7US3M25^[W6L
M[K%FX/&U!SGGILB8%!5'[(8#VY:R18C0UT!+?OTQ(Z;'>@+V?D]-=Z2[E\0>
M+D*]0 C$Y*13MP34MTH3V*_JM&:H>GKN)]]Z;DE()#U^!40K'YAKK'4.,"$;
M>FE"[4E4-%'5+NQAG*1Q[@GA,JYR@?M:T2U.IZ-67Y-NVQ1NL+*]OBE1;]L4
M.424?SJQX'HMQ?&:DUNZ)[@J;@.!^6RQ:JM9(/F[O0(S<LGDBE2:4'+;6\PW
ML'17E.]&%FTW%'KD] IN^1]H!IK2T+,U%FP[K3WP6<.M'-.)%'1;;@%X#O-R
MRIZ[5^5#O#]4X$2#8?IIUXQZB@D2V/&N=AUVU:LE(4&]#Q/3"YLT8U/07#JX
M$A%4\0_;W*6X- BML9;@'8\/_D*1L+*R=Y "M>6RL3Q1?8+;,PXP98TC.:K7
M'B^.0^IY.>C^V.@L@^A^LG@&X\6,->ML8M>'<Q#,"QRD#%^8(E5&$W.X=QX.
MJT//@Y&N>ISFX^2[SU4F?9+:AA-LBV9A7>N7!V E>3::K(?756:*R6T! FD^
M(^EE5B[UH6Q,ERO7,6%EBT]G+S*=2]HNGN8/39<33M26@ M%>O&WMMV+:9KN
M?;>3^[<A$/YP!X1W@/"'.R#\>P;"*8T9";_/"VIM3#:(.+P][.GN@I;"JT?:
M8T7%,>:)^J1_5&5B&@?$G@Q2O:U90864$Q?(819=BV8_,<F4DM3"Z13I)RJ-
MODQ=U;)@8U[($SMRS%-/N/@A6V8TR"4;R?P+% XGJ_K/9;_:/$P,25*A7#[=
M)BRJM$9<*\1Q'KQ;]!!>/ZK^-PLHDW\:@75BE"3:(S'^X**\0G(*_K>U@5<8
M'B&[(S)F1]RV.Y ]C6K) @D$H1?!:<@JL,_MV\SK?9ZFMZ4?%5='$0E.4\DD
MR:;B9 \'4M^(_\1!MPZ8/G>^E2!YQF:8 <>_;07Y TORNB3**QX7V=EJ3U5A
M3PN7_5ZL[73+,""ZX*85BQB5AK=KXI-*S^?+0K>)D"8+N/S6O<)C8VE"V42Q
M=F7+>Z+J=]=7)^FD%84:I'\WVSK;ZK:>FG9J+'R/:M1+UHGRKI_I,2,4Q+CL
MW(M+('X"U\<9JQN78.&_P.UYPJ^B@(,B^;47U1&8];U2F:$^$& $)[\BVA/)
M".)_GE;G:372L1H\MRYNI>O -ZJF4")&*9,;^%,^CQ$.G8=-F>Y^?$U&[$9H
M"(4XGUZ*)>D^"(%P4JL5;Z4$[_]DT9?O]_:<;SLV<J(+&.SZ;1[C.%V.08EE
MW%0!\Z/(2$ZY]:;L#P'AIF2X**U8;$5I>YX:1Y(599DEP\!ZS*^6!#F#I\UM
M88:R^51P!E\@")O*H*3H'YMH."(88F;[E;:"M')B522GB_>[G#%3L%>'+!MC
MH^XC/Q;>>$]5P"J@P)M<@),+-_!'.AMHC!6?L4O&(T<^;MZPP+H-!S1)D_/L
MA3YD%3K6="?ZI:J1C6EE^Q.R=8AH+55!"V$I$G=]-Q?X8JL7^/@3-8^67.N7
MF,"85JB!PBI07(J4OB4)0E>E!=(FZONQT0SL,EQ=V 3TICQ/.675VM+&DD6[
M2!I362LW\:+NYBL3=)M<"(\>KU^OD7R+"9+"7-CL?VM264R:#3BIU.NE3:+*
M=J.F;3-N4K7*-K=C:66:6#">/6!4[;IM(L4Q9LF$@G/"5VK#DC@'+-ZH2K O
ML7=LK@O;)#RROYC.)"IBI*+ZDGLK=Z^F.( 1);_OG^Y'LQ1]"A"OQZ<GO[QE
M/NU9=/C@P0.0D/OG^^"<3I;XF'UXPLC9O7JH0HLE@23W3JEWH61>\(4NX4XQ
M 9:QF_S<8,[DI0WC,T>A(*: O;HH*8>6B&!;K\EJ>T9';G:T,1WBV822V#&-
M.Z6>O#"A[)Q:8S<B3;\749)M593\@NE#Q.OX)KER'2M- 0SE%4[D$P:_;JJE
MU&W02<CPVJ4%;9&]\526OL#N5>$^)YZ/9+/F-T8!OF/;[Y_;K<1;SI=2T./G
MU7$9%O_$]VDS3B&=N&\:EE(+E]GT.DD1:3^&4]HVS3-_M(/7._#ZHQV\_JW"
MZ__&3,L?MXL"$6TR)[%[-'NH3V*G-;#)#AAQ"7ME2)922;UX5RUE"%3DFY6;
MDP$ZQO GZ4&P/7-J5P=ZL>1BQ64A>A'1$PX ,Z.^I"0WAC=!C;9VPV4X20U8
M.X8BFD6/KB/JU[@4EGI=L4^0"/='+-XN0YPRH<0F!FB$2ZKI^&'23"1C_!1S
MFK%N'X=CZR-5*LTL*Z:*AQK-MB2GAI&D5I!AFKW&R87PWHCY1U&#,4)2#;.U
MV=](V6<BN<>M'@B2D+OI>8 #)"> DH3AJBR6_"AV/"0'D7>="RCQ4*C$&HO7
M2Z1$"C2%GLUZ8.X@D%UUHQ-@65J\RF233V![R(\9>V'XQ P=,R\V.JO?C365
M;U4"_<I,T,J$NI"?!! A-*)F'%>"S<TX?%4@R?NT)'.*;&OL%))*:7-/#KM<
M>0FRN=)F*F%FS,QRXG3SXK\S]VB^=3)_TP/^+7NI+@?'%'R_4P4DN#\?""1S
M9\)CV?0"  H4Q],A?0",?3T<4!L YP>U'N0L[O;38GE$(%7&]765K''4!*8K
M>*LVI/5."GKTOY2B]Q?4Z-S6HCE6=WE;Z<HN#$PZE8ZO.EC62!%O65MVV**4
M8@Q0NX1(22&U#*.5.B]E.DSY'J !4'=-X[B)X7S"KH<7V2(F'577)2@V=GD3
M[LT0(2I$=*(&<J6)4<XNK)*D:U5<@L.<#18_65"6Z,*5>GLCJ+R=P2DS 1$[
MXL(3#$]IO8*;'VM0EO1!B^&5#(Z;- W2D^.,B=J9!#93KYNWVIX2!;96SZ7[
MW$[UC*4OH_+NN(-#MZ=,NZ/G&VB_T2Z4 E'9&(M)-*(*O.D4S&ZC1ATI4*T3
MI#S)#UL02J(KA& <KO7!S%MY1^N/7 4E72TB6K%E9B U'!,#9R08\@A+ R$\
M\,*Y(GG,282CS-,5<9. Z-&[U+GMR!0AG3!,AP9NV-'Z9LPZK+'<,QQUG]A,
M"G>]37YJS0F'\G0CMCR-VJU4X\6=))SA+33^+J"/?P<#2P!ET,5UZ<L68Q8Z
M G^%+7/W$"*@I8//:+7-!^F6Y7J^QCAMKE))B51#QNZI9N(\UUC-)/@5[\;I
M]I^=+]*(*4/R5GMG^U8 N_7WGO^?P/^V^+I;=)_#+WAV\GSOU"+6[ZF^\36L
M=GD%=LC)\UMY\ZU.8ZL/6P/D/=X!>1T@[_$.R/M6@;R-J0E.WD9_G)R]/3X]
MC?[X]?C#\;O7L48'NFA 5OL9L>Q!:+?/SZK@)$B3UY.,RTOEL;O=U;O9WNT;
M+X;:5WL[4<\DBQJ.G_G;/=I4=<,NL<GE),G-LL'1O&<V'DZ%.B#VA]'+=SCT
MMW^[=WCO^:O?WYU&9\<O?WW[[LV[7TZ.3Z-?/KS[_7T<G;Q]N>\.UHW>VCK:
MCP_]D]KWN8,'FWWNX5\#)__/+\O:'][6>UZ SQR>8$LHC]M">0N#80&Z_4F?
MH0/P)5ZT^2Z*K/R:!.$7L+#^@?D+1V>_?SB.WA_] O?]W>OHUW=O7AU_.(U>
MOWOSYMT?__TM&Y"[%^Q>\._U@ALZ#3_NG(:.T_#CSFGX5IV&>\]]?:;5V=F[
MZ,/Q+R>G9Q^.SD[>O8T^G/SRZ]EI=/3+A^/CWX[?GN%GT?X=#OH-X%NYH&\I
MR&H"&T^B_^^S__?U61FP 1:O@2D>+9N+LH++.XWXYR6S9]U@ZE_C',T.AJ9W
MT_W\&N='YOEM3?"KG.&W\K UZONGG?KNJ.^?=NK[VU/?OEU,03U8BQ?/J<UR
M=/3LAQ=?(=H? BIMZ.+WY^_SA )KKU33:\Q3^#8FL@)QI:ANJ WX'A4C. JJ
MP&=JKRFMP*RUW_K;XPY=4*0;1\TUCX:^R16-PN#NV\9L\^0Z)FZ"X:#)YEP2
M"G_&U"T[MIW!F"W E-G$D2F/LY6:\&8U*N+]3"VAI<2>%U568//.W+81^BVI
M/J9^('\X8$ZY]-/D(BG.B2O(?*B1K\V2B6U)Y0BG:H_.CSYL,@;QU9?4K,0+
MMY]=I#7SE5MJ@P0Y!3]AN!6^6*3G99-1]@$\8$(TA*U>LL'^[DAP/FMBV0N_
MVHY&,)/2.(\U<::63*I<S(=3Q.5QA/0IWL]4>/#5,YAC0FVC9DU=6#ZP -V0
MBSF;;W@T#4>3QB9 # ?5,D]-[M\YI=UCX!TIQ9;Y>2(IA#;9I_5RUSM$"!CD
MC1^P@/#1X:.]\0C;A]H2(,6OUB(R\/D\:(BNA0;S^(C=V5I+$_C/L0TA_EIV
MT'!CFDT,+MY^=!3:<MX>#.+322[2-A74C.*P^"VN8ZJYP*SU;IC)DT"L9)56
M_./DU=FO?[M'ZNUS91KKYP<=[4PNXGI(.1!EH"^2ENU&*O8?=_+MO)2XT^OY
MN,Q!8L^SZ;1LGIJ,M];C M+WWG,PTK("<U3&5?DQK5!Y>RE%=(CU#S(M0OA+
M]Z<IB(2*#+L)9M<LI*"GJ@.6PVZK/G.K**>2Q?3*;2"R2,SNFB\XCRH@^:C1
M,DID[/Z,-]&0"B*/&N4H4_LGW1V.7D1#H-ICHYHP$YS52R+I=^JX[+;_]K;?
M7*J:RQG\/?>V1'8PR2VOKO]A:@A$)*E4(KO;I-O;)+#(C2&&;("N04M/,22;
M!EUJ5/.0W=[<X@5BFQ9,<V6G:MVV6^S;6VS#9:PM.[(/39X+6>947(',!Y@$
M,Z>RHZPQN<H>=^\XJ;/=!MWB!OG]E>L+6&7Q[&RW8FZ.&UUF)?LL0O I'DQT
M^NN[W8;<WH:@DZ4-;7.#/-UM=H>ZWUDM$G2IC>67F%X72))!1*V4P2[=KYU%
MB.TJ5)$<.?!80V+=O-UFW[YXQ-TSY,F8V>]=2FX3H&CM+M+I.=48JG/BVIZ:
M9R(JN)"*"6N,:$QEMY';V4C/X".<Q+5/Y!*$$*@I7%:F3BF.YBE>TIK/@X>P
M[#;N%BUUM#;&IJVXU*>04#1X$^X@R%QD\-FM^RUZ2+8"C;NE.G) CZ#<^4),
M-A+:@#71R[_NHI>=Z.5?=]'+;R]Z^1F-)H,FX3Q!VFHD*2;+L&YWAJ&8PL&C
M1WZE:/HIE?I6BI=X%()]T0\4G@<_/WQ(%)(F<-%J(*-[$\!7=.".0BRV/W6,
MC0!LTZN>*$/OI"T9)-;><?QO#'_%8F%LKE*E-!&J72RQ;3RS-A;7%L66(!(U
M;?_(\0K3LE>M('?AOJ:J9([>F:^S)<WEGLN":1+!>,-4)=,3)D&IO<1&4!B%
MNI,.G"]\-R,MSI-SH=WH=3&(*;:JR,"<62N5'9;:>2RE3#!;($2,-"?H9^Y'
MK5?BTZ1),B,!=6W9F[$+SI+:GUE>^."(]LJ*STYQW49(J:F'@;UMC;R)5/B[
M&2OZ>?.)D6M\71NR& <DQ8BDQU$:(/W$KRF>=$O_K0.,IK0VD3K>@L8YN=:F
MOO''\1TU<P8,!Q/843@&7@#'+5ZHF<?KD[<?COBJ'SYZ!"8%,[SY[]< OQI!
M0L%EKE3'OTW+*WP'#"/XDI/?[N,K[N0\GW1;B3//#/8UZ.8%4-B;8_PUAV.S
M(NX_9WA6%55MR#'C=[:\=WM)9F!Y%DBP@RPN3%Y@O#F,ZG"KP*A95H5<1;HW
M"J7I3L&69X,91;MH1X7'6.([-4NII,;65I[4' ZZ=SND*G@0BKP3GUBG+:Y8
M9'M((Z&NQF0'^I8=!7$HY"51/9JPOS\=OF(![,,L"P[0A+:\UZ_0!792:N]<
M,S[%H:GW<#A8NXF1WD-%#Z'13Q@ XL\HW=12\79+-@%[D;RJUY8"P7L[Y5FL
M>'M+*YDL"4,&H66.-))0.]MYVYJI<A!?@H7:>F_G,&![MYYN;MR0<885[BKO
M@-?_B[<AV\!\ZN:,N*P5HEI&82]NNQ4I='E+YK[JRP%B;H:L:A]Z9V+QA#RR
M::0S(PV@>5B8'*145+KR?'J;H=A5)!#2;"J$3DS36;+,&T'I903FXO*#^*F8
M 62?& >BCJ7]I)!;V%0J;SGC-3D[O-I3_;A&TJ;,"10NX4T-1)L2QLLEM/7.
M9!&:$Z,]Q![QD)[6&"D"CZW1I.%>RZ'M,J"VC&?# '%LT#N=3Q2%TXET"I%E
M-8D-K<EPX'A-8@WB_V:RNM2@Y%(32UF$U"X)12]!=!FAPH-ABBH*^</?$,&<
M12Y*31MH5)5+N8-%T;#8"AWK.2&\+49HN<F(3'>M>#C[38@$NWOS=4D4U$4L
M1/TTMXNDXG4#7=Y2\=+@)*LFRSERZ$U2-A]Y8<B LTD8G D7VQQ'=6>#V8U(
M.\0<.KQH/&)N=T&R'\P]'#9:S\(_XWH&J;MV%VL<S#(CBP$L+&+786HE-MUR
MN97LT;EF<[ 8W*FU'\H5O%90VM@"M](-O$K-YOH*T?9+;O<==@3M;:V9L11"
MY6W:UR!!H"_56OF526- S#7# U?7,#G-L$LRM<SB$U?'&SY#VBT8^6N<MQF<
MNOR:,Y5(X&GQ[2^*M]#H:4H(HZ='\Z:DPS_OD+\.\O?S#OG[]T7^F(:J#8JP
MCCWGUK FZI\5EV5^R1Q71@6T[!O)_78$?&.+Z]D<#Z%4Q X(:(.8-D%I4I"O
M&39\LJ[3SG%J!HQ."OXG=7'@I'H-%(G\F=HF>[V3%9./.L=3)R<A>TL-L-<V
M.L6J,6UMY\$EL'-GVL0P@A6$3 D %3J[D!K#'/ ,Z>OFJ4^JQQZQ:E9(:"?Q
M#9H\&[2\,2E0TP *Y1DWA8HCU]/0:W$HE'S2M5HZZEF!W7;8[\RR,FOA=\[&
MIA77UGJ=F;*.]-,B+6HRI:A?>Z=1,<)>T]0I*$\1=<U)K^G7!>&+3!^'F?73
M=%[ P%<@J,EY@OZT'6=>UC4N"U$BPI_39$ZL9&QNLU6;I1YQH?IQ+QQ_)WOS
M1ZH6XV.:+MH&SG#@NL=P[WDR99(JSQRC-C>*,O;M7C;J$49P=\O<[F9PL0W%
MH[>E)!G5;Y+*])&,0 XNV6?G[F;WR]E]$A#:_2"[!_FQ*3M* BC6[Y(C1*=R
MKH%G>X&%=%S!M$+^25@>'E'XUF()KO5$1(".O-B(37\@1GM1Z#J2.8N=;9+*
M]L>J8&%A954C.0W$J3X^N,2K@)[REH9D6EC0<NNQ& >%1D(=58W-Z+I+$[:8
M3?">3TTT@MDH60]TRW>4<TZVICY?>7+%JL>P<\:,>,N-I<_7L=8?_85=JITJ
M3<"U$[U6W9+\F?QK"5>-LK>(^S/);3V.&S46@=$]J<C1\0-V72EF'RJ-3_4!
M15_)!-XX-%#+V801X,&\$UGR>WN;+ A";I5%0=R9:V,G5H>9R)8L8@C*Z>ZC
MV3@XI<L<]&9J^JX9:)YA!_3E/Y*3YM"2$ $K&@?DUV YA1$)>G:"OJ24'I&5
MW(IO"FZXD(]J!">6SI#JV6C9<_<W(T75+%N'>86XE*NV(8BE5]P'JTQ1R1JT
MJC4K%PFY =#465U?(;2"' &(:3_Z(^6I$S8P*1=9$.10MT06OA=<I)NMS;>Y
MW9="U*,)I6!6TN(Z]#KX$+/1VHAE0I+4VWL"4HT$QR.L6I.-KSNA0!35P\'!
M3X>]LOIN$/B[<Z!NPHYP^&"',K11AL,'.Y3A<U&&,5H$GW^X&?$%&?,D6BY
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MEQX_K?"\')V_(:%M9.#GDGMKKL7SEV<@!^5UDZ1<IFKU#&@_!?:U-TZ!"'X
MCCBIYC"-)/LAF*:Y@F?3>%K]@,R@BO?*I8KB9UE^7:CE@Q\UQWX$VA".[;\!
M%[0W58LDA;=L6!+]MH3;\"SX;ED](%V51CR.ITF6T&GN!R_E=L"%7N:EW*]\
MRG?0LC X@46)M DL"B@S;GR]B(%S9K-^4KBE,_@6S\ 16M-IDB; #)R;-QS@
MY)"05\%;N#_$3Q5($A8>P,)A!V \_5<U!_D_FP/?C?&;10X7/D$*7,231.%-
MIZM<%7E:TJ.E_C,%YC%>R6>L$D3Y8I%G^@?# 0E')?,(\0Z5-<@#WEUD+77)
MK!.O'3*,JJCA Q[LO 8^]?3@&RTL@51JX+C(>T T]FK/GVGK4U@$\F/DJB7P
MW9:V,!PTR$>()BCC"IDT[ PL7-/_=SN3W3M>THLX@YM"W/+L.H,CFR?+X>"U
M88[.VIHW8^W2OOT"EJ;UJV.UZKDK$[4"!3>*83KXYX6J:M#P5B'_!12I_XT_
M9+4&R%X%TQC//@46-X/_/\_3!'\@VL [X#LD8H%0Z/;H 8QJ-%;9>]BYX0"4
MHBJI:A8Z\C@]A^2O]42\,D;J3W# (OZ]3@J^B:FZQH]8\,U 2RNR!>P&3$OQ
M28 N':7 ]>[X-(Z 2X!VTKPN?!;M;7/N/;*)T8=HKK(97CP]C%D/K.B_]O;
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M>1A!BUIB[(C$"GG*'+ &\UC#%K]KAJ91Q#Z75&E^T+5R@G&1]86@^,6%>Q3
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M'ZDT,J&#5!4JJPI*-VZYEM;0L=0?T;]4P/TE'!#4LF0:EQ0(MU#P)4(8\-(
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M8?U,3-.>@&%]+T&E,XV<:"@M7WO*8_=7OU :GS YP"'0:BPAT4MDY4N^!)*
MX[)SX1H1U;<A1!+F%,T1HK'Y.JR4E(&3B.Y8\CMBV<.NT/>-3(2^B>^&=,\L
M),T"?3;#DK%5-SK=!?89($8CX!@GH.B2<@J0>+78 >!4:6@V2\M-X\/@N]T>
MUR(KZ/V)8/T%:C>1H!]>U\X.-,LL<^M$E!)J-%<),T;7 _4Z-&098I&19)*N
MV$E Y%&;2@NX#1G8$F4)!X&#?DV<Z'89T<N"U4_$QQRH\S2'FV>^T6<*PC$J
MDJ4?G]G^G4?-O1YNOF[]T8B'IM*6?@.[]=A%9X.1M7>1^G\X?L%&HI3F"#29
MAF\M;"'X.O"V(O9(JC2I4N*EQ?H6BI0B-\0GR8R9J=6P*2&/9@$)IVBQ"]ZD
MR/,OY3?# 5:S2+"$Q<1:#HUT"/2QPA@:I PR($38DCR-=8\9TIR!Q/29L/.*
M'J(3T85ZG(?VL:W*;]8E014(.:$P[**&-:B 7P(;K^=#L<@E<+-==G@]?/GM
M/7QY#U_>PY=_7)C<+GII0GTNU8=8=XM;QEGI(I4N"M,VV3H4QZ0?E;"R!LM4
M<;]+U&LQQ7L6:P&BC1_=_T_ROM$S"_K/8DF231<ZH)F3NB)<#)@]*2H^>]=X
M$C%CUR>+W+PC:BJTU6TZD9[>5 F2->AD4Q^VF!;]4I\"91Q?.2$O9NL=%'CE
MV9#M VGJ\NP,IX@85Y56C9 M6TUAFQ2V_E)2'3O2W/;>F3.\0]8J9G_@"]@,
M($Q(6P0X=%RV(JA,2*$#")"VV>/?LX%UW&(5CBOWT 1X!QQ84LX=YV()SY=3
MJ]ZT!]:H&8YGT"^<1T\T#]-+FC;#[J9Q7-I=I,IP<(9[6-$6"!/+7U 7S#4^
M;0XZA)&G$A)2K0NOX\*ITFG!67F4QJI@G,S.'&M&Y AZS_0]!.5#\"O*!^J:
M-FEE19XET1;)8U])*/7D5D.I-Q0ZZ88A[#65>!7"?+>V_:74:P.\QN':$)R+
M9,/[JZV&%T*%T]&Q2J&$+'>5/]#919S,9%*>]!VW>->:J ^-*9C"7DT8VX"8
MIG]T:2O>"EL:#I K2*Q4, /-?1GT#FCPD.F&UTA1(7F'&SEU6-E:#>1OC/TR
MHB!;R<(:&QK!3M;7F5\^!S=I Q4%.QCJ@BW!T<")T_QZE[N"FZS5O%'.Q-8N
MY!/:F-#>G"-;4NY^*2D7X^P,?M2Q"4*0NI2[#: C7MDS@4U]XGKE8'?.K7B;
M'+\@AMNQ28=Z#]BO&&@O?I\/S9FNV2DI_%G$C2EC0'Y[VAR,1_8@N7#%F'/=
M2)N=')L/QQ)SXXC@BZX3,DD"%A4OO'LL4ZHS_0/I2F27X' 3BRNN;T7JIOEX
M#MS,<X79%IZH=:DTGV$ERE:A!4(OR:6C@="=#:U(U^*2';L,-/*'MMFM^]A5
M9C2*)_Y=G;;N-"GR@G)@"8G0F29-DGF%DY/)R:C=N9P:Z'ST! LFR0EYW0BW
M[H-$^(_)V+YL28S^PZ+UVW5190P6$Q3?AG&;WKV%:>KB0-T'J%.0$Q.72V'U
M.XE.]65O=YM"NVZ2+S#PM#<S/"ZQC=KZ/+_&$/VMRYBY\[488&9=!: #146L
M]\&9J*TE2W4N2^,]%3%+7*4K6UXR?3E<O4OTK=W][9$LPRDP5^GSGD3'*:Q%
M3IM'09&A%"DB:>HNQK>YMAW6 <C*FL;$PKING$^"+ESK?I#2HB;=HWE$!C;N
M,J'H40HD32I;D:.[F$/0+-+0I \TE%"%Y+" >*(#*:VCI,'!X+8M5:%FH&3/
M-2U^$I-AJR*3Z['/[^ZQSWOL\\MK:T4E2]N&(%EM60XWTHLVN\+WK,0)@)4K
MV9["<J$JLH:+QZZY>+'$M(<4,^$R<V4<1&P=84X<J%:*!&<5 [-BT:[&^57L
MB@Q3M>IVE8K U2E>HDK:IPT%K PEF9F<!J.L M_MJ_6ZU]LP#Y1:!2:!YLTL
M*6<8M_]IRR%=::T+'U_D947A_#8OTS0(>D:V0E^4COLD1^ D$2N>&3J_0"+D
M&!@%DE!'>VGW."L!IEL@R2X6QB$K^PH&IUP]'KP&<HMPW!ST>D[DZ8J[*_#A
MUM.2Z8"E\4G:=#^)'S50-4P;(B<HB9*M3"XOE>F==HWJ7 NLZ%-@E2!!)5D+
MTHB"UV#V*E$!&F1I.XW9]"63^*?KO)&TI"]A+EV>N;4!3D("@QS=A9VC&]?5
MC"@PI<?QZ)HUR393<]>%A;O<"]QXYFKA!4BMM>-")RIK/9#D:W0F%7FS?5HF
M B=S#I<J60\UEOV-MN5:E7)M)%]O.+ @SA8 GM]+%3A-Q38B;/33_7_^\^\$
MW!J/O?9\>['77ETU6]?* .=KXEVW*N/D&0:/_HFS,JQXFX@:"FTR^^CEQ/>3
MCQ<;?'-4IS^T:1ZG_1E=^\&A62F-VIMK%=*U-T6&R?OA%!S></(@>W3$>[?T
M<:=&L8QK?&YM1]8FR,\IY3T<(%H83THYV9L<;/")SU7;VITHW3JOHWNF#J+(
M2,CZ?;8%LI*L9@\E[#P66CC4/CASR")^-^TN65KB)[/U JS/Z]M'($?08\+;
MQ#R'Z8QJUVW*>.,IYQEN-,ZU&6W/X5=B"&NZONS>"VMEN552P3#3@2()Z&TD
MOL5MJ715;AO:0QY'C"TF<XYD&3J/JE4S_Z3S ,B/4% #SL:,=*\_#09*Q_#A
MP!.[DUCO,(7GXNRQ6(!.-"&:0P@,+\BFDVN!?LQ7%^I]')A>BWAB2]D4,+BS
M&,%VJ2F-]0<*?6E-7#;66G>N 9U5ZMKT<[_80AO.:AZ3.7=E._(A0*1K2?:&
M<7TE?K?X5OUN)YI'G3L0A0[$JY"L#-<#^O3BZZWR4Q5 $Q2XWQ2^&@W120.!
MTX(8V([T& Y9@VL^K+,\V.G>$\IG9/MZC'"-$BFL6)=RO:::*3J.=F)1LS6B
MN3_2T('T-RH@NIJK51K#M2WWS-D=P1W!0<QSS<9]^)P35]S_H+BYG")A_(N.
M[GX2]L@B-7@4/GUR$#[]_FE?$;*/ZQ "AN)-6X1T2N]M.X2(D[))+!*EV=AZ
MY'UOU(=D42\ZZBU[.]==0E\U7<G-8?U>1MC3-N&T(GV=W.+7.Q_8&+8QX)VE
ML!LH];J"V.M'Y(B-#65-_4O25L^W#,+\_AZ(O <BOX(@S+OO__#=[?9_B OD
M3,&AS12Y;P2Q[>8QJSRV?3@SS3XO2#SJ4C!M^]PMA@+SIJ9YZXQ(;!%O[5G"
M4<%,IZJ'#1$<Y*[Y@]8!-:/WVJLTV[HZX:%]0&3_-Y)SSO+=^VKT>YV LDC9
M1PQ'LJ-?7>7)1-O9D[P>5Z$3RJ6C9S9K<&WA-!RTS?.0<VI7"T&DE;-5%!JQ
M9M]W!3\&#8D?*K>!W3 -"TM?I1A77+1U$X&5647"."N+*F(E'24UZ;3RY2A<
MN]N^'LEB@1GY13L$BOM&)5>[O(^E*53$N>'R;NHLR95NM ^^%VL)&X<5J66"
MG>-+G:G<A H\^Z&1KV*CM+W<%N6E]MB4'E@=9M'G;EW)M1"T:2C.P4]B*(%&
M&JNR+E:M99I)[_9"2E+(B+0UVD0I/.C.$P@N)W>4GBEV/+BQ%Z #R;)OW0\0
M%G)4^%8[9@_A^ [[M)FI4-,'BPBUW\-N<6H#0="T3NQL14UX;48[>CS[W8N;
MW BYB6W)OM6L[/<TL6;9+7U[V4?D&"9<VM(G]*]%\-UN5>P+VZ.%F_T&9W &
M&*JM95Z[P)B;B]K9(IS:!J+_E2L*.!*RQ>5GV+@"&1<Q,.ZMFZ9<*+!7!.6F
MO)F;XU<*E* *&=/U .F6&8R6513^'L DE,$_Y48XMKJ4L2C7-0QN5!Y^JR=C
M.R=[58>]]&,=*^/<+(S_I:CWT*(:C&KZ2#W'\_HO"QL&8^/K=O)D1"@"%QK1
M=8D38?&F\L:$8>^MV!N/XCI+$-:MFL#,36SAX<#TK<-E%1--A"Z2B8%$VO-G
M.V%IF= 71KFI_;O+HY"ODF0P_KQ<UZE3FI=BT5]0TC+#3XFV0\<7@6D,J84#
M6N>'Q4(3:G?#E1W\<04@:GD3'7:^18/KPI9Y-1$1'1/>.%LXF,U%<[I#*AM'
M;VMM.&T-$Z>!M?]F ;]@<:!5!$GF]DL42$Q[=3><</M&>LE'?1T7=1EG?UI4
M.X,E."]WA^HB=@2ZMC*D6G$82J^N>^\#_TT<,.C];CCH^J'5J^A*XQ:/XQ61
MIJ8 V0?V(G$&4K)@-DZ];JE&:67.3+JD\8EP52 Y%6<T[?O;\E3N&R!L);C?
M@OPZ1_EU[!J ++./Z\+T4.+.@^6-K-).?\($]2LN"# <B#6:K=K6:JL!*)4:
MX2:@.Y[D%J'C_(#\=!N96"C&%:&@4G[3L54\LWE3/'U7QU(N>U3JSD+-4-_0
M*A'X+?5C+"G.WAA\>E-@E"7Z][ .7%,_#6WO-BQ-A4K++.;"<&4TC[GVN/.Q
M,Y4V]+[K]R5T::+17-9K2&D4;]=?OI92F&?:Z&*NJ6!B?=9 [MNAS?^\1YO_
M,FCSIPVG_IP!L%WJP+%G^HKJ@VFK/?J/2$W),#;C20 IC)IXK0<^5A,W0%JG
M*KY>*FRG>CLC;J5\L\)V$^T[:"G?T[7*=^L\>E1KC%YS=.MVH-ZG4ZWM"4MD
M5 ?-?#:%VGWM%Z-.>Y-"2[BI3(M2V:=3KT&9NU3JQNO:"C6=&ON(.>FS]=1F
M=9KGVJB1\-':-:7=M-3KFQW25Z-=WVY._,LZFRBJ%B(E%5C-LAT!_IC;)^P*
MGP^E%0"B#43N^D_2MK!L$S;/X?AUR6]R8R\8.V6E?!&3OT+*(:/V8S#=IEI/
M,3;T.N+N7BU?3'M;-\^@,4UW"H@=A'!^I!H20%\BKILF$1:&05+''CJL[^K2
M)2'+DI5&2XP]0=4F]$64XJK871JV4P*9I;ZM8VO8/5.@O!<2!]ZU==J- ]/6
M:W-7%EJ(,9_2+"G.CU+!I[S+L4X5X4]V=+IA=T:!O\N[G/3)XMEO!L1"R)$\
M+7DC?:"DAP-"IWIVWK3@=8D)@YIVVC14UBQW %+*0M2E1U2$2<#64^?,Z9N#
MOQO"U!W,7#^';[F1MVIK@KHIW;=L+&29>3%3F31$%D<!6XKFLZZ8XT(J6BR6
M=5KFVIMDM[1]3JTQDM(Z-/!2-SK8.@<TV?)0V.'WQW<03LG=0F02]6+!6:G6
M\.45&^(WM97MU1S#I<ZP"(3KB]EH<@?^F= A^4?"=O,>W"8N/]AA#N_JZ$"O
MYOFUM&WFZN'N-P(VE+P/%$Q,E,MGOTV"U([U:6M78\\OW4!QOR1[X?U=HE<?
MQY):T1AKR_7C36EL$@7-VMC-<;O'89#QCQWF;K!#9KYR Q/7"$??V:%K1Y/>
M:?Q,-[! VJ#"<- N$"/>2 Y):':DY*XYI"H[!A<Q-3^SH]EYS;4__-P7C&4L
M8MUNCY[KV9+-%A1>4"]0/2^<O^-=G<NWU::)0WRWF7?5YXUFVC>AW41Y=$V:
ME9KRHCN'"@6N-#O$WF57G(KA/!FR$YB]AKKW _$;,')D\(8+[3 %XRE#R^#(
M_9D7_\HG3F?7I=OWG 9A="JP\>M;[1(2E6;P&S0\MQ1")_DT9S<<W!VQ2%Q,
M1Y*JL1/=7GR= 0+KPSX4QIC#VL7+3UYCB;[U$DK,B5,!/8<R3$,!<FR:2FL]
M%&+OLU\<#^6?"5-OQ->LI9=P.\CRT<$]9GF/67[QF&5OL45@T4L=#-]YH>'F
M";C0>_,R8L+87X,NH"1O :NA# IYFNNG@/2]TE'Q['U!FXEBZU';AMN:529H
MJ^>%%(JYSB["7"C)0Y[GM 93?6FMT4/X'>FCJ%%(#\@^]M"#=XWUZPT W)I#
M[SY66IGA"IP<D'D3R-9DZ*_E;,UJ1S:[#+M#D,U2X^SP)Z8@FYM-&FHA(9I#
M=V<AJQ(0^+?:Q'!E [$N@+19/7);G4Z#8VJ\*Z%#1A6F/98HF8SZDK"FP7]R
M-(/7(;"DL9=FZW2B2SNGSU:C<[(:J7$SMVZE;7$&%@RV7;R0EMU\(YF!O21^
MV759I5.OO_N\NY(XV;>WIK%B\Z 2SA.S.AS:F+Y.=F%>-:)7><H8RG/8XT7L
M%!, PK4-AVQ-D,Z2:MQ4A,BZ_[C[6HZM2;S]#C0D4FRLG2[E%HSQ0R@1II%*
M",58&E,95H8XEM1JS?EV.->=-%O*HXN;><%&E:LSRQ:IY;):[?;K@]Z!F>A)
M0AMI(Y>NXN7JL6MM*-/XS9T]48M!,QBP7L=8E&:<IMQJDR@:[8S-;B>4Z$NV
MIH_9F:*OW8=@HUS[RB82.3?T;@I+YUS?<IDS!-6EX[<BF[F"<VM1.U+P >QJ
M7 %?M5WJ[</AB$:N;(R)XZHQQG)9GW\^''RL/^ZF%L!VY"B6'(,N[OA+TA'$
M'<<E\)I3X)^8NCCF57VGL8-U+7LZH:!P;JH1:[:_U5M]W6W#<:Z\C+V>&89"
M+9L)RX1FM;:#"WD:_Z#MIP,,I7*TIAB>S!=)Y"YWG?7?#UP8F,^-P^S9CUT.
M?#=7K(\C=EY=X_[690%,P1N+G7B&YCH-J\UG6!"2^"-SDJ=*I0!A DE55PRH
M8E)OSM /MW=#?FU"7K0C>?,$.F3,&D'%QR$%=1PQZA5*HD]T2S9Z@MADK$RA
M\>:JY4 P,=O$NL94_9IU#?QRF5_'74B-4\]!)'6W=#9E7&\NGGUE3->$+A$B
MH@UN'2+&,Q *AT7E)[K@DQ<;SG$07XO#\G:+"1Q)T50;!'A(RJ+]U#U(HR+Y
MG11L8QED9E40"3[L?O;H(5C6Z#(T77E":N15S;UR75W%G=T7;PE1>I4^G<8R
MKH.) S84&UT2'^UE$ '%;XWV?40N4?>TMLRN?O3H'CSZRX!'?_7TZMMBK=-;
M9:VG7G$NIQS'U]1O[G8[!-F<=-S&)L#(\NJ7>9S%[?[D@D&"[# .!%>G]]MZ
M=XL9O[:5]$L!A7")_G+'.';K&(,%2U464?RQBD,F*P8#SC)JF8D]PS-2O;!I
M<$*>^^**<#Y=9ZM5)]+K$"3@JDW]=/(]26'SGE;!&%XRY1J=.@.:("J%T0_<
M+,7@?G:HKXI(;Y=*[44_1!#5)<*Q;B=E"@'L'+:B,(2T)%'"34_7-<8Z$B0(
MEH,CO4)(!DTIX\5K!,Z\V/P^ZBFL,.(R*Q"L83\N8MQ.HCQ'1(&]2,U5N\-?
M,/+KJ.]]IC\G?4\Y8V+M4"5@OX=JT^%L.[GJ/$VVS,?88W+,\ TKCI+(M"$?
MW<G1+/3?A:33[1Q+#1VI=65,3C>MN</B,<JCZ4"$8;'-UO)=\4:=>ZE;X[AQ
M>(4.T6M$#WFHK.)@CM#$TU'JC>GSM2$4CE;.H7!=OON- 4XZE*8KK,DIC,^A
M3)O#R1!4'FU'4E=Y6G.?MERZF<F?<'%@$R6B.TW@<,Q^HCN S8%Z:58_G:JD
M\XB;62PV@:4/<&<+A"L6JXJ?RJ=3:<L)>E\6K0+LD\+5H>@J-X&=&P6^6)/=
MG8 MVW@# 86TZTNHAK"3AJ= RI4,JB:30KJHZ7]2;+(M# CFH$U1YNLXSO/W
MW;N-;='!D,(DR6N0$*M@Y_'!+EJGP))@G F6/_&@*B?;6>+OT<WA5P=@>$#D
MIV[P'CK2%S%1ISB7E[:+53V<U ':7#][USDXK\Q!Z/'OT.&D80=WHXN63+U$
M!?*VV#=*0D1G\L$F;LIC\F!N@/V:&9>;I@Q;TY7)@!=XU;&3)J&BE=WF<+Q0
M^%TH<<&6B15-OH-1DQ\P=D."6ENE(S"J.<TIAE@PV];6<522'H8AP.VVLBMS
MC1)8.P)INT:B]),./MBH/B#WN!%]MFD3AX-M=[&K[R0PP[3FD_5:*,IU$8'
MA4[Q 5V:5+(-3+>]BK-\-'J)U*RF^B'NV.UXB6R2HP#M;D]'Q&SUS37.89Y/
M9T,>G*!,5Z^/84+&MJBF+.&_?.^DPFF)592!CA,L=PFZT9Z4C4^H@JQ&;=&C
MHC'W5L"VX_0:E[ ^59A./QYD*=!T@A5O5!;G=0D\F?S9[E9WE+SWC9K@B%#R
M*CBGFM]XUUXBRO[]WK_9+^P%''"#+I]BM=^Y84P=FB"J#9E?LFI40'1%W&#"
M:<4XY.,#[B%)Q?U1B5BP,USKK@*N2Q*/+F\]+_)ZQBMO\'+97:Y;!*QJ-HNM
M,2./QZ81%4*,?L_O#]AC!O?:=GAIH,<;8+C']S#</0SW%X'A;K?*X?>W:J._
M2<HH3E/FK??U#6\&;6C/4+8R77V9MSH%DI"7UYDH(*73;YG\^B2RC6KAQ;R4
MCH._G0$R'#2K+O2T4G4ZR.G&)$[;:D3_*.4!C1VJ Q'O:2NHE.XOZL;V4*B-
M'%,.W_>>5L%WWWY[$!S!"^"YG'I\O+]6,(&+&DX2^508_"_@^C"QJR1%U>QE
M"O;L1 5/'C_^YML0&X2@>,Z!K([F"..]!,LE0[!F.#@C,Q*4.L_T>A:HZ\7_
MG-1Y6<71?!^.)0QT:K/T5]Y;8ZHUUX BDU6ME4V1-NZY\<HTP6D$RME][PS
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M  !D=6]T7SAK+FAT;5!+ 0(4 Q0    (  28?%;[_Q #<(X  '#@ @ /
M          "  8 Q  !D=6]T7V5X,3!Z,2YH=&U02P$"% ,4    "  $F'Q6
MW C=$2Q6  "U] $ #P              @ $=P   9'5O=%]E>#$P>C(N:'1M
M4$L! A0#%     @ !)A\5KT?GDBL/@  *44!  X              ( !=A8!
E &1U;W1?97@S>C$N:'1M4$L%!@     '  < M $  $Y5 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
